<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0150">
    <title>129 Fungi Causing Eumycotic Mycetoma</title>
    <sect1 id="ch0150s0001">
      <title>129 Fungi Causing Eumycotic Mycetoma</title>
      <anchor id="ch0150s0001a0001"/>
      <anchor id="ch0150s0000a0001"/>
      <para id="ch0150s0000p0001" role="chapterAuthor">WENDY W. J. VAN DE SANDE</para>
      <para id="ch0150s0000p0002">Eumycetoma was recognized as a neglected tropical disease by the World Health Organization in 2016. It is a chronic, granulomatous, progressive subcutaneous fungal disease characterized by the production of large masses of fungal material called grains, which are discharged through sinus tracts. Eumycetoma is seen more frequently in tropical and subtropical regions and is rare in temperate countries, where it usually occurs among immigrants from the tropics. Several hyaline and dematiaceous fungi can cause eumycetoma, and their distributions are greatly affected by climate, especially rainfall, and by socioeconomic conditions.</para>
      <sect2 id="ch0150s0001s0001">
        <title>TAXONOMY AND DESCRIPTION OF THE AGENTS</title>
        <anchor id="ch0150s0001a0002"/>
        <anchor id="ch0150s0000a0002"/>
        <para id="ch0150s0000p0003">All fungi known to cause eumycetoma belong to the phylum Ascomycota. Although for many species no ascus-producing state is known (<link linkend="ch0150s0000li0001">1</link>), their phylogenetic affiliation has been proven by DNA sequencing. Ordinal relationships are hypothesized on the basis of ribosomal small subunit (<link linkend="ch0150s0000li0001">1</link>) and internal transcribed spacer (ITS) DNA sequences (<link linkend="ch0150s0000li0002">2</link>) (<anchor id="ch0150s0000a0003"/><link linkend="ch0150s0000a0008">Table 1</link>; see also listing by order below). The etiologic agents described in this chapter are species that are isolated most commonly from human or lower-animal eumycetoma. For species that are implicated as rare causative agents of eumycetoma but are more common in other conditions, please refer to the corresponding chapters in this <emphasis>Manual</emphasis>.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0002">
      <title>Order Sordariales</title>
      <anchor id="ch0150s0002a0001"/>
      <anchor id="ch0150s0000a0004"/>
      <sect2 id="ch0150s0002s0001">
        <title>Madurella Species</title>
        <anchor id="ch0150s0002a0002"/>
        <anchor id="ch0150s0000a0005"/>
        <para id="ch0150s0000p0004"><emphasis>Madurella mycetomatis</emphasis> is the most common fungal causative agent of eumycetoma (<link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0004">4</link>) (<anchor id="ch0150s0000a0006"/><link linkend="ch0150s0000a0019">Fig. 1A</link>,<link linkend="ch0150s0000a0006"> B</link>, and <link linkend="ch0150s0000a0006">C</link>). It is common in the arid climatic zone of Africa (Sudan, Mali, and Djibouti), and it is occasionally encountered in the Middle East and India. The taxonomy of <emphasis>M. mycetomatis</emphasis> was proved by a number of phylogenetic studies in which DNA sequences of the mitochondrial genome, the ribosomal DNA (rDNA) ITS, the beta-tubulin gene (<emphasis>BT2</emphasis>), and the RNA polymerase II subunit gene (<emphasis>RPB2</emphasis>) were determined (<link linkend="ch0150s0000li0001">1</link>, <link linkend="ch0150s0000li0005">5</link>, <link linkend="ch0150s0000li0006">6</link>). The complete genome (GenBank accession number LCTW00000000) has been sequenced for Sudanese isolate Mm55, which has been deposited in the CBS-KNAW fungal collection of the Westerdijk Fungal Biodiversity Institute under the number CBS 131320 (<link linkend="ch0150s0000li0007">7</link>). Three additional genome sequences were sequenced for Sudanese isolates NMM13 (GenBank accession number WOGW00000000), NMM15 (WOGY00000000), and NMM18 (GenBank accession number WOGX00000000) (<link linkend="ch0150s0000li0008">8</link>).</para>
        <para id="ch0150s0000p0005">Based on the ITS,<emphasis>BT2,</emphasis> and <emphasis>RPB2</emphasis> sequences, it appeared that several other species previously misidentified as <emphasis>M. mycetomatis</emphasis> belong to different <emphasis>Madurella</emphasis> species. These new <emphasis>Madurella</emphasis> species include <emphasis>Madurella pseudomycetomatis, M. tropicana</emphasis>, and <emphasis>M. fahalii</emphasis> (<link linkend="ch0150s0000li0005">5</link>, <link linkend="ch0150s0000li0009">9</link>). Of these species, <emphasis>M. fahalii</emphasis> seemed to be more resistant to antifungal agents (<link linkend="ch0150s0000li0005">5</link>). Since these species can be differentiated only on the basis of molecular identification, it is not clear how many of the previous reported eumycetoma cases attributed to <emphasis>M. mycetomatis</emphasis> might actually have been caused by a different <emphasis>Madurella</emphasis> species. In Sudan, it is likely that the majority of eumycetoma cases morphologically identified as <emphasis>M. mycetomatis</emphasis> are indeed caused by <emphasis>M. mycetomatis</emphasis>, as Ahmed et al. demonstrated with ITS sequencing that only 2 out of 67 <emphasis>M. mycetomatis</emphasis> suspected black-grain eumycetomata were caused by another <emphasis>Madurella</emphasis> species, namely, one by <emphasis>M. tropicana</emphasis> and one by <emphasis>M. fahalii</emphasis> (<link linkend="ch0150s0000li0010">10</link>). However, in Mexico, most <emphasis>M. mycetomatis</emphasis> suspected cases were due to <emphasis>M. pseudomycetomatis</emphasis> (<link linkend="ch0150s0000li0011">11</link>). Next to Mexico (<link linkend="ch0150s0000li0011">11</link>), <emphasis>M. pseudomycetomatis</emphasis> has been identified in Italy (<link linkend="ch0150s0000li0012">12</link>), Venezuela (<link linkend="ch0150s0000li0013">13</link>), Iran (<link linkend="ch0150s0000li0008">8</link>), and China (<link linkend="ch0150s0000li0009">9</link>). <emphasis>M. tropicana</emphasis> was identified in Sudan (<link linkend="ch0150s0000li0010">10</link>) and Indonesia (<link linkend="ch0150s0000li0005">5</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0003">
      <title>Order Pleosporales</title>
      <anchor id="ch0150s0003a0001"/>
      <anchor id="ch0150s0000a0007"/>
      <para role="_-HD-2-HD"><emphasis>Falciformispora senegalensis</emphasis> (Previously Known as <emphasis>Leptosphaeria senegalensis</emphasis>) and <emphasis>Falciformispora tompkinsii</emphasis> (Previously Known as <emphasis>L. tompkinsii</emphasis>)</para>
      <para id="ch0150s0000p0006">Based on the combined DNA sequence data set of the small ribosomal subunit (SSU), large ribosomal subunit (LSU),<emphasis>RPB2</emphasis>, and translation elongation factor 1-alpha (<emphasis>TEF1</emphasis>) genes, <emphasis>Leptosphaeria senegalensis</emphasis> and <emphasis>L. tompkinsii</emphasis> were found to cluster in the pleosporalean family Trematosphaeriaceae, with <emphasis>Falciformispora lignatilis</emphasis> as the closest relative. Therefore, <emphasis>L. senegalensis</emphasis> was renamed <emphasis>Falciformispora senegalensis</emphasis> and <emphasis>L. tompkinsii</emphasis> as <emphasis>F. tompkinsii</emphasis> (<link linkend="ch0150s0000li0014">14</link>). <emphasis>F. senegalensis</emphasis> is a dematiaceous filamentous fungus that produces cleistothecia containing large asci with eight ascospores; each of the ascospores is ellipsoidal, has four septa, and is surrounded by a slime sheath (<link linkend="ch0150s0000li0015">15</link>) (<link linkend="ch0150s0000a0019">Fig. 1D</link>, <link linkend="ch0150s0000a0006">E</link>, and <link linkend="ch0150s0000a0006">F</link>). <emphasis>F. senegalensis</emphasis> and the related species <emphasis>F. tompkinsii</emphasis> cause eumycetomata in the northern tropical portion of Africa, especially in Senegal and Mauritania, and in India (<link linkend="ch0150s0000li0016">16</link>–<link linkend="ch0150s0000li0019">19</link>).</para>
      <table id="ch0150s0000t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0150s0000a0008"/><link linkend="ch0150s0000a0003">TABLE 1</link></phrase></emphasis> Overview of species causing eumycotic eumycetoma
</title>
        
        <tgroup cols="8">
          <tbody>
            <row>
              <entry><phrase role="center">Order</phrase>
              </entry>
              <entry><phrase role="center">Species<superscript><emphasis><anchor id="ch0150s0000a0009"/><link linkend="ch0150s0000a0012">a</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center">No. of isolates<superscript><emphasis><anchor id="ch0150s0000a0010"/><link linkend="ch0150s0000a0013">b</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center">Prevalence<superscript><emphasis><anchor id="ch0150s0000a0011"/><link linkend="ch0150s0000a0014">c</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center">Color of grains</phrase>
              </entry>
              <entry><phrase role="center">Size of grains (mm)</phrase>
              </entry>
              <entry><phrase role="center">Geographic distribution</phrase>
              </entry>
              <entry><phrase role="center">Reference(s)</phrase>
              </entry>
            </row>
            <row>
              <entry>Sordariales</entry>
              <entry><emphasis>Madurella mycetomatis</emphasis>
              </entry>
              <entry>7,076</entry>
              <entry>C</entry>
              <entry>Black</entry>
              <entry>Up to 5.0 or more</entry>
              <entry>East Africa, Middle East, India</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0012">12</link>, <link linkend="ch0150s0000li0183">183</link>, <link linkend="ch0150s0000li0184">184</link></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Falciformispora senegalensis (syn. Leptosphaeria senegalensis)</emphasis>
              </entry>
              <entry>194</entry>
              <entry>O</entry>
              <entry>Black</entry>
              <entry>0.5–2.0</entry>
              <entry>West Africa, India</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0016">16</link>, <link linkend="ch0150s0000li0185">185</link></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Trematosphaeria grisea (syn. Madurella grisea)</emphasis>
              </entry>
              <entry>139</entry>
              <entry>O</entry>
              <entry>Black</entry>
              <entry>0.3–0.6</entry>
              <entry>South America, India</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0014">14</link>, <link linkend="ch0150s0000li0017">17</link>, <link linkend="ch0150s0000li0022">22</link>, <link linkend="ch0150s0000li0025">25</link>, <link linkend="ch0150s0000li0186">186</link>–<link linkend="ch0150s0000li0188">188</link>, <link linkend="ch0150s0000li0189">190</link>, <link linkend="ch0150s0000li0190">191</link></entry>
            </row>
            <row>
              <entry>Microascales</entry>
              <entry><emphasis>Scedosporium boydii</emphasis>
              </entry>
              <entry>96</entry>
              <entry>O</entry>
              <entry>White/white-yellow</entry>
              <entry>0.2–2.0</entry>
              <entry>Worldwide</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0038">38</link>–<link linkend="ch0150s0000li0040">40</link>, <link linkend="ch0150s0000li0077">77</link>, <link linkend="ch0150s0000li0191">192</link>–<link linkend="ch0150s0000li0196">197</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Medicopsis romeroi (syn. Pyrenochaeta romeroi)</emphasis>
              </entry>
              <entry>25</entry>
              <entry>O/R</entry>
              <entry>Black</entry>
              <entry>0.5–1.5</entry>
              <entry>Venezuela, Senegal, Somalia, India</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0014">14</link>, <link linkend="ch0150s0000li0028">28</link>–<link linkend="ch0150s0000li0030">30</link>, <link linkend="ch0150s0000li0077">77</link>, <link linkend="ch0150s0000li0190">191</link>, <link linkend="ch0150s0000li0196">197</link></entry>
            </row>
            <row>
              <entry>Sordariales</entry>
              <entry><emphasis>Amesia atrobrunnea (syn. Chaetomium atrobrunneum)</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry/>
              <entry>Sudan</entry>
              <entry><link linkend="ch0150s0000li0197">198</link>; <ulink url="ch0145#ch0145s0001">chapter 124</ulink></entry>
            </row>
            <row>
              <entry>Eurotiales</entry>
              <entry><emphasis>Aspergillus candidus</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White</entry>
              <entry>1.0–2.0</entry>
              <entry>India</entry>
              <entry><link linkend="ch0150s0000li0198">199</link>
              </entry>
            </row>
            <row>
              <entry>Eurotiales</entry>
              <entry><emphasis>Aspergillus flavus</emphasis>
              </entry>
              <entry>9</entry>
              <entry>R</entry>
              <entry>Green/white</entry>
              <entry/>
              <entry>Sudan, India, USA</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0012">12</link>, <link linkend="ch0150s0000li0199">200</link>–<link linkend="ch0150s0000li0201">202</link>; <ulink url="ch0144#ch0144s0001">chapter 123</ulink></entry>
            </row>
            <row>
              <entry>Eurotiales</entry>
              <entry><emphasis>Aspergillus fumigatus</emphasis>
              </entry>
              <entry>3</entry>
              <entry>R</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0003">3</link>; <ulink url="ch0144#ch0144s0001">chapter 123</ulink></entry>
            </row>
            <row>
              <entry>Eurotiales</entry>
              <entry><emphasis>Aspergillus nidulans</emphasis>
              </entry>
              <entry>5</entry>
              <entry>R</entry>
              <entry>White</entry>
              <entry>&lt;0.6</entry>
              <entry>Sudan</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0022">22</link>, <link linkend="ch0150s0000li0077">77</link>; <ulink url="ch0144#ch0144s0001">chapter 123</ulink></entry>
            </row>
            <row>
              <entry>Eurotiales</entry>
              <entry><emphasis>Aspergillus sydowii</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry/>
              <entry/>
              <entry>203</entry>
            </row>
            <row>
              <entry>Chaetothyriales</entry>
              <entry><emphasis>Cladophialophora bantiana</emphasis>
              </entry>
              <entry>2</entry>
              <entry>R</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0203">204</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Chaetothyriales</entry>
              <entry><emphasis>Cladophialophora mycetomatis</emphasis>
              </entry>
              <entry>1</entry>
              <entry>R</entry>
              <entry>Black</entry>
              <entry>0.5</entry>
              <entry/>
              <entry><link linkend="ch0150s0000li0204">205</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Corynespora cassiicola</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry>&lt;1.0</entry>
              <entry>Ethiopia</entry>
              <entry><link linkend="ch0150s0000li0077">77</link>, <link linkend="ch0150s0000li0205">206</link></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Curvularia geniculata</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry>0.5–1.0</entry>
              <entry>Worldwide</entry>
              <entry><link linkend="ch0150s0000li0206">207</link>, 208; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Curvularia lunata</emphasis>
              </entry>
              <entry>4</entry>
              <entry>R</entry>
              <entry>Black</entry>
              <entry>0.5–1.0</entry>
              <entry>Worldwide</entry>
              <entry><link linkend="ch0150s0000li0022">22</link>, <link linkend="ch0150s0000li0208">209</link>–<link linkend="ch0150s0000li0210">211</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Diaporthales</entry>
              <entry><emphasis>Diaporthe phaseolorum (syn. Phomopsis phaseoli)</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Yellow</entry>
              <entry/>
              <entry>Suriname</entry>
              <entry><link linkend="ch0150s0000li0211">212</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Emarellia grisea</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry>0.3–0.6</entry>
              <entry>India, Sri Lanka</entry>
              <entry><link linkend="ch0150s0000li0190">191</link>
              </entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Emarellia paragrisea</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry>0.3–0.6</entry>
              <entry>India, Sri Lanka</entry>
              <entry><link linkend="ch0150s0000li0190">191</link>
              </entry>
            </row>
            <row>
              <entry>Chaetothyriales</entry>
              <entry><emphasis>Exophiala dermatitidis</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Chaetothyriales</entry>
              <entry><emphasis>Exophiala jeanselmei</emphasis>
              </entry>
              <entry>10</entry>
              <entry>R</entry>
              <entry>Black</entry>
              <entry>0.5–1.0</entry>
              <entry>Worldwide</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0181">181</link>, <link linkend="ch0150s0000li0212">213</link>, <link linkend="ch0150s0000li0213">214</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Exserohilum rostratum</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Falciformispora tompkinsii (syn. Leptosphaeria tompkinsii)</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry>0.5–1.0</entry>
              <entry/>
              <entry><link linkend="ch0150s0000li0014">14</link>, <link linkend="ch0150s0000li0214">215</link></entry>
            </row>
            <row>
              <entry>Hypocreales</entry>
              <entry><emphasis>Fusarium falciforme (syn. Neocosmospora falciformis)</emphasis>
              </entry>
              <entry>4</entry>
              <entry>R</entry>
              <entry>White</entry>
              <entry>0.2–0.5</entry>
              <entry>Worldwide</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0075">75</link>, <link linkend="ch0150s0000li0215">216</link>–<link linkend="ch0150s0000li0218">219</link>; <ulink url="ch0145#ch0145s0001">chapter 124</ulink></entry>
            </row>
            <row>
              <entry>Hypocreales</entry>
              <entry><emphasis>Fusarium verticillioides</emphasis> (syn. <emphasis>Fusarium monoliforme</emphasis>)</entry>
              <entry/>
              <entry>R</entry>
              <entry>White</entry>
              <entry>0.5</entry>
              <entry>Italy</entry>
              <entry><link linkend="ch0150s0000li0182">182</link>, 220; <ulink url="ch0145#ch0145s0001">chapter 124</ulink></entry>
            </row>
            <row>
              <entry>Hypocreales</entry>
              <entry><emphasis>Fusarium oxysporum</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White</entry>
              <entry/>
              <entry>Mexico</entry>
              <entry><ulink url="ch0145#ch0145s0001">Chapter 124</ulink>
              </entry>
            </row>
            <row>
              <entry>Hypocreales</entry>
              <entry><emphasis>Fusarium solani (syn. Neocosmospora solani)</emphasis>
              </entry>
              <entry>7</entry>
              <entry>R</entry>
              <entry>White</entry>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0220">221</link>; <ulink url="ch0145#ch0145s0001">chapter 124</ulink></entry>
            </row>
            <row>
              <entry>Hypocreales</entry>
              <entry><emphasis>Fusarium chlamydosporum</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry/>
              <entry>Sudan</entry>
              <entry><link linkend="ch0150s0000li0221">222</link>; <ulink url="ch0145#ch0145s0001">chapter 124</ulink></entry>
            </row>
            <row>
              <entry>Saccharomycetales</entry>
              <entry><emphasis>Geotrichum candidum</emphasis>
              </entry>
              <entry>1</entry>
              <entry>R</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0003">3</link>; <ulink url="ch0142#ch0142s10001">chapter 121</ulink></entry>
            </row>
            <row>
              <entry>Hypocreales</entry>
              <entry><emphasis>Ilyonectria destructans (syn. Cylindrocarpon destructans)</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White</entry>
              <entry>0.5</entry>
              <entry>West Indies</entry>
              <entry><link linkend="ch0150s0000li0077">77</link>, <link linkend="ch0150s0000li0222">223</link></entry>
            </row>
            <row>
              <entry>Sordariales</entry>
              <entry><emphasis>Madurella fahalii</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry/>
              <entry>Sudan</entry>
              <entry>5</entry>
            </row>
            <row>
              <entry>Sordariales</entry>
              <entry><emphasis>Madurella pseudomycetomatis</emphasis>
              </entry>
              <entry>2</entry>
              <entry>R</entry>
              <entry>Black</entry>
              <entry/>
              <entry>Worldwide</entry>
              <entry><link linkend="ch0150s0000li0005">5</link>, <link linkend="ch0150s0000li0009">9</link>, <link linkend="ch0150s0000li0011">11</link>, <link linkend="ch0150s0000li0223">224</link></entry>
            </row>
            <row>
              <entry>Sordariales</entry>
              <entry><emphasis>Madurella tropicana</emphasis>
              </entry>
              <entry>1</entry>
              <entry>R</entry>
              <entry>Black</entry>
              <entry/>
              <entry>Indonesia, Sudan</entry>
              <entry><link linkend="ch0150s0000li0005">5</link>, <link linkend="ch0150s0000li0010">10</link></entry>
            </row>
            <row>
              <entry>Microascales</entry>
              <entry><emphasis>Microascus gracilis</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White</entry>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0224">225</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Onygenales</entry>
              <entry><emphasis>Microsporum audouini</emphasis>
              </entry>
              <entry>1</entry>
              <entry>R</entry>
              <entry>White</entry>
              <entry/>
              <entry/>
              <entry><ulink url="ch0148#ch0148s0001">Chapter 127</ulink>
              </entry>
            </row>
            <row>
              <entry>Onygenales</entry>
              <entry><emphasis>Microsporum canis</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0069">69</link>, <link linkend="ch0150s0000li0225">226</link>–<link linkend="ch0150s0000li0228">229</link>; <ulink url="ch0148#ch0148s0001">chapter 127</ulink></entry>
            </row>
            <row>
              <entry>Chaetothriales</entry>
              <entry><emphasis>Neocosomospora cyanescens (syn. Cylindrocarpon cyanescens)</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White</entry>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0229">230</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Botryosphaeriales</entry>
              <entry><emphasis>Neoscytalidium dimidiatum (syn. Scytalidium dimidiatum)</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Brown</entry>
              <entry>4.0</entry>
              <entry>Pakistan, India</entry>
              <entry><link linkend="ch0150s0000li0012">12</link>, 231; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Sordariales</entry>
              <entry><emphasis>Neotestudina rosatii</emphasis>
              </entry>
              <entry>4</entry>
              <entry>R</entry>
              <entry>White</entry>
              <entry>&lt;0.5–1.5</entry>
              <entry>Somalia</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0077">77</link></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Nigrograna mackinnonii (syn. Pyrenochaeta mackinnonii)</emphasis>
              </entry>
              <entry>8</entry>
              <entry>R</entry>
              <entry>Black</entry>
              <entry>0.3–1.0</entry>
              <entry>Central and South America</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0014">14</link>, <link linkend="ch0150s0000li0190">191</link></entry>
            </row>
            <row>
              <entry>Eurotiales</entry>
              <entry><emphasis>Paecilomyces variotii</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White</entry>
              <entry/>
              <entry>Brazil</entry>
              <entry><link linkend="ch0150s0000li0231">232</link>; <ulink url="ch0145#ch0145s0001">chapter 124</ulink></entry>
            </row>
            <row>
              <entry>Togniniales</entry>
              <entry><emphasis>Phaeoacremonium krajdenii</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White</entry>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0110">110</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Togniniales</entry>
              <entry><emphasis>Phaeoacremonium parasiticum</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White</entry>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0232">233</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Chaetothyriales</entry>
              <entry><emphasis>Phialophora verrucosa</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry/>
              <entry/>
              <entry><ulink url="ch0149#ch0149s0001">Chapter 128</ulink>
              </entry>
            </row>
            <row>
              <entry>Calosphaeriales</entry>
              <entry><emphasis>Pleurostoma ochraceum (syn. Pleurostomophora ochracea)</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Yellow</entry>
              <entry/>
              <entry>Sudan</entry>
              <entry><link linkend="ch0150s0000li0094">94</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Pleosporales</entry>
              <entry><emphasis>Pseudochaetosphaeronema larense</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>Black</entry>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry>Chaetothyriales</entry>
              <entry><emphasis>Rhinocladiella atrovirens</emphasis>
              </entry>
              <entry>2</entry>
              <entry>R</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0003">3</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Hysteriales</entry>
              <entry><emphasis>Rhytidhysteron rufulum</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0017">17</link>, <link linkend="ch0150s0000li0233">234</link></entry>
            </row>
            <row>
              <entry>Hypocreales</entry>
              <entry><emphasis>Sarocladium kiliense</emphasis> (syn. <emphasis>Acremonium kiliense</emphasis>)</entry>
              <entry>5</entry>
              <entry>R</entry>
              <entry>White-yellow</entry>
              <entry>&lt;1.5</entry>
              <entry>India, USA</entry>
              <entry><link linkend="ch0150s0000li0077">77</link>
              </entry>
            </row>
            <row>
              <entry>Microascales</entry>
              <entry><emphasis>Scedosporium apiospermum</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White/white-yellow</entry>
              <entry>0.2–2.0</entry>
              <entry>Worldwide</entry>
              <entry><link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0038">38</link>–<link linkend="ch0150s0000li0040">40</link>, <link linkend="ch0150s0000li0077">77</link>, <link linkend="ch0150s0000li0191">192</link>–<link linkend="ch0150s0000li0195">196</link>; <ulink url="ch0149#ch0149s0001">chapter 128</ulink></entry>
            </row>
            <row>
              <entry>Hypocreales</entry>
              <entry><emphasis>Xenoacremonium recifei (syn. Acremonium recifei)</emphasis>
              </entry>
              <entry/>
              <entry>R</entry>
              <entry>White-yellow</entry>
              <entry>&lt;1.5</entry>
              <entry>France, Brazil</entry>
              <entry><link linkend="ch0150s0000li0077">77</link>, <link linkend="ch0150s0000li0234">235</link></entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0150s0000a0012"/><link linkend="ch0150s0000a0009">a</link></emphasis></superscript>The top five most common causative agents are listed according to the number of cases. The more rarely encountered causative agents are listed in alphabetical order.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0150s0000a0013"/><link linkend="ch0150s0000a0010">b</link></emphasis></superscript>Numbers of isolates are from reference <link linkend="ch0150s0000li0004">4</link>. In that study, a meta-analysis of 17,607 mycetoma cases was performed. The species identification was unknown for 225 fungi. One should take into consideration that the species identification was based on histology and/or culturing. It is probable that molecular identification would yield different numbers of isolates for each species.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0150s0000a0014"/><link linkend="ch0150s0000a0011">c</link></emphasis></superscript>C, common (&gt;5% of the reported cases worldwide were caused by this species); O, occasional (caused 1 to 5%); R, rare (caused &lt;1%). Data according to references <link linkend="ch0150s0000li0003">3</link> and <link linkend="ch0150s0000li0004">4</link>.</para>
      <sect2 id="ch0150s0003s0001">
        <title>Trematosphaeria grisea (Previously Known as Madurella grisea)</title>
        <anchor id="ch0150s0003a0002"/>
        <anchor id="ch0150s0000a0015"/>
        <anchor id="ch0150s0000a0016"/>
        <anchor id="ch0150s0000a0017"/>
        <para id="ch0150s0000p0007">In 2004, it was demonstrated by molecular phylogeny and diagnostics that the members of the genus<emphasis>Madurella</emphasis> encompass a hidden diversity beyond the currently recognized species (<link linkend="ch0150s0000li0001">1</link>). Both an rRNA restriction fragment length polymorphism analysis and a species-specific ITS PCR were used for species distinction by Ahmed et al. (<link linkend="ch0150s0000li0020">20</link>, <link linkend="ch0150s0000li0021">21</link>). Based on the rDNA sequence, the taxonomic position of <emphasis>M. grisea</emphasis> was changed to the order Pleosporales, and therefore, it should no longer be considered a sister species to <emphasis>M. mycetomatis</emphasis>, which is a member of the Sordariales. In 2013, the name was officially changed to <emphasis>Trematosphaeria grisea</emphasis> (<link linkend="ch0150s0000li0009">9</link>). Based on the combined molecular data set of the SSU gene (18S rDNA), the LSU gene (28S rDNA), <emphasis>RPB2</emphasis>, and <emphasis>TEF1</emphasis>, it was demonstrated that <emphasis>M. grisea</emphasis> formed a well-supported clade with <emphasis>Trematosphaeria pertusa</emphasis> (<link linkend="ch0150s0000li0009">9</link>); hence the renaming to <emphasis>T. grisea. T. grisea</emphasis> has been reported to occur as an etiologic agent of black-grain eumycetoma in South America, India, Africa, and North and Central America (<link linkend="ch0150s0000li0022">22</link>–<link linkend="ch0150s0000li0025">25</link>), but older literature data need verification by sequencing (<link linkend="ch0150s0000li0017">17</link>). The fungus is a coelomycete, but conidial fruiting bodies may remain absent (<link linkend="ch0150s0000a0019">Fig. 1G</link>, <link linkend="ch0150s0000a0006">H</link>, and <link linkend="ch0150s0000a0006">I</link>). With strictly sterile cultures, molecular confirmation is required for identification, demonstrated by the finding that out of 31 fungal isolates deposited in either the National Collection of Pathogenic Fungi (NCPF, Bristol, United Kingdom) or the Institut Pasteur Culture Collection (UMIP, Paris, France) as <emphasis>M. grisea</emphasis>, 28 were in fact other pleosporalean agents of eumycetoma (<emphasis>Nigrograna mackinnonii</emphasis>, 8 isolates; <emphasis>Medicopsis romeroi</emphasis>, 10 isolates; <emphasis>Rhytidhysteron rufulum</emphasis>, 4 isolates; <emphasis>Emarellia grisea</emphasis>, 5 isolates; <emphasis>Emarellia paragrisea</emphasis>, 1 isolate) (<link linkend="ch0150s0000li0017">17</link>).</para>
      </sect2>
      <sect2 id="ch0150s0003s0002">
        <title>Medicopsis romeroi (Previously Known as Pyrenochaeta romeroi)</title>
        <anchor id="ch0150s0003a0003"/>
        <anchor id="ch0150s0000a0018"/>
        <para id="ch0150s0000p0008">Based on sequences of the 18S (small-subunit) rDNA and the 28S (large-subunit) rDNA, it has become clear that<emphasis>Pyrenochaeta romeroi</emphasis> is distantly related to the type species of <emphasis>Pyrenochaeta</emphasis> (<emphasis>Pyrenochaeta nobilis</emphasis>) (<link linkend="ch0150s0000li0026">26</link>). Therefore, <emphasis>P. romeroi</emphasis> was renamed as <emphasis>Medicopsis romeroi</emphasis> by de Gruyter et al. (<link linkend="ch0150s0000li0027">27</link>). <emphasis>M. romeroi</emphasis> is a coelomycetous anamorphic fungus. It might be misidentified as <emphasis>T. grisea</emphasis> when cultures lack pycnidia (<link linkend="ch0150s0000li0015">15</link>). Eumycetomata caused by <emphasis>M. romeroi</emphasis> have been reported from Somalia, Saudi Arabia, India, Pakistan, and South America (<link linkend="ch0150s0000li0017">17</link>, <link linkend="ch0150s0000li0028">28</link>–<link linkend="ch0150s0000li0030">30</link>). Colony appearance and microscopy of granules and fruiting bodies resemble those of <emphasis>T. grisea.</emphasis> This explains why at least 10 nonsporulating isolates of <emphasis>M. romeroi</emphasis> were misidentified as <emphasis>T. grisea</emphasis> in the past (<link linkend="ch0150s0000li0017">17</link>).</para>
        <figure id="ch0150s0000f0001"><title><phrase role="figureLabel"><anchor id="ch0150s0000a0019"/><link linkend="ch0150s0000a0006"><emphasis role="strong">FIGURE 1</emphasis></link></phrase> Cultures of eumycetoma-causative agents. <emphasis role="strong">(A)</emphasis> <emphasis>M. mycetomatis</emphasis> colony on Sabouraud dextrose agar. <emphasis role="strong">(B)</emphasis> <emphasis>M. mycetomatis</emphasis> sterile sclerotia. <emphasis role="strong">(C)</emphasis> <emphasis>M. mycetomatis</emphasis> phialides and minute conidia. <emphasis role="strong">(D)</emphasis> <emphasis>F. senegalensis</emphasis> colony on malt extract agar. <emphasis role="strong">(E)</emphasis> <emphasis>F. senegalensis</emphasis> ascomata. <emphasis role="strong">(F)</emphasis> <emphasis>F. senegalensis</emphasis> ascospore. <emphasis role="strong">(G)</emphasis> <emphasis>T. grisea</emphasis> colony on malt extract agar. <emphasis role="strong">(H)</emphasis> <emphasis>T. grisea</emphasis> pycnidia containing conidia. <emphasis role="strong">(I)</emphasis> <emphasis>T. grisea</emphasis> conidiophores and conidia. <emphasis role="strong">(J)</emphasis> <emphasis>N. rosatii</emphasis> colony on malt extract agar. <emphasis role="strong">(K)</emphasis> <emphasis>N. rosatii</emphasis> ascomata. <emphasis role="strong">(L)</emphasis> <emphasis>N. rosatii</emphasis> asci and ascospores.
</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0150f03.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
      </sect2>
      <sect2 id="ch0150s0003s0003">
        <title>Nigrograna mackinnonii (Previously Known as Pyrenochaeta mackinnonii)</title>
        <anchor id="ch0150s0003a0004"/>
        <anchor id="ch0150s0000a0020"/>
        <anchor id="ch0150s0000a0021"/>
        <anchor id="ch0150s0000a0022"/>
        <para id="ch0150s0000p0009">Molecular analysis of the 18S and 28S rRNA genes also revealed that<emphasis>Pyrenochaeta mackinnonii</emphasis> is distant from the type species of <emphasis>Pyrenochaeta</emphasis> (<emphasis>Pyrenochaeta nobilis</emphasis>) (<link linkend="ch0150s0000li0026">26</link>, <link linkend="ch0150s0000li0027">27</link>). Furthermore, <emphasis>M. romeroi</emphasis> (formerly <emphasis>Pyrenochaeta romeroi</emphasis>) and <emphasis>P. mackinnonii</emphasis> were found to be phylogenetically remote from each other, and therefore, <emphasis>P. mackinnonii</emphasis> was assigned to a different genus, <emphasis>Nigrograna</emphasis>, and renamed <emphasis>N. mackinnonii</emphasis> (<link linkend="ch0150s0000li0027">27</link>, <link linkend="ch0150s0000li0031">31</link>). Between 2014 and 2015, this species was named <emphasis>Biatriospora mackinnonii</emphasis> (<link linkend="ch0150s0000li0014">14</link>), but after a thorough taxonomic revision, it was changed back to <emphasis>N. mackinnonii</emphasis> in 2015 (<link linkend="ch0150s0000li0031">31</link>). The complete genome of <emphasis>N. mackinnonii</emphasis> has been sequenced from endophytic isolate E5202H, which was deposited in the American Type Culture Collection (ATCC) as SD-6893 (<link linkend="ch0150s0000li0032">32</link>). <emphasis>N. mackinnonii</emphasis> has been reported as the causative agent of eumycetoma in patients from Costa Rica, Mexico, and Venezuela.</para>
      </sect2>
      <sect2 id="ch0150s0003s0004">
        <title>Emarellia grisea and Emarellia paragrisea</title>
        <anchor id="ch0150s0003a0005"/>
        <anchor id="ch0150s0000a0023"/>
        <para id="ch0150s0000p0010">Based on the combined DNA sequence data of the LSU (28S rDNA), ITS, actin (<emphasis>ACT), RPB2</emphasis>, and <emphasis>TEF1</emphasis> genes, it was demonstrated that <emphasis>Emarellia grisea</emphasis> and <emphasis>E. paragrisea</emphasis> clustered among the pleosporalean causative agents of eumycetoma (<link linkend="ch0150s0000li0017">17</link>). In culture, these fungi produce only sterile, melanized hyphae. <emphasis>E. grisea</emphasis> causes eumycetomata in India and Sri Lanka (<link linkend="ch0150s0000li0017">17</link>).</para>
      </sect2>
      <sect2 id="ch0150s0003s0005">
        <title>Neotestudina rosatii</title>
        <anchor id="ch0150s0003a0006"/>
        <anchor id="ch0150s0000a0024"/>
        <para id="ch0150s0000p0011"><emphasis>Neotestudina rosatii</emphasis> has been isolated from soil from tropical countries; it is an ascomycete with spherical, deliquescent asci and rhomboid ascospores with one septum each (<link linkend="ch0150s0000li0015">15</link>) (<link linkend="ch0150s0000a0019">Fig. 1J</link>, <link linkend="ch0150s0000a0006">K</link>, and <link linkend="ch0150s0000a0006">L</link>). Eumycetomata caused by <emphasis>N. rosatii</emphasis> have been described in Australia, Cameroon, Guinea, Senegal, and Somalia (<link linkend="ch0150s0000li0029">29</link>, <link linkend="ch0150s0000li0033">33</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0004">
      <title>Order Microascales</title>
      <anchor id="ch0150s0004a0001"/>
      <anchor id="ch0150s0000a0025"/>
      <sect2 id="ch0150s0004s0001">
        <title>Scedosporium Species</title>
        <anchor id="ch0150s0004a0002"/>
        <anchor id="ch0150s0000a0026"/>
        <para id="ch0150s0000p0012">The genus<emphasis>Scedosporium</emphasis> comprises a small group of rather variable species (<link linkend="ch0150s0000li0034">34</link>–<link linkend="ch0150s0000li0037">37</link>). The nomenclature of the genera <emphasis>Scedosporium/Pseudallescheria</emphasis> has been revised in the last years. With the establishment of the “One Fungus = One Name” rule in fungal taxonomy, which allows only a single name per fungus, the genus name <emphasis>Scedosporium</emphasis> was retained and <emphasis>Pseudallescheria</emphasis> was abandoned (<link linkend="ch0150s0000li0037">37</link>). Already in the 1920s the genus was known to cause human eumycetoma (<link linkend="ch0150s0000li0038">38</link>), mainly in temperate climates (<link linkend="ch0150s0000li0039">39</link>) and occurring mostly in the limbs (<link linkend="ch0150s0000li0040">40</link>). Currently, the genus <emphasis>Scedosporium</emphasis> contains at least 10 species (<link linkend="ch0150s0000li0037">37</link>), of which only <emphasis>S. boydii</emphasis> and <emphasis>S. apiospermum</emphasis> are associated with eumycetoma.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0005">
      <title>Other Orders</title>
      <anchor id="ch0150s0005a0001"/>
      <anchor id="ch0150s0000a0027"/>
      <para id="ch0150s0000p0013">Eumycetoma can be caused by many different fungal species; most of these species are only rarely encountered in eumycetoma (<link linkend="ch0150s0000a0008">Table 1</link>).</para>
      <sect2 id="ch0150s0005s0001">
        <title>EPIDEMIOLOGY AND TRANSMISSION</title>
        <anchor id="ch0150s0005a0002"/>
        <anchor id="ch0150s0000a0028"/>
        <para id="ch0150s0000p0014">The number of species involved in eumycetoma is increasing, but little is known about the epidemiology and mode of transmission of these species. Case reports are indicative of the presence of certain species in particular geographical locations but do not provide a clear understanding of the environmental distribution of species and the possible ecological niches. Only for eumycetoma caused by<emphasis>M. mycetomatis</emphasis> has ecological niche modeling been performed. For that species, the presence of light clay soil, sandy loam soil, or loam soil (<link linkend="ch0150s0000li0042">42</link>), with a soil calcium concentration between 3 g/kg and 11 g/kg (<link linkend="ch0150s0000li0041">41</link>), and the presence of <emphasis>Acacia</emphasis> trees (<link linkend="ch0150s0000li0041">41</link>, <link linkend="ch0150s0000li0042">42</link>) were associated with eumycetoma. Also the vicinity of a river was positively correlated (<link linkend="ch0150s0000li0041">41</link>).</para>
        <para id="ch0150s0000p0015">Eumycetoma has been contracted in 102 countries, and reports have been found from every continent except Antarctica (<link linkend="ch0150s0000li0043">43</link>), but there are large differences in the burden of disease over the globe (<link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0004">4</link>, <link linkend="ch0150s0000li0043">43</link>). So far, the highest numbers of cases have been reported from Sudan (<link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0004">4</link>, <link linkend="ch0150s0000li0043">43</link>), Mexico, Senegal, and India (<link linkend="ch0150s0000li0003">3</link>, <link linkend="ch0150s0000li0004">4</link>, <link linkend="ch0150s0000li0019">19</link>, <link linkend="ch0150s0000li0043">43</link>). Countries with a high prevalence were Mauritania (prevalence of 3.49 cases per 100,000 inhabitants) and Sudan (1.81 cases per 100,000 inhabitants) (<link linkend="ch0150s0000li0003">3</link>). In villages with high endemicity in Sudan, a prevalence of 1 to 5.2 cases per 1,000 inhabitants was found in the 1960s (<link linkend="ch0150s0000li0044">44</link>) and 6.2 to 35 cases per 1,000 inhabitants in the 2010s (<link linkend="ch0150s0000li0044">44</link>, <link linkend="ch0150s0000li0045">45</link>).</para>
        <para id="ch0150s0000p0016">The causal agents of eumycetoma are largely saprobes that live on hard plant materials, such as various types of thorns and spines, that are associated with soil (<link linkend="ch0150s0000li0046">46</link>–<link linkend="ch0150s0000li0049">49</link>). Segretain and colleagues (<link linkend="ch0150s0000li0033">33</link>, <link linkend="ch0150s0000li0050">50</link>), using specific isolation media and techniques, showed that <emphasis>F. senegalensis</emphasis> and <emphasis>F. tompkinsii</emphasis> could be recovered from about 50% of the dry thorns of <emphasis>Acacia</emphasis> trees that they examined, particularly those that had been stained by mud during the rainy season. <emphasis>N. rosatii</emphasis> was isolated from sandy soil (<link linkend="ch0150s0000li0029">29</link>), and <emphasis>M. mycetomatis</emphasis> was isolated from soil and anthills (<link linkend="ch0150s0000li0051">51</link>, <link linkend="ch0150s0000li0052">52</link>). It should be noted, however, that the identity of these fungi has not been verified with molecular methods; the possibility that environmental strains do not always belong to the same species as the clinical strains cannot be excluded. Using ITS sequencing, Badali et al. (<link linkend="ch0150s0000li0053">53</link>) reidentified a collection of <emphasis>Exophiala jeanselmei</emphasis> clinical and environmental strains. <emphasis>E. jeanselmei</emphasis> identification was confirmed in all eumycetoma or eumycetoma-like infections, while other environmental strains were found to belong to other <emphasis>Exophiala</emphasis> species, suggesting some predilection of particular species for human invasion. Another example of possible human predilection is <emphasis>M. mycetomatis</emphasis>, which is a common agent of black-grain eumycetoma in the arid climate zones of East Africa. The direct isolation of this species from the environment is difficult (<link linkend="ch0150s0000li0054">54</link>), but its DNA has been found in soil (<link linkend="ch0150s0000li0054">54</link>), on thorns (<link linkend="ch0150s0000li0054">54</link>), and even in <emphasis>Hyalomma rufipes</emphasis> ticks (<link linkend="ch0150s0000li0055">55</link>). Recently, phylogenetic findings even suggest dung as a possible new habitat for <emphasis>M. mycetomatis</emphasis> (<link linkend="ch0150s0000li0056">56</link>).</para>
        <para id="ch0150s0000p0017">Borelli (<link linkend="ch0150s0000li0057">57</link>) isolated a sterile fungus, reported as <emphasis>Madurella grisea</emphasis> (now known as <emphasis>T. grisea</emphasis>), from soil in Venezuela; the ecological niche and clinical potential of this rare species have not yet been determined. Also, in relatively common fungi, such as <emphasis>M. mycetomatis</emphasis> and <emphasis>Scedosporium</emphasis> species, phenotypic identification alone is not enough to determine the exact epidemiology, since these apparently similar entities might hide significant diversity (see “Taxonomy and Description of the Agents” above).</para>
        <para id="ch0150s0000p0018">Eumycetoma may infect all people living in areas of endemicity but develops more commonly among persons who are in contact with contaminated materials, such as field workers, farmers, and fishermen. There is no obvious immune defect in eumycetoma patients, although association with some rare immune defects does occur (<link linkend="ch0150s0000li0058">58</link>–<link linkend="ch0150s0000li0062">62</link>). This concerns single-nucleotide polymorphisms in genes involved in the functioning of the host’s immune system, such as the chitinases acidic mammalian chitinase (AMCase) and chitotriosidase, complement receptor 1 (CR1), the CC chemokine ligand 5 (CCR5), the chemokines interleukin 8 (CXCL8) and interleukin 10, the interleukin receptor CXCR2, metalloproteases 2 and 9, the nitric oxide synthase NOS2, and trombospondin 4, and in the synthesis of sex hormones, such as cytochrome P450 subfamily 19 (CYP19) and catechol-<emphasis>O</emphasis>-methyltransferase (COMT) (<link linkend="ch0150s0000li0058">58</link>–<link linkend="ch0150s0000li0062">62</link>). The latter might explain why eumycetoma is more common in males than in females, as is also observed with many other opportunistic fungi.</para>
        <anchor id="ch0150s0000a0029"/>
        <beginpage pagenum="2553"/>
        <para id="ch0150s0000p0019">Areas of endemicity are particularly located in tropical climate zones.<emphasis>M. mycetomatis</emphasis> is limited to semiarid to arid climates, while <emphasis>Falciformispora</emphasis> species are found in the rain forest. Locally acquired eumycetomata in temperate climates invariably are caused by <emphasis>S. apiospermum</emphasis> complex. Cases observed in the United States and Europe caused by species other than <emphasis>S. apiospermum</emphasis> are imported by immigrants from tropical countries. For example, de Hoog et al. (<link linkend="ch0150s0000li0063">63</link>) reported cases in The Netherlands originating from Indonesia and Suriname, and Ahmed et al. (<link linkend="ch0150s0000li0020">20</link>) reported <emphasis>M. mycetomatis</emphasis> eumycetoma cases seen in France but originating in Mali.</para>
        <para id="ch0150s0000p0020">Climate has a definite influence on the prevalence and distribution of eumycetoma. Rivers that flood each year during the wet season in many countries of Africa and Asia influence the distribution of the causal agents. Rainfall also aids the spread of the etiologic agents on organic matter (<link linkend="ch0150s0000li0064">64</link>).</para>
      </sect2>
      <sect2 id="ch0150s0005s0002">
        <title>CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0150s0005a0003"/>
        <anchor id="ch0150s0000a0030"/>
        <para id="ch0150s0000p0021">Eumycetoma is a localized, chronic, noncontiguous, granulomatous infection involving cutaneous and subcutaneous tissues and eventually, in some cases, bones (<link linkend="ch0150s0000li0065">65</link>). Eumycetomata are generally confined to either the feet or the hands but occasionally affect sites such as the back, shoulders, and buttocks. Rarely, other body sites can be involved, such as the scalp, eye, jaw, and oral cavity (<link linkend="ch0150s0000li0009">9</link>, <link linkend="ch0150s0000li0066">66</link>–<link linkend="ch0150s0000li0068">68</link>). The triad of a painless subcutaneous mass, sinuses, and discharge containing grains (masses of fungal organisms) (<anchor id="ch0150s0000a0031"/><link linkend="ch0150s0000a0033">Fig. 2</link>) is characteristic of eumycetoma; however, a similar condition (actinomycetoma) may be caused by aerobic actinomycete bacteria.</para>
        <para id="ch0150s0000p0022">The disease is more commonly seen in humans than in animals. Only a few cases of eumycetoma involving animals, such as cats, dogs, horses, and goats, have been described in the literature (<link linkend="ch0150s0000li0022">22</link>, <link linkend="ch0150s0000li0069">69</link>–<link linkend="ch0150s0000li0073">73</link>). Most cases occur in otherwise healthy patients. The development of eumycetoma after an accidental implantation of the etiologic agent following surgery (<link linkend="ch0150s0000li0074">74</link>) and in a renal transplant recipient (<link linkend="ch0150s0000li0075">75</link>) has been reported.</para>
        <para id="ch0150s0000p0023">Eumycetoma develops after a traumatic injury by microbe-contaminated thorns, splinters, fish scales or fins, snake bites, insect bites, farm implements, and knives. The initial lesion is often characterized by a feeling of discomfort and pain at the point of inoculation. Weeks or months later, the subcutaneous tissue at the site of inoculation becomes indurated, abscesses develop, and fistulae may drain to the surface (<link linkend="ch0150s0000li0065">65</link>, <link linkend="ch0150s0000li0076">76</link>). As described above, eumycetomata are characterized by swelling, granulomas, abscesses, and sinuses from which serosanguinous fluid containing fungal grains is discharged. Grains, which are not seen in other subcutaneous mycoses, can vary from approximately 0.2 to over 5 mm in diameter (<link linkend="ch0150s0000li0077">77</link>). The size, color, shape, and internal architecture of the grains vary depending on the etiologic agent (<link linkend="ch0150s0000a0008">Table 1</link>). Some of the host material, especially at the periphery of the grain, provides a protective barrier for the fungus against antifungal agents and against components of humoral immune responses, such as antibodies.</para>
        <para id="ch0150s0000p0024">Eumycetoma develops slowly beneath thick fibrosclerous tissue. The subsequent phase of proliferation involves the invasion of muscles and intramuscular layers by portions of the sclerotium that break free from their parent structure. The granulomatous lesions can extend as deep as bone, where severe bone destruction, formation of small cavities, and complete remodeling may occur (<link linkend="ch0150s0000li0065">65</link>, <link linkend="ch0150s0000li0076">76</link>). Early osteolytic damage includes loss of the cortical margin and external erosion of the bone. As the infection progresses, blood, lymphatic vessels, and nerves may be damaged. Frequently, secondary bacterial infections and osteomyelitis producing total bone destruction occur. Pain in eumycetoma is often associated with bone involvement and secondary bacterial infection.</para>
        <anchor id="ch0150s0000a0032"/>
        <beginpage pagenum="2554"/>
        <figure id="ch0150s0000f0002"><title><phrase role="figureLabel"><anchor id="ch0150s0000a0033"/><link linkend="ch0150s0000a0031"><emphasis role="strong">FIGURE 2</emphasis></link></phrase> Grains of <emphasis>M. mycetomatis</emphasis> within subcutaneous tissue. <emphasis role="strong">(A)</emphasis> Black <emphasis>M. mycetomatis</emphasis> grains in formalin-fixed subcutaneous tissue. Magnification, ×1. Grains are clearly visible to the naked eye. <emphasis role="strong">(B)</emphasis> Black <emphasis>M. mycetomatis</emphasis> grain in subcutaneous tissue. Hematoxylin-eosin stain. Magnification, ×100. <emphasis role="strong">(C)</emphasis> Black <emphasis>E. jeanselmei</emphasis> grain in subcutaneous tissue. Hematoxylin-eosin stain. Magnification, ×100 (<link linkend="ch0150s0000li0181">181</link>). <emphasis role="strong">(D)</emphasis> White <emphasis>Fusarium verticilloides</emphasis> grain. Hematoxylin-eosin stain. Magnification, ×100 (<link linkend="ch0150s0000li0182">182</link>).
</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0150f02.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0150s0000p0025">Fungus balls in preexisting lung cavities are sometimes inappropriately called eumycetomata (<link linkend="ch0150s0000li0078">78</link>, <link linkend="ch0150s0000li0079">79</link>). In the absence of well-organized grains, they should be referred to as fungus balls, depending on the etiologic agent, e.g., aspergillomas (<link linkend="ch0150s0000li0080">80</link>). Similarly, mycelial aggregates formed by dermatophytes in cutaneous or subcutaneous tissues differ from grains of eumycetomata by lacking granule ontogeny, by presenting a distinct Splendore-Hoeppli reaction (see “Microscopy,” below) surrounding the mycelial aggregates, and by the entry of the fungus from the hair follicles into deeper tissue following the rupture of the follicular epithelium. Such infections caused by dermatophytes have been referred to as pseudomycetomata (<link linkend="ch0150s0000li0081">81</link>).</para>
      </sect2>
      <sect2 id="ch0150s0005s0003">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0150s0005a0004"/>
        <anchor id="ch0150s0000a0034"/>
        <para id="ch0150s0000p0026">Different specimens can be obtained from patients with eumycetoma, but direct examination and culture of fungi causing eumycetoma always require surgical tissue biopsies and/or bone curettage. Tissue materials should be divided and submitted for both microbiology and histopathology and preferably molecular examination as well. It should be noted that tissue biopsy specimens without visible grains usually result in negative cultures. The best specimen for fungal culture is usually collected during surgery as an excisional or incisional biopsy specimen (<link linkend="ch0150s0000li0082">82</link>). Grains are not always present in tissue specimens obtained by a cutaneous biopsy procedure with local anesthesia. However, when they contain grains, they can also result in positive cultures. The collection of grains collected with cotton swabs from the sinus tracts is not recommended, because such grains can be contaminated or dead.</para>
        <para id="ch0150s0000p0027">Several grains are usually needed for direct examination, culture, and DNA isolation, and therefore, as much tissue as possible should be obtained. Tissue should be collected in sterile, dry, leakproof containers and transported to the laboratory as soon as possible at room temperature. If transport is delayed for more than 2 h, specimens can be refrigerated, but care should be taken, since long storage can result in no growth. Small biopsy samples can be covered with 2 to 3 ml of sterile saline to prevent drying during transportation to the laboratory.</para>
      </sect2>
      <sect2 id="ch0150s0005s0004">
        <title>DIRECT EXAMINATION</title>
        <anchor id="ch0150s0005a0005"/>
        <anchor id="ch0150s0000a0035"/>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0006">
      <title>Imaging</title>
      <anchor id="ch0150s0006a0001"/>
      <anchor id="ch0150s0000a0036"/>
      <para id="ch0150s0000p0028">Magnetic resonance imaging (MRI) and radiology are often used to identify the limits of the lesions and to determine if bone is affected (<link linkend="ch0150s0000li0082">82</link>–<link linkend="ch0150s0000li0084">84</link>). Ultrasonic imaging can be used to differentiate between eumycetoma and nonmycetoma lesions and between actinomycetoma and eumycetoma lesions (<link linkend="ch0150s0000li0082">82</link>, <link linkend="ch0150s0000li0083">83</link>, <link linkend="ch0150s0000li0085">85</link>). In eumycetoma grains, the grains produce numerous sharp, bright hyper-reflective echoes (<link linkend="ch0150s0000li0083">83</link>, <link linkend="ch0150s0000li0085">85</link>). When grains are more towards the surface, dermoscopy can also be used to identify grains subcutaneously. For eumycetoma caused by <emphasis>Acremonium</emphasis> sp. and <emphasis>T. grisea</emphasis>, yellowish and white structures were identified (<link linkend="ch0150s0000li0086">86</link>, <link linkend="ch0150s0000li0087">87</link>). Subcutaneous black grains present as blue-white areas surrounded by a white halo and polymorphic vessels (<link linkend="ch0150s0000li0088">88</link>). Dermoscopy or ultrasound-guided biopsies will increase the yield of eumycetoma grains for microscopy.</para>
    </sect1>
    <sect1 id="ch0150s0007">
      <title>Microscopy (Grain Appearance)</title>
      <anchor id="ch0150s0007a0001"/>
      <anchor id="ch0150s0000a0037"/>
      <para id="ch0150s0000p0029">The grains of eumycetomata are composed of septate mycelial filaments at least 2 to 5 μm in diameter (<link linkend="ch0150s0000a0008">Table 1</link>). The mycelium may be distorted and unusual in form and size, and the cell walls of the fungi, especially toward the periphery of the grains, are thickened. Vesicles are frequently present, especially at the periphery of the grain. The mycelium of the grains may be embedded in a cement-like substance, depending on the species involved. The cement material is most likely composed of both fungal and host material. Wethered et al. (<link linkend="ch0150s0000li0089">89</link>) described the cement surrounding grains of <emphasis>M. mycetomatis</emphasis> as being an amorphous, electron-dense material with areas containing different-sized membrane-bound vesicular inclusions. <emphasis>M. mycetomatis</emphasis> grains were found to contain melanin, chitin, heavy metals, proteins, and lipids (<link linkend="ch0150s0000li0062">62</link>, <link linkend="ch0150s0000li0090">90</link>, <link linkend="ch0150s0000li0091">91</link>) and were surrounded by a collagen capsule (<link linkend="ch0150s0000li0061">61</link>). It was suggested that the elements composing the grains in eumycetoma may play a role in pathogenicity and resistance to antifungal agents (<link linkend="ch0150s0000li0090">90</link>–<link linkend="ch0150s0000li0092">92</link>). Often, the grains elicit an immune response, known as the Splendore-Hoeppli reaction (<link linkend="ch0150s0000li0065">65</link>, <link linkend="ch0150s0000li0081">81</link>), seen histologically in the form of an eosinophilic deposit of amorphous material around the grain. A similar tissue reaction in experimental eumycetoma in mice has been described (<link linkend="ch0150s0000li0093">93</link>).</para>
      <para id="ch0150s0000p0030">As shown in<link linkend="ch0150s0000a0008">Table 1</link>, grains are white or yellow-brown (white-grain eumycetoma) when the agent produces mostly hyaline mycelia, and black (black-grain eumycetoma) in the case of melanized fungi. A single proven yellow-grain fungal eumycetoma has been reported thus far, but earlier cases may have been incorrectly diagnosed as bacterial mycetomata (<link linkend="ch0150s0000li0094">94</link>). Reports of hyaline fungi such as be <emphasis>Acremonium (Sarocladium) kiliense</emphasis> or <emphasis>Sarocladium</emphasis> (formerly <emphasis>Acremonium</emphasis>) <emphasis>kiliense</emphasis> and <emphasis>Fusarium solani</emphasis> var. <emphasis>coeruleum</emphasis> forming black grains (<link linkend="ch0150s0000li0095">95</link>) are probably erroneous. Etiologic agents with melanized hyphae or conidia, such as <emphasis>Phaeoacremonium inflatipes</emphasis> and <emphasis>S. apiospermum</emphasis>, produce whitish grains in tissue (<link linkend="ch0150s0000li0049">49</link>, <link linkend="ch0150s0000li0096">96</link>–<link linkend="ch0150s0000li0098">98</link>). Melanin production in <emphasis>Phaeoacremonium</emphasis> species is facultative, while in <emphasis>Scedosporium</emphasis>, dark pigmentation is limited to the conidia.</para>
    </sect1>
    <sect1 id="ch0150s0008">
      <title>Black Grains</title>
      <anchor id="ch0150s0008a0001"/>
      <anchor id="ch0150s0000a0038"/>
      <para id="ch0150s0000p0031">Although black grains might resemble each other, species-specific features can be noted. The color of black grains is probably caused by melanin, a high-molecular-weight compound that is anchored to extracellular proteins. In ascomycetous fungi, melanin can be produced via different melanin biosynthetic pathways, starting with different precursors. The most common pathways are the 1,8-dihydroxynaphthalene (DHN)-melanin, the 3,4-dihydroxyphenylalanine (DOPA)-melanin, and the pyomelanin biosynthetic pathways (<link linkend="ch0150s0000li0065">65</link>, <link linkend="ch0150s0000li0099">99</link>, <link linkend="ch0150s0000li0100">100</link>).</para>
      <sect2 id="ch0150s0008s0001">
        <title>Madurella mycetomatis</title>
        <anchor id="ch0150s0008a0002"/>
        <anchor id="ch0150s0000a0039"/>
        <para id="ch0150s0000p0032">In<emphasis>M. mycetomatis</emphasis>, melanin has been shown to be produced through the DHN-melanin and pyomelanin pathways, and it offers the fungus protection against strong oxidants and antifungal drugs (<link linkend="ch0150s0000li0090">90</link>).</para>
        <para id="ch0150s0000p0033">In tissue, the grains produced by<emphasis>M. mycetomatis</emphasis> are reddish brown to black (<link linkend="ch0150s0000a0033">Fig. 2A</link> and <link linkend="ch0150s0000a0031">B</link>). They may reach 5 mm or more in diameter and are firm to hard. In tissue sections, the grains are compact, variable in size and shape, and frequently multilobulated. They are composed of hyphae 1.2 to 5 μm in diameter that terminate in enlarged hyphal cells at the periphery of the grains, which measure 12 to 15 μm in diameter. The cell wall pigment is minimal, but hyphal cells contain brown particles. The hyphae are embedded in a conspicuous brown matrix that is characteristic of <emphasis>M. mycetomatis.</emphasis> Within the cement material, proteins of both the host and the pathogen can be found (<link linkend="ch0150s0000li0061">61</link>, <link linkend="ch0150s0000li0101">101</link>–<link linkend="ch0150s0000li0103">103</link>). The cement material is absent in early grains (<link linkend="ch0150s0000li0101">101</link>, <link linkend="ch0150s0000li0104">104</link>). In experimental models, four different steps in grain formation were noted, which include (i) the recognition of pathogen and host, (ii) crosslinking of host cells and pathogens to form the early grain, (iii) degranulation of host cells and generation of reactive oxygen species, and (iv) melanization of the grain (<link linkend="ch0150s0000li0101">101</link>). Cement material is formed only in the last stage. Within a single lesion, the grains might be in different developmental stages. Some grains are vesicular and more regular in size and shape. The vesicles are predominantly visible in the peripheral zone in a dense, brown, cement-like matrix (<link linkend="ch0150s0000li0105">105</link>).</para>
        <anchor id="ch0150s0000a0040"/>
        <beginpage pagenum="2555"/>
      </sect2>
      <sect2 id="ch0150s0008s0002">
        <title>Falciformispora Species</title>
        <anchor id="ch0150s0008a0003"/>
        <anchor id="ch0150s0000a0041"/>
        <para id="ch0150s0000p0034">Melanin in<emphasis>F. senegalensis</emphasis> is produced through the DHN-, DOPA-, and pyomelanin pathways, while <emphasis>F. tompkinsii</emphasis> produces melanin via the DHN-melanin pathway only (<link linkend="ch0150s0000li0100">100</link>). The grains of the two <emphasis>Falciformispora</emphasis> species that cause mycetoma are indistinguishable from each other (<link linkend="ch0150s0000li0077">77</link>) and are difficult to distinguish from the grains of <emphasis>T. grisea</emphasis> (<link linkend="ch0150s0000li0082">82</link>). They are black, 0.5 to 2 mm in size, and firm to hard. In tissue sections, the grains are round to polylobulated, with large vesicles. At the periphery, the mycelium is embedded in a black, cement-like substance. The central portion of each grain is nonpigmented and consists of a loose network of hyphae (<link linkend="ch0150s0000li0077">77</link>, <link linkend="ch0150s0000li0106">106</link>). Although it is quite difficult to distinguish <emphasis>Falciformispora</emphasis> grains from those of <emphasis>T. grisea</emphasis>, the borders of <emphasis>F. senegalensis</emphasis> grains are less even and more crenelated and the peripheral zones show larger vesicles and a more irregular hyphal arrangement (<link linkend="ch0150s0000li0106">106</link>).</para>
      </sect2>
      <sect2 id="ch0150s0008s0003">
        <title>Trematosphaeria grisea</title>
        <anchor id="ch0150s0008a0004"/>
        <anchor id="ch0150s0000a0042"/>
        <para id="ch0150s0000p0035"><emphasis>T. grisea</emphasis> produces melanin via the DHN-melanin pathway (<link linkend="ch0150s0000li0100">100</link>). Grains of <emphasis>T. grisea</emphasis> are black, 0.3 to 0.6 mm in diameter, and soft to firm. In tissue sections, the grains resemble those of <emphasis>Falciformispora</emphasis> species and are oval, lobulated, or reniform (kidney shaped), and sometimes vermiform (worm shaped) (<link linkend="ch0150s0000li0106">106</link>). They are composed of a dense network of hyphae that are weakly pigmented in the center and brown to blackish brown in the peripheral region as the result of the presence of a brown, cement-like interstitial material (<link linkend="ch0150s0000li0077">77</link>, <link linkend="ch0150s0000li0082">82</link>, <link linkend="ch0150s0000li0106">106</link>).</para>
      </sect2>
      <sect2 id="ch0150s0008s0004">
        <title>Medicopsis romeroi</title>
        <anchor id="ch0150s0008a0005"/>
        <anchor id="ch0150s0000a0043"/>
        <para id="ch0150s0000p0036"><emphasis>M. romeroi</emphasis> forms its melanin via the DHN-, DOPA-, and pyomelanin pathways (<link linkend="ch0150s0000li0100">100</link>). It produces soft to firm black sclerotia that are oval, lobulated, sometimes vermiform, and about 1.0 mm in diameter. They resemble those of <emphasis>T. grisea</emphasis> (<link linkend="ch0150s0000li0107">107</link>).</para>
      </sect2>
      <sect2 id="ch0150s0008s0005">
        <title>Curvularia geniculata</title>
        <anchor id="ch0150s0008a0006"/>
        <anchor id="ch0150s0000a0044"/>
        <para id="ch0150s0000p0037"><emphasis>C. geniculata</emphasis> grains are black to dark brown, firm, and 0.5 to 1.0 mm or more in size (<link linkend="ch0150s0000li0077">77</link>). In tissue sections, grains are spherical, ovoid, or irregularly shaped and are often surrounded by a zone of epithelioid cells. The periphery of the grain is a dense, interwoven mass of dematiaceous mycelium and thick-walled, chlamydospore-like cells embedded in a cement-like substance (<link linkend="ch0150s0000li0077">77</link>). The interior of the grains is vacuolar and consists of a loose network of septate, hyphal filaments. The grains of <emphasis>Curvularia lunata</emphasis> resemble those of <emphasis>C. geniculata</emphasis> in their morphologic characteristics (<link linkend="ch0150s0000li0077">77</link>).</para>
      </sect2>
      <sect2 id="ch0150s0008s0006">
        <title>Exophiala jeanselmei</title>
        <anchor id="ch0150s0008a0007"/>
        <anchor id="ch0150s0000a0045"/>
        <para id="ch0150s0000p0038">In host tissue,<emphasis>E. jeanselmei</emphasis> produces dark brown to black grains that are irregular in shape and fragile (<link linkend="ch0150s0000a0033">Fig. 2C</link>). Detached portions or fragments of the grains often are found within giant cells (<link linkend="ch0150s0000li0077">77</link>). When extruded through fistulae, the grains often look like worms (vermiform) because of their elongated shapes and irregular surfaces (<link linkend="ch0150s0000li0077">77</link>). In tissue sections, grains appear as hollow structures or as sinuous bands that are vermiform. The external surface is composed of brown, thick-walled hyphae and thick-walled chlamydospore-like cells. The grains are cement free. Within the hollow grains, smaller, degenerated hyphal fragments with leukocytes and giant cells may be seen (<link linkend="ch0150s0000li0077">77</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0009">
      <title>White Grains</title>
      <anchor id="ch0150s0009a0001"/>
      <anchor id="ch0150s0000a0046"/>
      <para id="ch0150s0000p0039">Grains of<emphasis>Scedosporium</emphasis> species and <emphasis>Fusarium</emphasis> species are histopathologically similar and almost impossible to distinguish from each other (<link linkend="ch0150s0000li0108">108</link>). However, there are some features that might help in recognizing individual organisms (<link linkend="ch0150s0000li0109">109</link>).</para>
      <sect2 id="ch0150s0009s0001">
        <title>Scedosporium Species</title>
        <anchor id="ch0150s0009a0002"/>
        <anchor id="ch0150s0000a0047"/>
        <para id="ch0150s0000p0040">Grains of<emphasis>Scedosporium</emphasis> species in tissue are white to yellowish white and soft to firm; they vary from globose to subglobose or lobulated and are 0.2 to 2.0 mm in diameter (<link linkend="ch0150s0000li0077">77</link>). They are composed of hyaline hyphae 1.5 to 5.0 μm in diameter that radiate from the center into terminal thick-walled cells 15 to 20 μm in diameter at the peripheries. The central portion of each grain consists of loosely interwoven hyaline mycelium, and some vesicles can be noted (<link linkend="ch0150s0000li0109">109</link>).</para>
      </sect2>
      <sect2 id="ch0150s0009s0002">
        <title>Fusarium Species</title>
        <anchor id="ch0150s0009a0003"/>
        <anchor id="ch0150s0000a0048"/>
        <para id="ch0150s0000p0041">The grains of<emphasis>Fusarium</emphasis> spp. (<link linkend="ch0150s0000a0033">Fig. 2D</link>) are white to pale yellow, soft, and 0.2 to 0.5 mm in diameter. They are composed of slender, polymorphic, septate hyphae 1.5 to 2.0 μm in diameter with irregular bulbous swellings and peripheral cementing material (<link linkend="ch0150s0000li0077">77</link>, <link linkend="ch0150s0000li0109">109</link>).</para>
      </sect2>
      <sect2 id="ch0150s0009s0003">
        <title>Neotestudina rosatii</title>
        <anchor id="ch0150s0009a0004"/>
        <anchor id="ch0150s0000a0049"/>
        <para id="ch0150s0000p0042">The sclerotia of<emphasis>N. rosatii</emphasis> are white to brownish white, 0.5 to 1.0 mm in diameter, and soft. In tissue sections, the sclerotia appear to be polyhedral to subregular and consist of hyphae, which are embedded in the peripheral cementing material. The grains demonstrate an eosinophilic border. The central portion of each grain consists of more or less disintegrated mycelium and chlamydospores (<link linkend="ch0150s0000li0077">77</link>).</para>
      </sect2>
      <sect2 id="ch0150s0009s0004">
        <title>Phaeoacremonium Species</title>
        <anchor id="ch0150s0009a0005"/>
        <anchor id="ch0150s0000a0050"/>
        <para id="ch0150s0000p0043">Although<emphasis>Phaeoacremonium</emphasis> is a dematiaceous fungus and a well-known agent of phaeohyphomycosis, it seems that melanin production is facultative in eumycetoma. White-grain eumycetoma caused by <emphasis>P. krajdenii</emphasis> has been reported by Hemashettar et al. (<link linkend="ch0150s0000li0110">110</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0010">
      <title>Nucleic Acid Detection</title>
      <anchor id="ch0150s0010a0001"/>
      <anchor id="ch0150s0000a0051"/>
      <para id="ch0150s0000p0044">Molecular diagnostics have been developed for selected agents. However, most of these molecular assays have been used for culture identification. Only recently, methods have been developed to isolate DNA directly from fungal grains of<emphasis>M. mycetomatis.</emphasis> To isolate DNA directly from fungal grains, 2-mm metal beads are added to isolated grains and treated in a Bead-Beater for 2 min. DNA is isolated from the lysate with either the DNeasy plant minikit (Qiagen) or the ZR fungal/bacterial DNA miniprep kit (Zymo Research) (<link linkend="ch0150s0000li0111">111</link>). The DNA quantity and quality obtained with this isolation method are adequate for any of the molecular identification assays developed and listed in the section “Molecular Identification” of this chapter, below.</para>
      <anchor id="ch0150s0000a0052"/>
      <beginpage pagenum="2556"/>
      <sect2 id="ch0150s0010s0001">
        <title>ISOLATION PROCEDURES</title>
        <anchor id="ch0150s0010a0002"/>
        <anchor id="ch0150s0000a0053"/>
        <para id="ch0150s0000p0045">To maximize the chances of obtaining pure cultures of the etiologic agents, grains from eumycotic eumycetomata should be washed several times with saline containing antibacterial antibiotics, such as penicillin and streptomycin (<link linkend="ch0150s0000li0083">83</link>). The grains are then cultured on Sabouraud’s glucose agar (SGA) containing chloramphenicol (50 mg/liter) and SGA containing chloramphenicol and cycloheximide (500 mg/liter) in petri dishes. When <emphasis>Scedosporium</emphasis> spp. are suspected, the use of semiselective plates such as Dichloran Rose Bengal Chloramphenicol agar or Mycosel agar could be considered (<link linkend="ch0150s0000li0037">37</link>). Plates should be incubated at 25 and 37°C. Because many of the fungi that cause eumycetoma grow slowly, culture plates should be incubated for 6 weeks before being discarded as negative. Identification of the isolated fungus is based on gross morphology of fruiting bodies and conidia, if present.</para>
      </sect2>
      <sect2 id="ch0150s0010s0002">
        <title>IDENTIFICATION</title>
        <anchor id="ch0150s0010a0003"/>
        <anchor id="ch0150s0000a0054"/>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0011">
      <title>Morphological Identification</title>
      <anchor id="ch0150s0011a0001"/>
      <anchor id="ch0150s0000a0055"/>
      <para id="ch0150s0000p0046">The mycological identification of most of the fungi causing eumycetoma can be achieved by studying the morphological characteristics described below and in<ulink url="ch0144#ch0144s0001">chapters 123</ulink>, <ulink url="ch0145#ch0145s0001">124</ulink>, <ulink url="ch0148#ch0148s0001">127</ulink>, and <ulink url="ch0149#ch0149s0001">128</ulink> of this <emphasis>Manual.</emphasis> For additional morphological features and simplified identification keys, readers are referred to specialized references such as the <emphasis>Atlas of Clinical Fungi</emphasis> (<link linkend="ch0150s0000li0015">15</link>). One should be careful when relying solely on morphological features. Many misidentifications have occurred in the past. Currently, molecular identification tools have been proven to be the most reliable in species identification (<link linkend="ch0150s0000li0017">17</link>).</para>
      <sect2 id="ch0150s0011s0001">
        <title>Madurella mycetomatis</title>
        <anchor id="ch0150s0011a0002"/>
        <anchor id="ch0150s0000a0056"/>
        <para id="ch0150s0000p0047">In culture,<emphasis>M. mycetomatis</emphasis> shows wide variation. Colonies are slow growing and white at first, becoming olivaceous, yellow, or brown; flat or dome-shaped; and velvety to glabrous, often with a rust-brown diffusible pigment (<link linkend="ch0150s0000a0019">Fig. 1A</link>). <emphasis>M. tropicana, M. pseudomycetomatis</emphasis>, and <emphasis>M. fahalii</emphasis> are indistinguishable from <emphasis>M. mycetomatis.</emphasis> The optimal growth temperature for <emphasis>M. fahalii, M. tropicana</emphasis>, and <emphasis>M. pseudomycetomatis</emphasis> is 30°C, and that for <emphasis>M. mycetomatis</emphasis> 37°C (<link linkend="ch0150s0000li0005">5</link>). On minimal media (<link linkend="ch0150s0000li0090">90</link>), sclerotial bodies 750 μm in diameter develop for <emphasis>M. mycetomatis.</emphasis> These are black and consist of undifferentiated polygonal cells (<link linkend="ch0150s0000a0019">Fig. 1B</link>). On SGA, the mycelium is sterile. On nutritionally poor media, such as soil extract or hay infusion agar, about 50% of the isolates produce round to pyriform conidia 3 to 4 μm in diameter at the tips of phialides (<link linkend="ch0150s0000li0077">77</link>). The phialides are tapering, ranging from 3 to 15 μm in length, often with an inconspicuous collarette (<link linkend="ch0150s0000a0019">Fig. 1C</link>).</para>
      </sect2>
      <sect2 id="ch0150s0011s0002">
        <title>Falciformispora Species</title>
        <anchor id="ch0150s0011a0003"/>
        <anchor id="ch0150s0000a0057"/>
        <para id="ch0150s0000p0048"><emphasis>F. senegalensis</emphasis> and <emphasis>F. tompkinsii</emphasis> grow rapidly and produce gray-brown colonies (<link linkend="ch0150s0000a0019">Fig. 1D</link>). The optimal growth temperature for <emphasis>F. senegalensis</emphasis> is 33°C, and that for <emphasis>F. tompkinsii</emphasis> is 36°C (<link linkend="ch0150s0000li0014">14</link>). On cornmeal agar, both species produce ascostromata that are nonostiolate (without natural opening), scattered, immersed or superficial, globose to subglobose, black, and covered with brown, smoothly bent hyphae (<link linkend="ch0150s0000a0019">Fig. 1E</link>). The asci, produced after prolonged incubation on plant stems, are eight-spored, clavate to cylindrical, and double walled. The major difference between the two species is found in the ascospores, which differ in size, shape, septation, and the nature of the gelatinous sheath that surrounds them (<link linkend="ch0150s0000li0018">18</link>, <link linkend="ch0150s0000li0112">112</link>) (<link linkend="ch0150s0000a0019">Fig. 1F</link>).</para>
      </sect2>
      <sect2 id="ch0150s0011s0003">
        <title>Trematosphaeria grisea</title>
        <anchor id="ch0150s0011a0004"/>
        <anchor id="ch0150s0000a0058"/>
        <para id="ch0150s0000p0049"><emphasis>T. grisea</emphasis> forms slow-growing, velvety colonies that are cerebriform, radially furrowed or smooth, and dark gray to olive brown to black (<link linkend="ch0150s0000a0019">Fig. 1G</link>). The reverses of the colonies are black. The optimal growth temperature is 30°C, and no growth is observed at 37°C (<link linkend="ch0150s0000li0014">14</link>). Microscopically, the hyphae are septate, light to dark brown, 1 to 3 μm in diameter, and nonsporulating. Chlamydospores are rare. Large moniliform hyphae, 3 to 5 μm in diameter, are often present. Some isolates of <emphasis>T. grisea</emphasis> have been described as producing abortive or fertile pycnidia (<link linkend="ch0150s0000li0107">107</link>, <link linkend="ch0150s0000li0113">113</link>). Such isolates are morphologically indistinguishable from <emphasis>N. mackinnonii</emphasis> (<link linkend="ch0150s0000li0114">114</link>, <link linkend="ch0150s0000li0115">115</link>), but rRNA ITS sequence data (<link linkend="ch0150s0000li0001">1</link>) show large differences between these species. Furthermore, the optimal growth temperature of <emphasis>N. mackinnonii</emphasis> is 24°C, which is lower than that of <emphasis>T. grisea</emphasis> (<link linkend="ch0150s0000li0014">14</link>). Environmental isolates of <emphasis>T. grisea</emphasis> are rapid growing and produce conidiomata (pycnidia) after 8 weeks of incubation (<link linkend="ch0150s0000a0019">Fig. 1I</link>).</para>
      </sect2>
      <sect2 id="ch0150s0011s0004">
        <title>Medicopsis romeroi</title>
        <anchor id="ch0150s0011a0005"/>
        <anchor id="ch0150s0000a0059"/>
        <para id="ch0150s0000p0050">Colonies of<emphasis>M. romeroi</emphasis> are fast growing and floccose to velvety, with a gray surface and whitish margin. The reverse of the colony is black, with no diffusible pigment. The optimal growth temperature is 33°C (<link linkend="ch0150s0000li0014">14</link>). On nutritionally deficient media such as oatmeal agar under near-UV light, pycnidia develop after 3 to 4 weeks (<link linkend="ch0150s0000li0014">14</link>). The pycnidia are subglobose, 80 to 160 μm in diameter, and dark brick to fawn, later becoming dark brown with short necks. They are ostiolate (with a natural opening), and setae around ostioles are septate and roughened and measure 80 to 100 by 3 μm. The conidiophores inside the conidiomata are sparse and have lateral branches. Conidiogenous cells are hyaline and are borne on branches, or arise directly from cells lining the conidiomatal cavity which produce hyaline to yellowish, short, cylindrical conidia measuring 1 to 2 by 1.0 μm (<link linkend="ch0150s0000li0014">14</link>).</para>
      </sect2>
      <sect2 id="ch0150s0011s0005">
        <title>Scedosporium spp.</title>
        <anchor id="ch0150s0011a0006"/>
        <anchor id="ch0150s0000a0060"/>
        <para id="ch0150s0000p0051"><emphasis>Scedosporium</emphasis> fungi will grow without difficulty on standard mycological media such as Sabouraud’s dextrose agar or potato dextrose agar (<link linkend="ch0150s0000li0037">37</link>). Semiselective media in which either benomyl, cycloheximide, or dichloran are incorporated, such as Dichloran Rose Bengal Chloramphenicol medium or Mycoselagar, can be used to select for growth of <emphasis>Scedosporium</emphasis> spp. (<link linkend="ch0150s0000li0037">37</link>). The colonies of <emphasis>S. apiospermum</emphasis> and <emphasis>S. boydii</emphasis> are indistinguishable from each other (<link linkend="ch0150s0000li0037">37</link>)<emphasis>. Scedosporium</emphasis> colonies grow rapidly and are floccose and white at first, becoming gray as conidia are produced. With age, the colonies become dark grayish brown. Submerged ascocarps (cleistothecia) may be produced when isolates are grown on cornmeal agar and are visible macroscopically as small black dots. They are globose, nonostiolate, 100 to 300 μm in diameter (<link linkend="ch0150s0000li0037">37</link>), and often covered with brown, thick-walled, septate hyphae 2 to 3 μm wide. They have a wall 4 to 6 μm thick that is composed of two or three layers of interwoven, flattened, dark brown cells, each 2 to 6 μm wide. The cleistothecia open at maturity by an irregular rupture of the wall. The eight-spored asci are ellipsoidal to nearly spherical and 12 to 18 by 9 to 13 μm. The ascospores are ellipsoidal to oblate, are symmetrical or slightly flattened, measure 6 to 9 by 3.5 to 6.0 μm, are straw colored, and have two germ pores. The anamorph produces conidia that are oval to clavate, truncate, and subhyaline, becoming pale gray to pale brown in masses. Conidia are produced singly and are 5 to 7 by 4 to 6 μm in size for <emphasis>S. apiospermum</emphasis> and 4 to 9 by 6 to 10 μm for <emphasis>S. boydii</emphasis> (<link linkend="ch0150s0000li0037">37</link>). They remain attached at the tips of annellides. Annellations can be detected at the tips of conidiogenous cells as swollen rings. Some isolates also produce a graphium-like anamorph, which is characterized by rope-like bundles of hyphae with annellidic conidiogenesis. The hyphae are fused into long stalks known as synnemata. The conidia produced are hyaline, cylindric to clavate, and truncate at the base. A fungus consisting of elongate, multicellular conidia and described as <emphasis>Polycytella hominis</emphasis> (<link linkend="ch0150s0000li0116">116</link>) was recently proven to be a degenerate anamorph of <emphasis>S. boydii</emphasis> (<link linkend="ch0150s0000li0117">117</link>).</para>
        <anchor id="ch0150s0000a0061"/>
        <beginpage pagenum="2557"/>
      </sect2>
      <sect2 id="ch0150s0011s0006">
        <title>Neotestudina rosatii</title>
        <anchor id="ch0150s0011a0007"/>
        <anchor id="ch0150s0000a0062"/>
        <para id="ch0150s0000p0052">Colonies of<emphasis>N. rosatii</emphasis> are slow growing, attaining diameters of 25 to 28 mm in 2 weeks, and have an aerial mycelium that is grayish black to brownish black (<link linkend="ch0150s0000a0019">Fig. 1J</link>). On potato-carrot or cornmeal agar incubated at 30°C, most of the ascomata are submerged (<link linkend="ch0150s0000a0019">Fig. 1K</link>). The ascostromal walls are smooth and are surrounded by interwoven, brown to hyaline hyphae. The eight-spored asci, 12 to 35 by 10 to 25 μm, are scattered in the central part of the ascostroma (<link linkend="ch0150s0000a0019">Fig. 1L</link>) and are globose to subglobose, thick walled, and bitunicate, becoming evanescent as the ascospores mature. The ascospores vary in size (9 to 12.5 by 4.5 to 8.0 μm) and shape, ranging from ellipsoidal to rhomboidal, asymmetrical, or slightly curved; they are constricted at the median transverse septum and have brown, smooth walls.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0012">
      <title>Assimilation Patterns</title>
      <anchor id="ch0150s0012a0001"/>
      <anchor id="ch0150s0000a0063"/>
      <para id="ch0150s0000p0053">To discriminate fungi causing mycetoma only on the basis of morphological features is difficult. Therefore, some biochemical analyses can be performed to aid in the identification (<anchor id="ch0150s0000a0064"/><link linkend="ch0150s0000a0065">Table 2</link>). For <emphasis>S. apiospermum</emphasis> and <emphasis>S. boydii</emphasis>, this has been done with the Taxa Profile Micronaut assay from Marlin Diagnostika; however, no clear discrimination between the two species was noted (<link linkend="ch0150s0000li0118">118</link>). With respect to growth temperatures, both <emphasis>S. apiospermum</emphasis> and <emphasis>S. boydii</emphasis> grow well at 40°C but not at 45°C (<link linkend="ch0150s0000li0037">37</link>).</para>
      <table id="ch0150s0000t0002"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0150s0000a0065"/><link linkend="ch0150s0000a0064">TABLE 2</link></phrase></emphasis> Assimilation patterns of species causing eumycotic eumycetoma
</title>
        
        <tgroup cols="7">
          <tbody>
            <row>
              <entry><phrase role="center">Test<superscript><emphasis><anchor id="ch0150s0000a0066"/><link linkend="ch0150s0000a0067">a</link></emphasis></superscript></phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>M. mycetomatis</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>F. senegalensis</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>F. tompkinsii</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>T. grisea</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>M. romeroi</emphasis>
                </phrase>
              </entry>
              <entry><phrase role="center">
                  <emphasis>N. mackinnonii</emphasis>
                </phrase>
              </entry>
            </row>
            <row>
              <entry>Growth at 37°C</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
            </row>
            <row>
              <entry>Assimilation of:</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Galactose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry>Actidione</entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Saccharose (sucrose)</entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis>N</emphasis>-Acetyl-glucosamine</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">DL</emphasis>-Lactate</entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">L</emphasis>-Arabinose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Cellobiose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Raffinose</entry>
              <entry><phrase role="center">W</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Maltose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Trehalose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry>Potassium 2-ketogluconate</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis>methyl</emphasis>-<emphasis role="smallcaps">D</emphasis>-Glucopyranoside</entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Mannitol</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Lactose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
            </row>
            <row>
              <entry>Inositol</entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Sorbitol</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Xylose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Ribose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
            </row>
            <row>
              <entry>Glycerol</entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">L</emphasis>-Rhamnose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry>Palatinose</entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry>Erythritol</entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Melibiose</entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry>Sodium glucuronate</entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Melezitose</entry>
              <entry><phrase role="center">W</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry>Potassium gluconate</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
            </row>
            <row>
              <entry>Levulinate</entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+/−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">D</emphasis>-Glucose</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis role="smallcaps">L</emphasis>-Sorbose</entry>
              <entry><phrase role="center">W</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">W</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
            </row>
            <row>
              <entry>Glucosamine</entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">−</phrase>
              </entry>
            </row>
            <row>
              <entry>Esculin</entry>
              <entry><phrase role="center">−</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">W</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry>Salt tolerance test (NaCl)</entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">20%</phrase>
              </entry>
              <entry><phrase role="center">20%</phrase>
              </entry>
              <entry><phrase role="center">20%</phrase>
              </entry>
              <entry><phrase role="center">20%</phrase>
              </entry>
              <entry><phrase role="center">20%</phrase>
              </entry>
            </row>
            <row>
              <entry>Laccase test</entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">−/W</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
            <row>
              <entry>Urease test</entry>
              <entry><phrase role="center">ND</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
              <entry><phrase role="center">+</phrase>
              </entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0150s0000a0067"/><link linkend="ch0150s0000a0066">a</link></emphasis></superscript>Data from reference <link linkend="ch0150s0000li0014">14</link>. Results were positive (+), negative (−), weak (W), positive or negative (+/−), negative or positive (−/+), or not done (ND).</para>
      <para id="ch0150s0000p0054">It is known that<emphasis>M. mycetomatis</emphasis> grows better at 37°C than at 30°C, with a maximum of 40°C, whereas <emphasis>T. grisea</emphasis> grows better at 30°C than at 37°C. <emphasis>M. mycetomatis</emphasis> is slowly proteolytic and utilizes glucose, maltose, and galactose but not sucrose. It utilizes potassium nitrate, ammonium sulfate, asparagine, and urea, and it hydrolyzes starch. <emphasis>T. grisea</emphasis>, on the other hand, is weakly proteolytic and assimilates glucose, maltose, and sucrose but not lactose (<link linkend="ch0150s0000a0065">Table 2</link>).</para>
      <anchor id="ch0150s0000a0068"/>
      <beginpage pagenum="2558"/>
      <para id="ch0150s0000p0055">The pleosporalean eumycetoma-causative agents<emphasis>F. senegalensis, F. tompkinsii, T. grisea, M. romeroi, N. mackinnonii,</emphasis> and <emphasis>Pseudochaetosphaeronema larense</emphasis> all are able to assimilate <emphasis role="smallcaps">D</emphasis>-galactose, <emphasis role="smallcaps">D</emphasis>-saccharose, <emphasis>N</emphasis>-acetylglucosamine, <emphasis role="smallcaps">D</emphasis>-cellobiose, <emphasis role="smallcaps">D</emphasis>-raffinose, <emphasis role="smallcaps">D</emphasis>-maltose, <emphasis role="smallcaps">D</emphasis>-trehalose, <emphasis role="smallcaps">D</emphasis>-mannitol, <emphasis role="smallcaps">L</emphasis>-rhamnose, <emphasis role="smallcaps">D</emphasis>-melezitose, palatinose, and <emphasis role="smallcaps">D</emphasis>-glucose but not <emphasis role="smallcaps">DL</emphasis>-lactate, potassium gluconate, sodium glucuronate, and glucosamine (<link linkend="ch0150s0000li0014">14</link>). <emphasis>F. senegalensis</emphasis> does not assimilate potassium 2-ketogluconate, erythritol, or <emphasis role="smallcaps">D</emphasis>-melibiose, whereas <emphasis>F. tompkinsii, T. grisea, M. romeroi, N. mackinnonii</emphasis>, and <emphasis>P. larense</emphasis> do (<link linkend="ch0150s0000li0014">14</link>). Furthermore, <emphasis>F. senegalensis</emphasis> is able to assimilate <emphasis role="smallcaps">D</emphasis>-lactose, whereas the majority of the pleosporalean eumycetoma-causative agents do not. <emphasis>F. tompkinsii</emphasis> is the only species that does not assimilate inositol and sorbitol (<link linkend="ch0150s0000li0014">14</link>). <emphasis>M. romeroi</emphasis> is the only species that does not assimilate methyl-<emphasis role="smallcaps">D</emphasis>-glucopyranoside, and <emphasis>N. mackinnonii</emphasis> is susceptible to cycloheximide and able to assimilate <emphasis role="smallcaps">D</emphasis>-xylose (<link linkend="ch0150s0000li0014">14</link>).</para>
    </sect1>
    <sect1 id="ch0150s0013">
      <title>Molecular Identification</title>
      <anchor id="ch0150s0013a0001"/>
      <anchor id="ch0150s0000a0069"/>
      <para id="ch0150s0000p0056">Currently the gold standard for species identification of all fungi is sequencing of the ITS region—the primary fungal DNA barcode—with primers V9G and LS266. Identification is then performed either by Sanger sequencing (<link linkend="ch0150s0000li0119">119</link>), by restriction fragment length polymorphism analysis (<link linkend="ch0150s0000li0021">21</link>), or by using rolling-circle amplification (RCA) (<link linkend="ch0150s0000li0120">120</link>, <link linkend="ch0150s0000li0121">121</link>), all of which are more reliable than identification based on culture (<link linkend="ch0150s0000li0017">17</link>). Padlock probes for RCA have been developed for <emphasis>M. mycetomatis</emphasis> (<link linkend="ch0150s0000li0120">120</link>), <emphasis>M. pseudomycetomatis</emphasis> (<link linkend="ch0150s0000li0120">120</link>), <emphasis>M. fahalii</emphasis> (<link linkend="ch0150s0000li0120">120</link>), <emphasis>M. tropicana, F. senegalensis</emphasis> (<link linkend="ch0150s0000li0120">120</link>), <emphasis>F. tompkinsii</emphasis> (<link linkend="ch0150s0000li0120">120</link>), <emphasis>T. grisea</emphasis> (<link linkend="ch0150s0000li0120">120</link>), <emphasis>M. romeroi</emphasis> (<link linkend="ch0150s0000li0120">120</link>), <emphasis>S. boydii</emphasis> (<link linkend="ch0150s0000li0121">121</link>, <link linkend="ch0150s0000li0122">122</link>), and <emphasis>S. apiospermum</emphasis> (<link linkend="ch0150s0000li0122">122</link>).</para>
      <para id="ch0150s0000p0057">Molecular assays that can directly identify the causative agent were also developed for some species. For<emphasis>M. mycetomatis</emphasis> (<link linkend="ch0150s0000li0021">21</link>, <link linkend="ch0150s0000li0123">123</link>), <emphasis>M. pseudomycetomatis</emphasis> (<link linkend="ch0150s0000li0011">11</link>), and <emphasis>S. apiospermum</emphasis> (<link linkend="ch0150s0000li0124">124</link>–<link linkend="ch0150s0000li0127">127</link>), species-specific PCRs have been developed which can be directly performed on DNA isolated from infected tissue. These PCRs were based on the ITS region or on specific regions identified by sequencing specific genomic fragments. Currently, the <emphasis>M. mycetomatis</emphasis>-specific PCR developed by Ahmed et al. is most widely used (<link linkend="ch0150s0000li0021">21</link>). However, recently it was demonstrated that this PCR gives rise to a PCR product of another size with <emphasis>M. pseudomycetomatis</emphasis> (<link linkend="ch0150s0000li0011">11</link>, <link linkend="ch0150s0000li0123">123</link>). The other PCR developed in the same paper cross-reacted with <emphasis>M. tropicana, M. fahalii</emphasis>, and <emphasis>M. pseudomycetomatis</emphasis>, species not described at the time that PCR was developed (<link linkend="ch0150s0000li0011">11</link>). The primers developed by Lim et al. seemed more specific, as no cross-reaction was noted with any of the other eumycetoma-causative agents (<link linkend="ch0150s0000li0123">123</link>).</para>
      <para id="ch0150s0000p0058">In contrast to classical PCRs, which are visualized on a gel, real-time PCRs were developed for<emphasis>Madurella</emphasis> and <emphasis>Scedosporium</emphasis> species (<link linkend="ch0150s0000li0128">128</link>, <link linkend="ch0150s0000li0129">129</link>). For <emphasis>M. mycetomatis</emphasis> and <emphasis>M. fahalii</emphasis>, species-specific primers were designed on the ITS region (<link linkend="ch0150s0000li0128">128</link>). A real-time multiplex assay has been developed to differentiate <emphasis>M. mycetomatis, M. pseudomycetomatis, M. tropicana</emphasis>, and <emphasis>M. fahalii</emphasis> (<link linkend="ch0150s0000li0128">128</link>). Further, isothermal amplification techniques, including loop-mediated amplification (LAMP) (<link linkend="ch0150s0000li0111">111</link>, <link linkend="ch0150s0000li0130">130</link>, <link linkend="ch0150s0000li0131">131</link>) and recombinase polymerase amplification (RPA) (<link linkend="ch0150s0000li0111">111</link>), have been developed for <emphasis>M. mycetomatis</emphasis> and <emphasis>S. apiospermum.</emphasis> Of these isothermal amplification techniques, the RPA had a lower detection limit than LAMP, and fewer false-negative reactions were observed (<link linkend="ch0150s0000li0111">111</link>).</para>
      <sect2 id="ch0150s0013s0001">
        <title>MALDI-TOF MS</title>
        <anchor id="ch0150s0013a0002"/>
        <anchor id="ch0150s0000a0070"/>
        <para id="ch0150s0000p0059">Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has been used to identify black grain eumycetoma-causative agents and<emphasis>Scedosporium</emphasis> spp. The VITEK MS v3.2 database for the bioMérieux VITEK MS contains spectra for the occasional causative agent <emphasis>S. boydii</emphasis> and the rare causative agents <emphasis>Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Cladophialophora bantiana, Fusarium oxysporum, Fusarium solani, Microsporum audouinii, Microsporum canis</emphasis>, and <emphasis>Scedosporium apiospermum</emphasis>, but not the common causative agent <emphasis>M. mycetomatis</emphasis> and the occasional causative agents <emphasis>F. senegalensis, T. grisea, M. romeroi</emphasis>, and <emphasis>N. mackinnonii.</emphasis> The Bruker filamentous fungal library version 4.0 from the Bruker MALDI Biotyper does not contain the most common causative agents of black grain human eumycetoma (<link linkend="ch0150s0000li0132">132</link>). It does contain <emphasis>S. boydii</emphasis> and <emphasis>S. apiospermum</emphasis>, the most common causative agents of white grain eumycetoma. Fraser et al. constructed a database for the Bruker MALDI Biotyper able to identify all 50 isolates of <emphasis>M. mycetomatis, F. senegalensis, M. romeroi, N. mackinnonii, E. grisea, E. paragrisea, M. fahalii</emphasis>, and <emphasis>R. rufulum</emphasis> when using a MALDI-TOF log score of &gt;1.8, and 33 isolates when using a log score of &gt;2.0 (<link linkend="ch0150s0000li0133">133</link>). The identification of <emphasis>Scedosporium</emphasis> spp. by the Bruker MALDI Biotyper was also improved when spectra from local strains were included in the database (<link linkend="ch0150s0000li0134">134</link>, <link linkend="ch0150s0000li0135">135</link>).</para>
      </sect2>
      <sect2 id="ch0150s0013s0002">
        <title>TYPING SYSTEMS</title>
        <anchor id="ch0150s0013a0003"/>
        <anchor id="ch0150s0000a0071"/>
        <para id="ch0150s0000p0060">Over the years, many molecular typing techniques have been established for a number of fungal species, including those causing eumycetoma. Such techniques are useful not only in genotyping but also in accurate species identification (<link linkend="ch0150s0000li0021">21</link>). Genotyping enables differentiation of environmental and clinical isolates, and therefore it is an important tool in understanding the environmental distribution of species and source of infection. For <emphasis>M. mycetomatis</emphasis>, several typing techniques have been developed over the years, including random amplified polymorphic DNA (RAPD) (<link linkend="ch0150s0000li0136">136</link>, <link linkend="ch0150s0000li0137">137</link>), restriction endonuclease assay (REA) (<link linkend="ch0150s0000li0137">137</link>), amplified fragment length polymorphism (AFLP) (<link linkend="ch0150s0000li0138">138</link>), variable number tandem repeat (VNTR) (<link linkend="ch0150s0000li0138">138</link>), and the short tandem repeat assay MmySTR (<link linkend="ch0150s0000li0139">139</link>). Of these techniques, MmySTR was found to be stable, reproducible, and specific and had the highest diversity index (<link linkend="ch0150s0000li0139">139</link>). An AFLP was also developed for <emphasis>M. pseudomycetomatis</emphasis> (<link linkend="ch0150s0000li0011">11</link>).</para>
        <para id="ch0150s0000p0061">For<emphasis>S. boydii</emphasis> and <emphasis>S. apiospermum</emphasis>, web-based multilocus sequence typing (MLST) assays have been developed (<ulink url="https://mlst.mycologylab.org">https://mlst.mycologylab.org</ulink>) (<link linkend="ch0150s0000li0140">140</link>). Subspecific typing of <emphasis>S. apiospermum</emphasis> at the population level is not problematic, because of the large degree of heterogeneity. Rainer et al. (<link linkend="ch0150s0000li0141">141</link>) found with M-13 fingerprinting, a PCR-based typing system in which the core sequence of phage M13 is used as a single primer, that nearly all strains analyzed belonged to different genotypes; several genotypes were recovered from a single sampling site. The high degree of polymorphism enabled Zouhair et al. (<link linkend="ch0150s0000li0142">142</link>) to monitor the dissemination of a strain colonizing the lungs of a patient with cystic fibrosis to cutaneous locations by using multilocus enzyme electrophoresis and randomly amplified polymorphic DNA. In a longitudinal study, Defontaine et al. (<link linkend="ch0150s0000li0143">143</link>) analyzed nine patients with cystic fibrosis, none of whom were found to harbor strains that shared the same genotype.</para>
        <anchor id="ch0150s0000a0072"/>
        <beginpage pagenum="2559"/>
      </sect2>
      <sect2 id="ch0150s0013s0003">
        <title>SEROLOGIC TESTS</title>
        <anchor id="ch0150s0013a0004"/>
        <anchor id="ch0150s0000a0073"/>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0014">
      <title>(1→3)-β-D-Glucan Detection</title>
      <anchor id="ch0150s0014a0001"/>
      <anchor id="ch0150s0000a0074"/>
      <para id="ch0150s0000p0062">There are currently no specific commercially available antigen tests for detecting any of the eumycetoma-causative agents, but the panfungal (1→3)-β-<emphasis role="smallcaps">D</emphasis>-glucan detection assay could be of use to monitor disease progression (see <ulink url="ch0141#ch0141s0001">chapter 120</ulink> of this <emphasis>Manual</emphasis>). (1→3)-β-<emphasis role="smallcaps">D</emphasis>-glucan has been detected in serum of eumycetoma patients (<link linkend="ch0150s0000li0144">144</link>). Unfortunately, since (1→3)-β-<emphasis role="smallcaps">D</emphasis>-glucan is panfungal, it cannot discriminate between the different causative agents (<link linkend="ch0150s0000li0144">144</link>). Furthermore, it also cannot discriminate between actinomycetoma and eumycetoma, as (1→3)-β-<emphasis role="smallcaps">D</emphasis>-glucan has been detected in serum from both types (<link linkend="ch0150s0000li0144">144</link>).</para>
    </sect1>
    <sect1 id="ch0150s0015">
      <title>In-House-Made Antibody Detection Methods</title>
      <anchor id="ch0150s0015a0001"/>
      <anchor id="ch0150s0000a0075"/>
      <para id="ch0150s0000p0063">Antibody detection tests created in-house have been used in some locations where eumycetoma is endemic (<link linkend="ch0150s0000li0145">145</link>–<link linkend="ch0150s0000li0149">149</link>); these include immunodiffusion, counter-immunoelectrophoresis (CIE), and enzyme-linked immunosorbent assays (ELISAs) using crude antigens prepared from fungal hyphae (<link linkend="ch0150s0000li0083">83</link>) or recombinant proteins, such as the <emphasis>M. mycetomatis</emphasis> translationally controlled tumor protein, fructose bisphosphate aldolase, and pyruvate kinase (<link linkend="ch0150s0000li0102">102</link>, <link linkend="ch0150s0000li0103">103</link>, <link linkend="ch0150s0000li0115">115</link>, <link linkend="ch0150s0000li0150">150</link>). Immunodiffusion could discriminate between eumycetomas due to <emphasis>M. mycetomatis</emphasis> and actinomycetoma (<link linkend="ch0150s0000li0146">146</link>). The ELISA developed by Wethered et al. (<link linkend="ch0150s0000li0148">148</link>) for <emphasis>M. mycetomatis</emphasis> cytoplasmic antigens could clearly differentiate between patients and healthy controls based on IgM antibody responses, but when this ELISA was repeated by Zaini et al. (<link linkend="ch0150s0000li0150">150</link>), no differentiation between patients and healthy controls was obtained. The clinical value of all of these in-house serological tests is hampered by lack of standardized antigen preparations, sensitivity, and specificity, and therefore none of them is still in use.</para>
      <para id="ch0150s0000p0064">Recently, three immunodominant proteins of 45 kDa, 60 kDa, and 95 kDa with high specificity for<emphasis>M. mycetomatis</emphasis> were identified in a cytoplasmatic extract of <emphasis>M. mycetomatis</emphasis> (<link linkend="ch0150s0000li0145">145</link>). This preparation was tested with 100 patients in Sudan, but clinical use of this assay still needs to be evaluated (<link linkend="ch0150s0000li0145">145</link>). Of all the assays described, CIE was deemed most reliable and was used for many years by the Mycetoma Research Centre in Khartoum, Sudan, as a routine diagnostic tool, until problems with the reproducibility of the antigen preparation ended use of this assay.</para>
      <para id="ch0150s0000p0065">For<emphasis>S. boydii</emphasis> and <emphasis>S. apiospermum</emphasis>, a specific monoclonal antibody recognizing a 120-kDa extracellular antigen located in the spore and hyphal walls has been generated that enables species identification (<link linkend="ch0150s0000li0151">151</link>). Furthermore, two recombinant proteins corresponding to <emphasis>S. boydii</emphasis> catalase A1 (CatA1) and <emphasis>S. boydii</emphasis> cytosolic Cu,Zn-superoxide dismutase (SODC) were able to detect antibodies generated during a respiratory infection in cystic fibrosis patients (<link linkend="ch0150s0000li0152">152</link>). It is still to be determined whether these recombinant antigens are also able to detect antibodies in eumycetoma patients.</para>
      <sect2 id="ch0150s0015s0001">
        <title>ANTIMICROBIAL SUSCEPTIBILITIES</title>
        <anchor id="ch0150s0015a0002"/>
        <anchor id="ch0150s0000a0076"/>
      </sect2>
    </sect1>
    <sect1 id="ch0150s0016">
      <title>In Vitro Susceptibility Testing</title>
      <anchor id="ch0150s0016a0001"/>
      <anchor id="ch0150s0000a0077"/>
      <para id="ch0150s0000p0066">For most of the eumycetoma-causative agents,<emphasis>in vitro</emphasis> susceptibility assays based on the M38A protocol of the Clinical and Laboratory Standards Institute (CLSI) have been used (<link linkend="ch0150s0000li0092">92</link>). These either were in-house assays (<link linkend="ch0150s0000li0153">153</link>–<link linkend="ch0150s0000li0159">159</link>) or used the commercial YeastOne testing panel (<link linkend="ch0150s0000li0159">159</link>–<link linkend="ch0150s0000li0161">161</link>). For some of the causative agents, such as the nonsporulating <emphasis>Madurella</emphasis> species, adaptation of these protocols was required to perform <emphasis>in vitro</emphasis> susceptibility testing with hyphal fragments instead of conidia (<link linkend="ch0150s0000li0092">92</link>). This consisted of generation of hyphal fragments by either sonication (<link linkend="ch0150s0000li0153">153</link>) or bead-beating with glass beads (<link linkend="ch0150s0000li0162">162</link>) and the use of viability dyes such as XTT (<link linkend="ch0150s0000li0153">153</link>, <link linkend="ch0150s0000li0154">154</link>, <link linkend="ch0150s0000li0157">157</link>) and resazurin (<link linkend="ch0150s0000li0163">163</link>). When using the resazurin derivative alamar blue, the pyomelanin secreted by <emphasis>M. mycetomatis</emphasis> did not influence visual endpoint reading; however, it resulted in a loss in the resorufin peak when read spectrophotometrically (<link linkend="ch0150s0000li0161">161</link>).</para>
      <para id="ch0150s0000p0067">Recently, as well as these microdilution-based methods, disk diffusion, E-testing, and VIP check have also been used (<link linkend="ch0150s0000li0162">162</link>). Comparable MICs (MICs within a 2-dilution-step difference) between microdilution and E-testing for itraconazole and posaconazole were obtained for 80% and 90% of the isolates tested, respectively (<link linkend="ch0150s0000li0162">162</link>).</para>
      <para id="ch0150s0000p0068">When using microdilution assays, with the exception of<emphasis>M. fahalii, Madurella</emphasis> species have in general low minimal inhibitory concentrations (MICs) for the azoles ketoconazole (<link linkend="ch0150s0000li0011">11</link>, <link linkend="ch0150s0000li0157">157</link>, <link linkend="ch0150s0000li0159">159</link>), itraconazole (<link linkend="ch0150s0000li0011">11</link>, <link linkend="ch0150s0000li0157">157</link>, <link linkend="ch0150s0000li0159">159</link>), posaconazole (<link linkend="ch0150s0000li0011">11</link>, <link linkend="ch0150s0000li0157">157</link>), voriconazole (<link linkend="ch0150s0000li0011">11</link>, <link linkend="ch0150s0000li0157">157</link>, <link linkend="ch0150s0000li0159">159</link>), isavuconazole (<link linkend="ch0150s0000li0155">155</link>), and ravuconazole (<link linkend="ch0150s0000li0154">154</link>) and the orotomide olorofim (<link linkend="ch0150s0000li0156">156</link>). Higher MICs have been obtained for the azole fluconazole (<link linkend="ch0150s0000li0011">11</link>, <link linkend="ch0150s0000li0157">157</link>, <link linkend="ch0150s0000li0159">159</link>), the polyene amphotericin B (<link linkend="ch0150s0000li0153">153</link>, <link linkend="ch0150s0000li0159">159</link>, <link linkend="ch0150s0000li0160">160</link>), and terbinafine (<link linkend="ch0150s0000li0157">157</link>).</para>
      <para id="ch0150s0000p0069">For the pleosporalean fungi,<emphasis>F. senegalensis, F. tompkinsii, T. grisea, M. romeroi, N. mackinnonii, E. grisea</emphasis>, and <emphasis>E. paragrisea</emphasis>, in general 10 times higher MICs for the azoles are reported. For terbinafine, the opposite was noted. <emphasis>F. senegalensis</emphasis> and <emphasis>M. romeroi</emphasis> had in general 10-fold lower MICs for terbinafine than <emphasis>M. mycetomatis</emphasis> (<link linkend="ch0150s0000li0164">164</link>).</para>
      <para id="ch0150s0000p0070">None of the eumycetoma-causative agents was susceptible to the echinocandins or 5-flucytosine (<anchor id="ch0150s0000a0078"/><link linkend="ch0150s0000a0082">Table 3</link>). <emphasis>In vitro</emphasis>, no difference was noted when itraconazole was combined with either terbinafine or olorofim (<link linkend="ch0150s0000li0156">156</link>, <link linkend="ch0150s0000li0165">165</link>).</para>
      <para id="ch0150s0000p0071">The<emphasis>in vitro</emphasis> susceptibility assay for <emphasis>M. mycetomatis</emphasis> has also been used in the open source drug-discovery program MycetOS (<ulink url="https://github.com/OpenSourceMycetoma/General-Start-Here">https://github.com/OpenSourceMycetoma/General-Start-Here</ulink>), in which currently more than 1,200 drug-like compounds have been screened (<link linkend="ch0150s0000li0166">166</link>).</para>
    </sect1>
    <sect1 id="ch0150s0017">
      <title>In Vivo Animal Models</title>
      <anchor id="ch0150s0017a0001"/>
      <anchor id="ch0150s0000a0079"/>
      <para id="ch0150s0000p0072">There is currently a large gap between the<emphasis>in vitro</emphasis> susceptibility data and clinical outcome. Only seven studies have tested the efficacy of antifungal agents against eumycetoma in animals: five in the invertebrate <emphasis>Galleria mellonella</emphasis> (<link linkend="ch0150s0000li0164">164</link>, <link linkend="ch0150s0000li0166">166</link>–<link linkend="ch0150s0000li0168">168</link>) and two in mice (<link linkend="ch0150s0000li0169">169</link>, <link linkend="ch0150s0000li0170">170</link>). In all <emphasis>in vivo</emphasis> models, <emphasis>M. mycetomatis</emphasis> was the causative agent studied (<link linkend="ch0150s0000li0164">164</link>, <link linkend="ch0150s0000li0168">168</link>–<link linkend="ch0150s0000li0170">170</link>). In these studies, it was demonstrated that although <emphasis>M. mycetomatis</emphasis> was highly susceptible <emphasis>in vitro</emphasis> to azole antifungal agents, <emphasis>in vivo</emphasis> therapeutic efficacy was found only for ravuconazole (<link linkend="ch0150s0000li0164">164</link>) and bitertanol (<link linkend="ch0150s0000li0166">166</link>), whereas no therapeutic efficacy was demonstrated for ketoconazole (<link linkend="ch0150s0000li0168">168</link>), itraconazole (<link linkend="ch0150s0000li0167">167</link>, <link linkend="ch0150s0000li0168">168</link>, <link linkend="ch0150s0000li0170">170</link>), or voriconazole (<link linkend="ch0150s0000li0168">168</link>). The therapeutic efficacy of posaconazole was concentration dependent (<link linkend="ch0150s0000li0166">166</link>, <link linkend="ch0150s0000li0168">168</link>), and that from luliconazole and eberconazole was time dependent (<link linkend="ch0150s0000li0164">164</link>). Although higher MICs have been obtained for amphotericin B and terbinafine, these antifungal agents showed better therapeutic efficacy in larvae of <emphasis>G. mellonella</emphasis> (<link linkend="ch0150s0000li0167">167</link>, <link linkend="ch0150s0000li0168">168</link>) and mice (<link linkend="ch0150s0000li0170">170</link>). Combining amphotericin B, terbinafine, or itraconazole was antagonistic in <emphasis>G. mellonella</emphasis> larvae (<link linkend="ch0150s0000li0167">167</link>).</para>
      <anchor id="ch0150s0000a0080"/>
      <beginpage pagenum="2560"/>
      <anchor id="ch0150s0000a0081"/>
      <beginpage pagenum="2561"/>
      <table id="ch0150s0000t0003"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0150s0000a0082"/><link linkend="ch0150s0000a0078">TABLE 3</link></phrase></emphasis> <emphasis>In vitro</emphasis> susceptibilities of eumycetoma-causative fungi<superscript><emphasis><anchor id="ch0150s0000a0083"/><link linkend="ch0150s0000a0086">a</link></emphasis></superscript>
</title>
        
        <tgroup cols="16">
          <tbody>
            <row>
              <entry><phrase role="center">Species</phrase>
              </entry>
              <entry><phrase role="center">MIC<subscript>50</subscript> (μg/ml) (range; <emphasis>n</emphasis>)</phrase>
              </entry>
              <entry><phrase role="center">Reference(s)</phrase>
              </entry>
            </row>
            <row>
              <entry><phrase role="center">AMB</phrase>
              </entry>
              <entry><phrase role="center">KTZ</phrase>
              </entry>
              <entry><phrase role="center">ITZ</phrase>
              </entry>
              <entry><phrase role="center">PCZ</phrase>
              </entry>
              <entry><phrase role="center">FLZ</phrase>
              </entry>
              <entry><phrase role="center">VCZ</phrase>
              </entry>
              <entry><phrase role="center">ISA</phrase>
              </entry>
              <entry><phrase role="center">RVZ</phrase>
              </entry>
              <entry><phrase role="center">TBF</phrase>
              </entry>
              <entry><phrase role="center">5-FC</phrase>
              </entry>
              <entry><phrase role="center">CAS</phrase>
              </entry>
              <entry><phrase role="center">ANI</phrase>
              </entry>
              <entry><phrase role="center">MCF</phrase>
              </entry>
              <entry><phrase role="center">OLO</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis>Madurella mycetomatis</emphasis>
              </entry>
              <entry>0.5 (&lt;0.016–4; 34)</entry>
              <entry>0.06 (&lt;0.03–4; 38)</entry>
              <entry>0.03 (&lt;0.03–0.5; 38)</entry>
              <entry>&lt;0.03 (&lt;0.03–0.125; 34)</entry>
              <entry>4 (0.25–&gt;128; 34)</entry>
              <entry>0.06 (&lt;0.016–1; 34)</entry>
              <entry>0.03 (&lt;0.016–0.25; 22)</entry>
              <entry>0.004 (&lt;0.002–0.03; 23)</entry>
              <entry>8 (1–&gt;16; 34)</entry>
              <entry>&gt;64 (&gt;64; 34)</entry>
              <entry>64 (6–&gt;128; 17)</entry>
              <entry>&gt;128 (0.5–&gt;128; 17)</entry>
              <entry>&gt;128 (8–&gt;128; 17)</entry>
              <entry>0.016 (0.004–0.125; 21)</entry>
              <entry><link linkend="ch0150s0000li0153">153</link>–<link linkend="ch0150s0000li0159">159</link>, <link linkend="ch0150s0000li0235">236</link>, <link linkend="ch0150s0000li0236">237</link></entry>
            </row>
            <row>
              <entry><emphasis>Madurella pseudomycetomatis</emphasis>
              </entry>
              <entry>0.5 (0.125–1; 7)</entry>
              <entry>0.03 (0.03; 1)</entry>
              <entry>0.03 (0.016–0.06; 7)</entry>
              <entry>0.016 (0.008–0.06; 7)</entry>
              <entry>16 (0.125–32; 7)</entry>
              <entry>0.06 (0.008–0.25; 7)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry>&gt;64 (&gt;64; 7)</entry>
              <entry>&gt;8 (&gt;8; 7)</entry>
              <entry>&gt;8 (&gt;8; 7)</entry>
              <entry>&gt;8 (&gt;8; 7)</entry>
              <entry/>
              <entry><link linkend="ch0150s0000li0005">5</link>, <link linkend="ch0150s0000li0011">11</link></entry>
            </row>
            <row>
              <entry><emphasis>Madurella tropicana</emphasis>
              </entry>
              <entry>0.125 (0.125; 1)</entry>
              <entry>0.01 (0.01; 1)</entry>
              <entry>0.01 (0.01; 1)</entry>
              <entry>0.03 (0.03; 1)</entry>
              <entry>4 (4; 1)</entry>
              <entry>0.03 (0.03; 1)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry>&gt;64 (&gt;64; 1)</entry>
              <entry>&gt;16 (&gt;16; 1)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0005">5</link>
              </entry>
            </row>
            <row>
              <entry><emphasis>Madurella fahalii</emphasis>
              </entry>
              <entry>0.5 (0.5; 1)</entry>
              <entry>2 (2; 1)</entry>
              <entry>&gt;16 (&gt;16; 1)</entry>
              <entry>1 (1; 1)</entry>
              <entry>&gt;256 (&gt;256; 1)</entry>
              <entry>1 (1; 1)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry>&gt;64 (&gt;64; 1)</entry>
              <entry>&gt;16 (&gt;16; 1)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0005">5</link>
              </entry>
            </row>
            <row>
              <entry><emphasis>Scedosporium boydii</emphasis>
              </entry>
              <entry>1 (0.25–2; 21)</entry>
              <entry/>
              <entry>0.25 (&lt;0.03–4; 21)</entry>
              <entry>0.5 (ND; 30)</entry>
              <entry>16 (8–32; 21)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0235">236</link>, <link linkend="ch0150s0000li0237">238</link>, <link linkend="ch0150s0000li0238">239</link></entry>
            </row>
            <row>
              <entry><emphasis>Falciformispora senegalensis</emphasis>
              </entry>
              <entry>2 (2; 4)</entry>
              <entry>0.5 (0.5–1; 4)</entry>
              <entry>0.125 (0.125–0.25; 4)</entry>
              <entry>0.06 (0.06–0.25; 4)</entry>
              <entry>64 (64–128; 4)</entry>
              <entry>0.25 (0.25–0.5; 4)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0160">160</link>, <link linkend="ch0150s0000li0235">236</link></entry>
            </row>
            <row>
              <entry><emphasis>Falciformispora tomkinsii</emphasis>
              </entry>
              <entry>2 (2; 3)</entry>
              <entry>1 (1; 2)</entry>
              <entry>0.25 (0.25; 3)</entry>
              <entry>0.25 (0.25; 3)</entry>
              <entry>64 (64; 3)</entry>
              <entry>0.5 (0.5; 3)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry>64 (64; 3)</entry>
              <entry>&gt;16 (&gt;16; 3)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0160">160</link>
              </entry>
            </row>
            <row>
              <entry><emphasis>Trematosphaeria grisea</emphasis>
              </entry>
              <entry>8 (2–&gt;16; 3)</entry>
              <entry>1 (0.125–8; 11)</entry>
              <entry>0.5 (0.03–4; 11)</entry>
              <entry>0.03 (0.03–0.25; 3)</entry>
              <entry>64 (16–64, 3)</entry>
              <entry>0.25 (0.25–0.5; 3)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry>64 (16–&gt;64; 3)</entry>
              <entry>&gt;16 (8–&gt;16; 3)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0160">160</link>, <link linkend="ch0150s0000li0235">236</link>, <link linkend="ch0150s0000li0239">240</link></entry>
            </row>
            <row>
              <entry><emphasis>Medicopsis romeroi</emphasis>
              </entry>
              <entry>1 (0.125–4; 14)</entry>
              <entry>4 (0.125–8; 7)</entry>
              <entry>8 (0.125–&gt;16; 16)</entry>
              <entry>0.5 (0.25–1; 5)</entry>
              <entry>&gt;256 (&gt;256; 5)</entry>
              <entry>0.25 (0.125–0.5; 14)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry>8 (8–32, 5)</entry>
              <entry>8 (4–&gt;16; 5)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0160">160</link>, <link linkend="ch0150s0000li0235">236</link>, <link linkend="ch0150s0000li0239">240</link></entry>
            </row>
            <row>
              <entry><emphasis>Nigrograna mackinnonii</emphasis>
              </entry>
              <entry>0.5 (0.25–2; 10)</entry>
              <entry>0.5 (0.5; 2)</entry>
              <entry>0.5 (0.25–2; 10)</entry>
              <entry>0.125 (0.125–0.25; 2)</entry>
              <entry>64 (64; 2)</entry>
              <entry>0.5 (0.125–1; 10)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry>8 (8–64; 2)</entry>
              <entry>16 (2–&gt;16; 10)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0160">160</link>
              </entry>
            </row>
            <row>
              <entry><emphasis>Emarellia grisea</emphasis>
              </entry>
              <entry>0.5 (0.25–4; 5)</entry>
              <entry/>
              <entry>0.25 (0.06–0.5; 5)</entry>
              <entry/>
              <entry/>
              <entry>0.25 (0.125–0.5; 5)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry>8 (4–16; 5)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0017">17</link>
              </entry>
            </row>
            <row>
              <entry><emphasis>Emarellia paragrisea</emphasis>
              </entry>
              <entry>1 (1; 1)</entry>
              <entry/>
              <entry>0.125 (0.125; 1)</entry>
              <entry/>
              <entry/>
              <entry>0.125 (0.125; 1)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry>8 (8; 1)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0017">17</link>
              </entry>
            </row>
            <row>
              <entry><emphasis>Exophiala dermatitidis</emphasis>
              </entry>
              <entry>1 (0.25–4; 51)</entry>
              <entry/>
              <entry>1 (&lt;0.015–2; 51)</entry>
              <entry>0.5 (&lt;0.03–2; 51)</entry>
              <entry>32 (8–&gt;64; 51)</entry>
              <entry>0.25 (0.06–2; 18)</entry>
              <entry/>
              <entry/>
              <entry>0.25 (&lt;0.03–4; 18)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0240">241</link>
              </entry>
            </row>
            <row>
              <entry><emphasis>Exophiala jeanselmei</emphasis>
              </entry>
              <entry>1 (0.25–2; 17)</entry>
              <entry>4 (1–8; 3)</entry>
              <entry>0.06 (0.015–0.25; 17)</entry>
              <entry>0.03 (0.016–0.063; 17)</entry>
              <entry>16 (8–32; 9)</entry>
              <entry>0.5 (0.125–2; 17)</entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry>4 (2–8; 9)</entry>
              <entry>0.5 (0.063–4; 9)</entry>
              <entry/>
              <entry/>
              <entry><link linkend="ch0150s0000li0053">53</link>, <link linkend="ch0150s0000li0235">236</link>, <link linkend="ch0150s0000li0236">237</link>, <link linkend="ch0150s0000li0241">242</link></entry>
            </row>
            <row>
              <entry>Blood/serum level</entry>
              <entry/>
              <entry/>
              <entry>&gt;1–2<superscript><emphasis><anchor id="ch0150s0000a0084"/><link linkend="ch0150s0000a0087">b</link></emphasis></superscript></entry>
              <entry>&gt;0.5–1.5<superscript><emphasis><link linkend="ch0150s0000a0087">b</link></emphasis></superscript></entry>
              <entry/>
              <entry>&gt;1–6<superscript><emphasis><link linkend="ch0150s0000a0087">b</link></emphasis></superscript></entry>
              <entry/>
              <entry/>
              <entry>2.8–3<superscript><emphasis><anchor id="ch0150s0000a0085"/><link linkend="ch0150s0000a0088">c</link></emphasis></superscript></entry>
              <entry>&gt;20–50<superscript><emphasis><link linkend="ch0150s0000a0087">b</link></emphasis></superscript></entry>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
              <entry/>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0150s0000a0086"/><link linkend="ch0150s0000a0083">a</link></emphasis></superscript>Antifungal agents abbreviated as follows: amphotericin B (AMB), ketoconazole (KTZ), itraconazole (ITZ), posaconazole (PCZ), fluconazole (FLZ), voriconazole (VCZ), isavuconazole (ISA), ravuconazole (RVZ), terbinafine (TBF), 5-flucytosine (5FC), caspofungin (CAS), anidulafungin (ANI), micafungin (MCF), olorofim (OLO). Table derived from reference <link linkend="ch0150s0000li0092">92</link>.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0150s0000a0087"/><link linkend="ch0150s0000a0084">b</link></emphasis></superscript>Therapeutic goal according to reference <link linkend="ch0150s0000li0242">243</link>.</para>
      <para role="table-footnote"><superscript><emphasis><anchor id="ch0150s0000a0088"/><link linkend="ch0150s0000a0085">c</link></emphasis></superscript>Serum level modeled by Dolton et al. (<link linkend="ch0150s0000li0243">244</link>).</para>
      <para id="ch0150s0000p0073">Of the new drugs identified in the open source drug discovery program MycetOS, fenbendazole (<link linkend="ch0150s0000li0164">164</link>), olorofim (<link linkend="ch0150s0000li0164">164</link>), MMV006357 (<link linkend="ch0150s0000li0166">166</link>), MMV675968 (<link linkend="ch0150s0000li0166">166</link>), MMV022478 (<link linkend="ch0150s0000li0166">166</link>), and the fenarimol analogues EPL-BS0178 (<link linkend="ch0150s0000li0166">166</link>), EPL-BS0495 (<link linkend="ch0150s0000li0166">166</link>), and EPL-BS1025 (<link linkend="ch0150s0000li0166">166</link>) prolonged larval survival.</para>
      <para id="ch0150s0000p0074">So far, no clear correlation between IC<subscript>50</subscript> or MIC<subscript>50</subscript> and <emphasis>in vivo</emphasis> efficacy in the <emphasis>G. mellonella</emphasis> larval model was found (<link linkend="ch0150s0000li0092">92</link>). This might be due to the difference between a hyphal inoculum and the presence of grains in tissue (<link linkend="ch0150s0000li0092">92</link>). For <emphasis>M. mycetomatis</emphasis>, it has been demonstrated that adding isolated <emphasis>M. mycetomatis</emphasis> melanin, a key component of black grains, results in a 4 to 5 2-fold-dilution-step increase in MIC for ketoconazole and itraconazole (<link linkend="ch0150s0000li0090">90</link>). For the fenarimol compounds, the log<subscript>D</subscript>value at pH 7.4 was more indicative than the IC<subscript>50</subscript> or MIC<subscript>50</subscript> (<link linkend="ch0150s0000li0166">166</link>).</para>
    </sect1>
    <sect1 id="ch0150s0018">
      <title>Clinical Studies</title>
      <anchor id="ch0150s0018a0001"/>
      <anchor id="ch0150s0000a0089"/>
      <para id="ch0150s0000p0075">The management and prognosis of actinomycetoma differ from those of eumycetoma. Actinomycetoma is treated with antimicrobial therapy only, with a high success rate. Eumycetoma is treated with a combination of antifungal therapy and surgery, with limited success (<link linkend="ch0150s0000li0171">171</link>).</para>
      <para id="ch0150s0000p0076">Currently there are no linked data between MICs obtained for any of the causative agents and clinical outcome. Furthermore, since surgery is always a component of eumycetoma treatment, direct comparison between MIC and outcome might be complicated (<link linkend="ch0150s0000li0092">92</link>). Only limited patient-based studies have been performed to determine the outcome of antifungal treatment, and studies comparing different antifungal agents with clinical outcome are lacking. The first large clinical study to determine the therapeutic efficacy of itraconazole and fosravuconazole only started in 2017, and currently, no data are available from this study (<link linkend="ch0150s0000li0172">172</link>). Nevertheless, in summarizing the few published studies, we can draw some conclusions. In the case of <emphasis>M. mycetomatis</emphasis> eumycetoma, ketoconazole resulted in cure of only 5 out of 13 patients (<link linkend="ch0150s0000li0173">173</link>), a finding which was confirmed when a cohort of 571 patients treated with 200 to 400 mg of ketoconazole was followed. In that cohort, only 321 (56.2%) of patients were cured, and 35 (6.1%) underwent amputation (<link linkend="ch0150s0000li0092">92</link>, <link linkend="ch0150s0000li0174">174</link>). Since ketoconazole is now no longer approved for the treatment of fungal diseases, itraconazole has become the recommended antifungal agent (<link linkend="ch0150s0000li0175">175</link>, <link linkend="ch0150s0000li0176">176</link>). In the few studies performed with this drug, itraconazole resulted in cure of only 1 patient out of 13, while the rest of the patients either had stable lesions or improved (<link linkend="ch0150s0000li0177">177</link>). All 23 patients receiving itraconazole together with trimethoprim-sulfamethoxazole and surgery were cured (<link linkend="ch0150s0000li0178">178</link>). However, with newer azoles, such as posaconazole, better outcomes have been achieved (<link linkend="ch0150s0000li0179">179</link>). Negroni and his group treated six eumycetoma patients with posaconazole; they were able to cure four patients, and the other two either were clinically improved or had stable eumycetoma lesion (<link linkend="ch0150s0000li0179">179</link>). The only non-azole drug thatwas evaluated clinically for treatment of eumycetoma is terbinafine. In the study by N’diaye et al., 20 patients were treated with terbinafine; 4 were cured, 12 showed clinical improvement, and 4 showed no effect (<link linkend="ch0150s0000li0180">180</link>). In the study by Sow et al., in which terbinafine was combined with surgery, it was demonstrated that out of the 22 patients for whom data were available until the end of treatment, 20 (90.9%) of patients were cured and 2 (9.1%) had a recurrence (<link linkend="ch0150s0000li0178">178</link>).</para>
      <para id="ch0150s0000p0077">In terms of drug discovery and drug development for eumycetoma, fosravuconazole is currently being explored in a large clinical trial (<link linkend="ch0150s0000li0172">172</link>). Fosravuconazole is a prodrug of ravuconazole, and <emphasis>M. mycetomatis</emphasis> appeared to be highly susceptible to this drug <emphasis>in vitro</emphasis> (<link linkend="ch0150s0000li0154">154</link>); unfortunately the outcome of this trial is currently still unknown.</para>
      <sect2 id="ch0150s0018s0001">
        <title>EVALUATION, INTERPRETATION, AND REPORTING OF RESULTS</title>
        <anchor id="ch0150s0018a0002"/>
        <anchor id="ch0150s0000a0090"/>
        <para id="ch0150s0000p0078">Because agents of eumycotic eumycetoma are soil or plant saprobes, their etiologic role in mycetoma must be carefully established. A definitive diagnosis is based on the demonstration of grains in tissue, which are expelled through draining sinuses. Grains may become entangled in gauze bandages placed over fistulae. Pus, exudate, or biopsy material should be examined for the presence of grains that are detectable with the naked eye. Their color, internal architecture, size, and shape give a fair indication of the identity of the possible etiologic agents, but molecular identification tools are often needed for final identification. With the generation of DNA isolation techniques that can now be performed directly on isolated grains from the lesion, time to identification can be shortened considerably.</para>
        <para id="ch0150s0000p0079">When no molecular identification tools can be used, actinomycotic mycetomata can be differentiated from eumycotic eumycetomata by the examination of crushed, Gram-stained grains. Actinomycotic grains, as well as coccoid and bacillary forms, are composed of Gram-positive, interwoven, thin filaments, 0.5 to 1.0 μm in diameter. Grains of the eumycotic agents, on the other hand, are composed of broader, interwoven, septate hyphae, 2 to 5 μm in diameter, with many unusually shaped, swollen cells up to 15 μm in diameter, especially at the periphery of the grains. In many species, the grains are embedded in cement-like material. The differentiation between actinomycetoma and eumycetoma can at least lead to indication of proper therapy, namely antibiotic treatment for actinomycetoma and a combination of antifungal therapy and surgery for eumycetoma.</para>
        <para id="ch0150s0000p0080">Now that it has become apparent that there are differences in susceptibility of the causative agents and that as more antifungal drugs become available, a definitive identification of the etiologic agent based on molecular identification, MALDI-TOF, or culture should be made. Careful evaluation of culture results is important, especially when new or uncommon fast-growing species are reported, since some of these species might represent contamination during collection of specimens or isolation.</para>
      </sect2>
      <sect2 id="ch0150s0018s0002">
        <title>REFERENCES</title>
        <anchor id="ch0150s0018a0003"/>
        <anchor id="ch0150s0000a0091"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0150s0000li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">de Hoog GS, Adelmann D, Ahmed AO, van Belkum A.</emphasis> 2004. Phylogeny and typification of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle>, with a comparison of other agents of eumycetoma. <citetitle><emphasis>Mycoses</emphasis></citetitle> 47<emphasis role="strong">:</emphasis>121–130.</para>
          </listitem>
          <listitem id="ch0150s0000li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Desnos-Ollivier M, Bretagne S, Dromer F, Lortholary O, Dannaoui E.</emphasis> 2006. Molecular identification of black-grain mycetoma agents. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 44<emphasis role="strong">:</emphasis>3517–3523.</para>
          </listitem>
          <listitem id="ch0150s0000li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">van de Sande WWJ.</emphasis> 2013. Global burden of human mycetoma: a systematic review and meta-analysis. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 7<emphasis role="strong">:</emphasis>e2550.</para>
          </listitem>
          <listitem id="ch0150s0000li0004" role="bibliographyEntry">
            <anchor id="ch0150s0000a0092"/>
            <para>4.<emphasis role="strong">van de Sande W, Fahal A, Ahmed SA, Serrano JA, Bonifaz A, Zijlstra E, Eumycetoma Working Group.</emphasis> 2018. Closing the mycetoma knowledge gap. <citetitle><emphasis>Med Mycol</emphasis></citetitle> <emphasis role="strong">56</emphasis>(Suppl 1)<emphasis role="strong">:</emphasis>153–164.</para>
          </listitem>
          <listitem id="ch0150s0000li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">de Hoog GS, van Diepeningen AD, Mahgoub S, van de Sande WW.</emphasis> 2012. New species of <citetitle><emphasis>Madurella</emphasis></citetitle>, causative agents of black-grain mycetoma. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>988–994.</para>
          </listitem>
          <listitem id="ch0150s0000li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">van de Sande WW.</emphasis> 2012. Phylogenetic analysis of the complete mitochondrial genome of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> confirms its taxonomic position within the order Sordariales. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">7:</emphasis>e38654.</para>
          </listitem>
          <listitem id="ch0150s0000li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Smit S, Derks MF, Bervoets S, Fahal A, van Leeuwen W, van Belkum A, van de Sande WW.</emphasis> 2016. Genome sequence of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> mm55, isolated from a human mycetoma case in Sudan. <citetitle><emphasis>Genome Announc</emphasis></citetitle> <emphasis role="strong">4:</emphasis>e00418–16.</para>
          </listitem>
          <listitem id="ch0150s0000li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Khidir ES, Ahmed A, Fahal AH, Ibrahim AA.</emphasis> 2020. Draft genome sequences of three clinical isolates of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle>, the major cause of black-grain mycetoma. <citetitle><emphasis>Microbiol Resour Announc</emphasis></citetitle> <emphasis role="strong">9:</emphasis>e01533–19.</para>
          </listitem>
          <listitem id="ch0150s0000li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Yan J, Deng J, Zhou CJ, Zhong BY, Hao F.</emphasis> 2010. Phenotypic and molecular characterization of <citetitle><emphasis>Madurella pseudomycetomatis</emphasis></citetitle> sp. nov., a novel opportunistic fungus possibly causing black-grain mycetoma. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">48:</emphasis>251–257.</para>
          </listitem>
          <listitem id="ch0150s0000li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Ahmed EA, Nour BYM, Abakar AD, Hamid S, Mohamadani AA, Daffalla M, Mahmoud M, Altayb HN, Desnos-Ollivier M, de Hoog S, Ahmed SA.</emphasis> 2020. The genus <citetitle><emphasis>Madurella</emphasis></citetitle>: molecular identification and epidemiology in Sudan. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">14:</emphasis>e0008420.</para>
          </listitem>
          <listitem id="ch0150s0000li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Nyuykonge B, Klaassen CHW, Zandijk WHA, de Hoog GS, Ahmed SA, Desnos-Ollivier M, Verbon A, Bonifaz A, van de Sande WWJ.</emphasis> 2020. Diagnostic implications of mycetoma derived from <citetitle><emphasis>Madurella pseudomycetomatis</emphasis></citetitle> isolates from Mexico. <citetitle><emphasis>J Eur Acad Dermatol Venereol</emphasis></citetitle> <emphasis role="strong">34:</emphasis>1828–1834.</para>
          </listitem>
          <listitem id="ch0150s0000li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Padhi S, Uppin SG, Uppin MS, Umabala P, Challa S, Laxmi V, Prasad VB.</emphasis> 2010. Mycetoma in South India: retrospective analysis of 13 cases and description of two cases caused by unusual pathogens: <citetitle><emphasis>Neoscytalidium dimidiatum</emphasis></citetitle> and <citetitle><emphasis>Aspergillus flavus. Int J Dermatol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>1289–1296.</para>
          </listitem>
          <listitem id="ch0150s0000li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Rojas OC, León-Cachón RB, Moreno-Treviño M, González GM.</emphasis> 2017. Molecular identification of unusual mycetoma agents isolated from patients in Venezuela. <citetitle><emphasis>Mycoses</emphasis></citetitle> <emphasis role="strong">60:</emphasis>129–135.</para>
          </listitem>
          <listitem id="ch0150s0000li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Ahmed SA, van de Sande WW, Stevens DA, Fahal A, van Diepeningen AD, Menken SB, de Hoog GS.</emphasis> 2014. Revision of agents of black-grain eumycetoma in the order <citetitle><emphasis>Pleosporales. Persoonia</emphasis></citetitle> <emphasis role="strong">33:</emphasis>141–154.</para>
          </listitem>
          <listitem id="ch0150s0000li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">De Hoog GS, Guarro J, Gene J, Figueras M.</emphasis> 2016. <citetitle><emphasis>Atlas of Clinical Fungi.</emphasis></citetitle> Utrecht, The Netherlands.</para>
          </listitem>
          <listitem id="ch0150s0000li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Destombes P, Mariat F, Rosati L, Segretain G.</emphasis> 1977. [Mycetoma in Somalia—results of a survey done from 1959 to 1964]. <citetitle><emphasis>Acta Trop</emphasis></citetitle> <emphasis role="strong">34:</emphasis>355–373.</para>
          </listitem>
          <listitem id="ch0150s0000li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Borman AM, Desnos-Ollivier M, Campbell CK, Bridge PD, Dannaoui E, Johnson EM.</emphasis> 2016. Novel taxa associated with human fungal black-grain mycetomas: <citetitle><emphasis>Emarellia grisea</emphasis></citetitle> gen. nov., sp. nov., and <citetitle><emphasis>Emarellia paragrisea</emphasis></citetitle> sp. nov. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">54:</emphasis>1738–1745.</para>
          </listitem>
          <listitem id="ch0150s0000li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">el-Ani AS.</emphasis> 1966. A new species of <citetitle><emphasis>Leptosphaeria</emphasis></citetitle>, an etiologic agent of mycetoma. <citetitle><emphasis>Mycologia</emphasis></citetitle> <emphasis role="strong">58:</emphasis>406–411.</para>
          </listitem>
          <listitem id="ch0150s0000li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Oladele RO, Ly F, Sow D, Akinkugbe AO, Ocansey BK, Fahal AH, van de Sande WWJ.</emphasis> 2021. Mycetoma in West Africa. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">115:</emphasis>328–336.</para>
          </listitem>
          <listitem id="ch0150s0000li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Ahmed AO, Desplaces N, Leonard P, Goldstein F, De Hoog S, Verbrugh H, van Belkum A.</emphasis> 2003. Molecular detection and identification of agents of eumycetoma: detailed report of two cases. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>5813–5816.</para>
          </listitem>
          <listitem id="ch0150s0000li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Ahmed AO, Mukhtar MM, Kools-Sijmons M, Fahal AH, de Hoog S, van den Ende BG, Zijlstra EE, Verbrugh H, Abugroun ES, Elhassan AM, van Belkum A.</emphasis> 1999. Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of <citetitle><emphasis>Madurella mycetomatis. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">37:</emphasis>3175–3178.</para>
          </listitem>
          <listitem id="ch0150s0000li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Mahgoub ES.</emphasis> 1973. Mycetomas caused by <citetitle><emphasis>Curvularia lunata</emphasis></citetitle>, <citetitle><emphasis>Madurella grisea</emphasis></citetitle>, <citetitle><emphasis>Aspergillus nidulans</emphasis></citetitle>, and <citetitle><emphasis>Nocardia brasiliensis</emphasis></citetitle> in Sudan. <citetitle><emphasis>Sabouraudia</emphasis></citetitle> <emphasis role="strong">11:</emphasis>179–182.</para>
          </listitem>
          <listitem id="ch0150s0000li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">Butz WC, Ajello L.</emphasis> 1971. Black grain mycetoma. A case due to <citetitle><emphasis>Madurella grisea. Arch Dermatol</emphasis></citetitle> <emphasis role="strong">104:</emphasis>197–201.</para>
          </listitem>
          <listitem id="ch0150s0000li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Mackinnon JE, Ferrada LV, Montemayor L.</emphasis> 1949. <citetitle><emphasis>Madurella grisea</emphasis></citetitle> n. sp., a new species of fungus producing black variety of maduromycosis in South America. <citetitle><emphasis>Mycopathol Mycol Appl</emphasis></citetitle> <emphasis role="strong">4:</emphasis>385–392.</para>
          </listitem>
          <listitem id="ch0150s0000li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Montes LF, Freeman RG, McClarin W.</emphasis> 1969. Maduromycosis due to <citetitle><emphasis>Madurella grisea</emphasis></citetitle>. Report of the fifth North American case. <citetitle><emphasis>Arch Dermatol</emphasis></citetitle> 99<emphasis role="strong">:</emphasis>74–79.</para>
          </listitem>
          <listitem id="ch0150s0000li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">de Gruyter J, Woudenberg JH, Aveskamp MM, Verkley GJ, Groenewald JZ, Crous PW.</emphasis> 2010. Systematic reappraisal of species in Phoma section Paraphoma, Pyrenochaeta and Pleurophoma. <citetitle><emphasis>Mycologia</emphasis></citetitle> 102<emphasis role="strong">:</emphasis>1066–1081.</para>
          </listitem>
          <listitem id="ch0150s0000li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">de Gruyter J, Woudenberg JHC, Aveskamp MM, Verkley GJM, Groenewald JZ, Crous PW.</emphasis> 2013. Redisposition of phoma-like anamorphs in Pleosporales. <citetitle><emphasis>Stud Mycol</emphasis></citetitle> 75<emphasis role="strong">:</emphasis>1–36.</para>
          </listitem>
          <listitem id="ch0150s0000li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Klokke AH, Swamidasan G, Anguli R, Verghese A.</emphasis> 1968. The causal agents of mycetoma in South India. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 62<emphasis role="strong">:</emphasis>509–516.</para>
          </listitem>
          <listitem id="ch0150s0000li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Mariat F, Destombes P, Segretain G.</emphasis> 1977. The mycetomas: clinical features, pathology, etiology and epidemiology. <citetitle><emphasis>Contrib Microbiol Immunol</emphasis></citetitle> 4<emphasis role="strong">:</emphasis>1–39.</para>
          </listitem>
          <listitem id="ch0150s0000li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Borelli D.</emphasis> 1959. <citetitle><emphasis>Pyrenochaeta romeroi</emphasis></citetitle> n. sp. <citetitle><emphasis>Rev Dermatol Venez</emphasis></citetitle> 1<emphasis role="strong">:</emphasis>325–327.</para>
          </listitem>
          <listitem id="ch0150s0000li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Jaklitsch WM, Voglmayr H.</emphasis> 2016. Hidden diversity in <citetitle><emphasis>Thyridaria</emphasis></citetitle> and a new circumscription of the <citetitle><emphasis>Thyridariaceae. Stud Mycol</emphasis></citetitle> 85<emphasis role="strong">:</emphasis>35–64.</para>
          </listitem>
          <listitem id="ch0150s0000li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">Shaw JJ, Spakowicz DJ, Dalal RS, Davis JH, Lehr NA, Dunican BF, Orellana EA, Narváez-Trujillo A, Strobel SA.</emphasis> 2015. Biosynthesis and genomic analysis of medium-chain hydrocarbon production by the endophytic fungal isolate <citetitle><emphasis>Nigrograna mackinnonii</emphasis></citetitle> E5202H. <citetitle><emphasis>Appl Microbiol Biotechnol</emphasis></citetitle> 99<emphasis role="strong">:</emphasis>3715–3728.</para>
          </listitem>
          <listitem id="ch0150s0000li0033" role="bibliographyEntry">
            <para>33.<emphasis role="strong">Segretain G, Destombes P.</emphasis> 1961. [Description of a new agent for maduromycosis, <citetitle><emphasis>Neotestudina rosatii</emphasis></citetitle>, n. gen., n. sp., isolated in Africa]. <citetitle><emphasis>C R Hebd Seances Acad Sci</emphasis></citetitle> <emphasis role="strong">253:</emphasis>2577–2579.</para>
          </listitem>
          <listitem id="ch0150s0000li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Gilgado F, Cano J, Gené J, Guarro J.</emphasis> 2005. Molecular phylogeny of the <citetitle><emphasis>Pseudallescheria boydii</emphasis></citetitle> species complex: proposal of two new species. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>4930–4942.</para>
          </listitem>
          <listitem id="ch0150s0000li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Gilgado F, Cano J, Gené J, Sutton DA, Guarro J.</emphasis> 2008. Molecular and phenotypic data supporting distinct species statuses for <citetitle><emphasis>Scedosporium apiospermum</emphasis></citetitle> and <citetitle><emphasis>Pseudallescheria boydii</emphasis></citetitle> and the proposed new species <citetitle><emphasis>Scedosporium dehoogii. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>766–771.</para>
          </listitem>
          <listitem id="ch0150s0000li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">Rainer J, De Hoog GS.</emphasis> 2006. Molecular taxonomy and ecology of <citetitle><emphasis>Pseudallescheria, Petriella</emphasis></citetitle> and <citetitle><emphasis>Scedosporium prolificans</emphasis></citetitle> (Microascaceae) containing opportunistic agents on humans. <citetitle><emphasis>Mycol Res</emphasis></citetitle> <emphasis role="strong">110:</emphasis>151–160.</para>
          </listitem>
          <listitem id="ch0150s0000li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Chen SC, Halliday CL, Hoenigl M, Cornely OA, Meyer W.</emphasis> 2021. <citetitle><emphasis>Scedosporium</emphasis></citetitle> and <citetitle><emphasis>Lomentospora</emphasis></citetitle> infections: contemporary microbiological tools for the diagnosis of invasive disease. <citetitle><emphasis>J Fungi (Basel)</emphasis></citetitle> <emphasis role="strong">7:</emphasis>23.</para>
          </listitem>
          <listitem id="ch0150s0000li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">Shear CL.</emphasis> 1922. Life history of an undescribed ascomycete from a granular mycetoma of man. <citetitle><emphasis>Mycologia</emphasis></citetitle> <emphasis role="strong">14:</emphasis>243–293.</para>
          </listitem>
          <listitem id="ch0150s0000li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Castro LG, Belda Júnior W, Salebian A, Cucé LC.</emphasis> 1993. Mycetoma: a retrospective study of 41 cases seen in São Paulo, Brazil, from 1978 to 1989. <citetitle><emphasis>Mycoses</emphasis></citetitle> <emphasis role="strong">36:</emphasis>89–95.</para>
          </listitem>
          <listitem id="ch0150s0000li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Venugopal PV, Venugopal TV.</emphasis> 1995. Pale grain eumycetomas in Madras. <citetitle><emphasis>Australas J Dermatol</emphasis></citetitle> <emphasis role="strong">36:</emphasis>149–151.</para>
          </listitem>
          <listitem id="ch0150s0000li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Hassan R, Simpson H, Cano J, Bakhiet S, Ganawa E, Argaw D, Newport MJ, Deribe K, Fahal AH.</emphasis> 2021. Modelling the spatial distribution of mycetoma in Sudan. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">115:</emphasis>1144–1152.</para>
          </listitem>
          <listitem id="ch0150s0000li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Samy AM, van de Sande WW, Fahal AH, Peterson AT.</emphasis> 2014. Mapping the potential risk of mycetoma infection in Sudan and South Sudan using ecological niche modeling. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">8:</emphasis>e3250.</para>
          </listitem>
          <listitem id="ch0150s0000li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Emery D, Denning DW.</emphasis> 2020. The global distribution of actinomycetoma and eumycetoma. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">14:</emphasis>e0008397.</para>
          </listitem>
          <listitem id="ch0150s0000li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">van de Sande WW, Maghoub S, Fahal AH, Goodfellow M, Welsh O, Zijlstra E.</emphasis> 2014. The mycetoma knowledge gap: identification of research priorities. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">8:</emphasis>e2667.</para>
          </listitem>
          <listitem id="ch0150s0000li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Ganawa ETS, Bushara MA, Musa AEA, Bakhiet SM, Fahal AH.</emphasis> 2021. Mycetoma spatial geographical distribution in the Eastern Sennar locality, Sennar State, Sudan. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 115<emphasis role="strong">:</emphasis>375–382.</para>
          </listitem>
          <listitem id="ch0150s0000li0046" role="bibliographyEntry">
            <anchor id="ch0150s0000a0093"/>
            <para>46.<emphasis role="strong">Ajello L.</emphasis> 1962. Epidemiology of human fungus infections, p 69–83. <citetitle><emphasis>In</emphasis></citetitle> Dalldorf G (ed), <citetitle><emphasis>Fungi and Fungous Diseases.</emphasis></citetitle> Charles C Thomas, Springfield, IL.</para>
          </listitem>
          <listitem id="ch0150s0000li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">Baylet R, Camain R, Rey M.</emphasis> 1961. Champignons de mycétomes isolés des épineux au Sénégal. <citetitle><emphasis>Bull Soc Med Afr Noire Lang Fr</emphasis></citetitle> 6<emphasis role="strong">:</emphasis>317–319.</para>
          </listitem>
          <listitem id="ch0150s0000li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Emmons CW.</emphasis> 1962. Soil reservoirs of pathogenic fungi. <citetitle><emphasis>J Wash Acad Sci</emphasis></citetitle> 52<emphasis role="strong">:</emphasis>3–9.</para>
          </listitem>
          <listitem id="ch0150s0000li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Mackinnon JE, Conti-Diaz IA, Gezuele E, Civila E.</emphasis> 1971. Datos sobre ecologia de <citetitle><emphasis>Allescheria boydii</emphasis></citetitle>, Shear. <citetitle><emphasis>Rev Urug Pathol Clin Microbiol</emphasis></citetitle> 9<emphasis role="strong">:</emphasis>37–43.</para>
          </listitem>
          <listitem id="ch0150s0000li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Segretain G, Mariat F.</emphasis> 1968. [Research on the presence of agents of mycetoma in the soil and thorny plants of Senegal and Mauritania]. <citetitle><emphasis>Bull Soc Pathol Exot</emphasis></citetitle> 61<emphasis role="strong">:</emphasis>194–202.</para>
          </listitem>
          <listitem id="ch0150s0000li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">Segretain G.</emphasis> 1972. Recherches sur l’écologie de <citetitle><emphasis>Madurella mycetomi</emphasis></citetitle> au Senegal. <citetitle><emphasis>Bull Soc Fr Mycol Med</emphasis></citetitle> 14<emphasis role="strong">:</emphasis>121–124.</para>
          </listitem>
          <listitem id="ch0150s0000li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">Thirumalachar MJ, Padhye AA.</emphasis> 1968. Isolation of <citetitle><emphasis>Madurella mycetomi</emphasis></citetitle> from soil in India. <citetitle><emphasis>Hindustan Antibiot Bull</emphasis></citetitle> <emphasis role="strong">10:</emphasis>314–318.</para>
          </listitem>
          <listitem id="ch0150s0000li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Badali H, Najafzadeh MJ, van Esbroeck M, van den Enden E, Tarazooie B, Meis JF, de Hoog GS.</emphasis> 2010. The clinical spectrum of <citetitle><emphasis>Exophiala jeanselmei</emphasis></citetitle>, with a case report and in vitro antifungal susceptibility of the species. <citetitle><emphasis>Med Mycol</emphasis></citetitle> 48<emphasis role="strong">:</emphasis>318–327.</para>
          </listitem>
          <listitem id="ch0150s0000li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Ahmed A, Adelmann D, Fahal A, Verbrugh H, van Belkum A, de Hoog S.</emphasis> 2002. Environmental occurrence of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle>, the major agent of human eumycetoma in Sudan. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 40<emphasis role="strong">:</emphasis>1031–1036.</para>
          </listitem>
          <listitem id="ch0150s0000li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Azrag RS, Bakhiet SM, Mhmoud NA, Almalik AM, Mohamed AH, Fahal AH.</emphasis> 2021. A possible role for ticks in the transmission of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> in a mycetoma-endemic village in Sudan. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 115<emphasis role="strong">:</emphasis>364–374.</para>
          </listitem>
          <listitem id="ch0150s0000li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">de Hoog GS, Ahmed SA, Najafzadeh MJ, Sutton DA, Keisari MS, Fahal AH, Eberhardt U, Verkleij GJ, Xin L, Stielow B, van de Sande WWJ.</emphasis> 2013. Phylogenetic findings suggest possible new habitat and routes of infection of human eumyctoma. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 7<emphasis role="strong">:</emphasis>e2229.</para>
          </listitem>
          <listitem id="ch0150s0000li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Borelli D.</emphasis> 1962. <citetitle><emphasis>Madurella mycetomi</emphasis></citetitle> y <citetitle><emphasis>Madurella grisea. Arch Venez Med Trop Parasitol Med</emphasis></citetitle> 4<emphasis role="strong">:</emphasis>195–211.</para>
          </listitem>
          <listitem id="ch0150s0000li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">van de Sande WW, Fahal A, Tavakol M, van Belkum A.</emphasis> 2010. Polymorphisms in catechol-O-methyltransferase and cytochrome p450 subfamily 19 genes predispose towards <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle>-induced mycetoma susceptibility. <citetitle><emphasis>Med Mycol</emphasis></citetitle> 48<emphasis role="strong">:</emphasis>959–968.</para>
          </listitem>
          <listitem id="ch0150s0000li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">van de Sande WW, Fahal A, Verbrugh H, van Belkum A.</emphasis> 2007. Polymorphisms in genes involved in innate immunity predispose toward mycetoma susceptibility. <citetitle><emphasis>J Immunol</emphasis></citetitle> 179<emphasis role="strong">:</emphasis>3065–3074.</para>
          </listitem>
          <listitem id="ch0150s0000li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Mhmoud NA, Fahal AH, van de Sande WW.</emphasis> 2013. The association between the interleukin-10 cytokine and CC chemokine ligand 5 polymorphisms and mycetoma granuloma formation. <citetitle><emphasis>Med Mycol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>527–533.</para>
          </listitem>
          <listitem id="ch0150s0000li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Geneugelijk K, Kloezen W, Fahal AH, van de Sande WW.</emphasis> 2014. Active matrix metalloprotease-9 is associated with the collagen capsule surrounding the <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> grain in mycetoma. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 8<emphasis role="strong">:</emphasis>e2754.</para>
          </listitem>
          <listitem id="ch0150s0000li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Verwer PE, Notenboom CC, Eadie K, Fahal AH, Verbrugh HA, van de Sande WW.</emphasis> 2015. A polymorphism in the chitotriosidase gene associated with risk of mycetoma due to <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> mycetoma—a retrospective study. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 9<emphasis role="strong">:</emphasis>e0004061.</para>
          </listitem>
          <listitem id="ch0150s0000li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">de Hoog GS, et al.</emphasis> 1993. Diagnostic problems with imported cases of mycetoma in The Netherlands. <citetitle><emphasis>Mycoses</emphasis></citetitle> 36<emphasis role="strong">:</emphasis>81–87.</para>
          </listitem>
          <listitem id="ch0150s0000li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Destombes P, Ravisse P, Nazimoff O.</emphasis> 1970. [Summary of deep mycoses established in 20 years of histopathology in the Institut Pasteur de Brazzaville]. <citetitle><emphasis>Bull Soc Pathol Exot</emphasis></citetitle> 63<emphasis role="strong">:</emphasis>315–324.</para>
          </listitem>
          <listitem id="ch0150s0000li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">McGinnis MR.</emphasis> 1996. Mycetoma. <citetitle><emphasis>Dermatol Clin</emphasis></citetitle> 14<emphasis role="strong">:</emphasis>97–104.</para>
          </listitem>
          <listitem id="ch0150s0000li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Suleiman AM, Fahal AH.</emphasis> 2013. Oral cavity eumycetoma: a rare and unusual condition. <citetitle><emphasis>Oral Surg Oral Med Oral Pathol Oral Radiol</emphasis></citetitle> 115<emphasis role="strong">:</emphasis>e23–e25.</para>
          </listitem>
          <listitem id="ch0150s0000li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Joshi A, Acharya S, Anehosur VS, Tayaar AS, Gopalkrishnan K.</emphasis> 2014. Oral eumycetoma of infancy: a rare presentation and a brief review. <citetitle><emphasis>J Craniomaxillofac Surg</emphasis></citetitle> 42<emphasis role="strong">:</emphasis>35–40.</para>
          </listitem>
          <listitem id="ch0150s0000li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Gueye NN, Seck SM, Diop Y, Ndiaye Sow MN, Agboton G, Diakhaté M, Dieng M, Dieng MT.</emphasis> 2013. [Orbital mycetoma: a case report]. <citetitle><emphasis>J Fr Ophtalmol</emphasis></citetitle> 36<emphasis role="strong">:</emphasis>435–441.</para>
          </listitem>
          <listitem id="ch0150s0000li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Kano R, Edamura K, Yumikura H, Maruyama H, Asano K, Tanaka S, Hasegawa A.</emphasis> 2009. Confirmed case of feline mycetoma due to <citetitle><emphasis>Microsporum canis. Mycoses</emphasis></citetitle> 52<emphasis role="strong">:</emphasis>80–83.</para>
          </listitem>
          <listitem id="ch0150s0000li0070" role="bibliographyEntry">
            <para>70.<emphasis role="strong">Brodey RS, Schryver HF, Deubler MJ, Kaplan W, Ajello L.</emphasis> 1967. Mycetoma in a dog. <citetitle><emphasis>J Am Vet Med Assoc</emphasis></citetitle> 151<emphasis role="strong">:</emphasis>442–451.</para>
          </listitem>
          <listitem id="ch0150s0000li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Lambrechts N, Collett MG, Henton M.</emphasis> 1991. Black grain eumycetoma (<citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle>) in the abdominal cavity of a dog. <citetitle><emphasis>J Med Vet Mycol</emphasis></citetitle> 29<emphasis role="strong">:</emphasis>211–214.</para>
          </listitem>
          <listitem id="ch0150s0000li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Lopez MJ, Robinson SO, Cooley AJ, Prichard MA, McGinnis MR.</emphasis> 2007. Molecular identification of <citetitle><emphasis>Phialophora oxyspora</emphasis></citetitle> as the cause of mycetoma in a horse. <citetitle><emphasis>J Am Vet Med Assoc</emphasis></citetitle> 230<emphasis role="strong">:</emphasis>84–88.</para>
          </listitem>
          <listitem id="ch0150s0000li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Sun PL, Peng PC, Wu PH, Chiang YL, Ju YM, Chang CC, Wang PC.</emphasis> 2013. Canine eumycetoma caused by <citetitle><emphasis>Cladophialophora bantiana</emphasis></citetitle> in a Maltese: case report and literature review. <citetitle><emphasis>Mycoses</emphasis></citetitle> 56<emphasis role="strong">:</emphasis>376–381.</para>
          </listitem>
          <listitem id="ch0150s0000li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Pankovich AM, Auerbach BJ, Metzger WI, Barreta T.</emphasis> 1981. Development of maduromycosis (<citetitle><emphasis>Madurella mycetomi</emphasis></citetitle>) after nailing of a closed tibial fracture: a case report. <citetitle><emphasis>Clin Orthop Relat Res</emphasis></citetitle> 154<emphasis role="strong">:</emphasis>220–222.</para>
          </listitem>
          <listitem id="ch0150s0000li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Van Etta LL, Peterson LR, Gerding DN.</emphasis> 1983. Acremonium falciforme (<citetitle><emphasis>Cephalosporium falciforme</emphasis></citetitle>) mycetoma in a renal transplant patient. <citetitle><emphasis>Arch Dermatol</emphasis></citetitle> 119<emphasis role="strong">:</emphasis>707–708.</para>
          </listitem>
          <listitem id="ch0150s0000li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Zijlstra EE, van de Sande WWJ, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH.</emphasis> 2016. Mycetoma: a unique neglected tropical disease. <citetitle><emphasis>Lancet Infect Dis</emphasis></citetitle> 16<emphasis role="strong">:</emphasis>100–112.</para>
          </listitem>
          <listitem id="ch0150s0000li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Kwon-Chung KJ, Bennet JE.</emphasis> 1992. <citetitle><emphasis>Medical Mycology.</emphasis></citetitle> Lea and Febiger, Philadelphia, PA.</para>
          </listitem>
          <listitem id="ch0150s0000li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Fahey PJ, Utell MJ, Hyde RW.</emphasis> 1981. Spontaneous lysis of mycetomas after acute cavitating lung disease. <citetitle><emphasis>Am Rev Respir Dis</emphasis></citetitle> 123<emphasis role="strong">:</emphasis>336–339.</para>
          </listitem>
          <listitem id="ch0150s0000li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">Hadjiliadis D, Sporn TA, Perfect JR, Tapson VF, Davis RD, Palmer SM.</emphasis> 2002. Outcome of lung transplantation in patients with mycetomas. <citetitle><emphasis>Chest</emphasis></citetitle> 121<emphasis role="strong">:</emphasis>128–134.</para>
          </listitem>
          <listitem id="ch0150s0000li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Matsumoto T, Ajello L.</emphasis> 1986. No granules, no mycetomas. <citetitle><emphasis>Chest</emphasis></citetitle> 90<emphasis role="strong">:</emphasis>151–152.</para>
          </listitem>
          <listitem id="ch0150s0000li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Ajello L, Kaplan W, Chandler FW.</emphasis> 1980. <citetitle><emphasis>Superficial, Cutaneous and Subcutaneous Infections.</emphasis></citetitle> Pan American Health Organization, Washington, DC.</para>
          </listitem>
          <listitem id="ch0150s0000li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">van de Sande WWJ, Fahal AH, Goodfellow M, Mahgoub S, Welsh O, Zijlstra EE.</emphasis> 2014. Merits and pitfalls of currently used diagnostic tools in mycetoma. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 8<emphasis role="strong">:</emphasis>e2918.</para>
          </listitem>
          <listitem id="ch0150s0000li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Fahal AH.</emphasis> 2006. <citetitle><emphasis>Mycetoma, Clinicopathological Monograph.</emphasis></citetitle> Khartoum University Press, Khartoum.</para>
          </listitem>
          <listitem id="ch0150s0000li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Kumar J, Kumar A, Sethy P, Gupta S.</emphasis> 2007. The dot-in-circle sign of mycetoma on MRI. <citetitle><emphasis>Diagn Interv Radiol</emphasis></citetitle> 13<emphasis role="strong">:</emphasis>193–195.</para>
          </listitem>
          <listitem id="ch0150s0000li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Fahal AH, Sheik HE, Homeida MM, Arabi YE, Mahgoub ES.</emphasis> 1997. Ultrasonographic imaging of mycetoma. <citetitle><emphasis>Br J Surg</emphasis></citetitle> 84<emphasis role="strong">:</emphasis>1120–1122.</para>
          </listitem>
          <listitem id="ch0150s0000li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Reis LM, Lima BZ, Zillo FC, Rezende CM, Fabricio LH, Pinto CA.</emphasis> 2014. Dermoscopy assisting the diagnosis of mycetoma: case report and literature review. <citetitle><emphasis>An Bras Dermatol</emphasis></citetitle> 89<emphasis role="strong">:</emphasis>832–833.</para>
          </listitem>
          <listitem id="ch0150s0000li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Ankad BS, Manjula R, Tejasvi T, Nikam BP.</emphasis> 2019. Dermoscopy of eumycotic mycetoma: a case report. <citetitle><emphasis>Dermatol Pract Concept</emphasis></citetitle> 9<emphasis role="strong">:</emphasis>297–299.</para>
          </listitem>
          <listitem id="ch0150s0000li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Litaiem N, Midassi O, Zeglaoui F.</emphasis> 2019. Detecting subclinical mycetoma’s black grains using dermoscopy. <citetitle><emphasis>Int J Dermatol</emphasis></citetitle> 58<emphasis role="strong">:</emphasis>231–232.</para>
          </listitem>
          <listitem id="ch0150s0000li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Wethered DB, Markey MA, Hay RJ, Mahgoub ES, Gumaa SA.</emphasis> 1987. Ultrastructural and immunogenic changes in the formation of mycetoma grains. <citetitle><emphasis>J Med Vet Mycol</emphasis></citetitle> 25<emphasis role="strong">:</emphasis>39–46.</para>
          </listitem>
          <listitem id="ch0150s0000li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">van de Sande WW, de Kat J, Coppens J, Ahmed AO, Fahal A, Verbrugh H, van Belkum A.</emphasis> 2007. Melanin biosynthesis in <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> and its effect on susceptibility to itraconazole and ketoconazole. <citetitle><emphasis>Microbes Infect</emphasis></citetitle> 9<emphasis role="strong">:</emphasis>1114–1123.</para>
          </listitem>
          <listitem id="ch0150s0000li0091" role="bibliographyEntry">
            <anchor id="ch0150s0000a0094"/>
            <para>91.<emphasis role="strong">Ibrahim AI, El Hassan AM, Fahal A, van de Sande WW.</emphasis> 2013. A histopathological exploration of the <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> grain. <citetitle><emphasis>PLoS One</emphasis></citetitle> 8<emphasis role="strong">:</emphasis>e57774.</para>
          </listitem>
          <listitem id="ch0150s0000li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">van de Sande WWJ.</emphasis> 2021. In vitro susceptibility testing for black grain eumycetoma causative agents. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 115<emphasis role="strong">:</emphasis>343–354.</para>
          </listitem>
          <listitem id="ch0150s0000li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Ahmed AO, van Vianen W, ten Kate MT, van de Sande WW, van Belkum A, Fahal AH, Verbrugh HA, Bakker-Woudenberg IA.</emphasis> 2003. A murine model of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> eumycetoma. <citetitle><emphasis>FEMS Immunol Med Microbiol</emphasis></citetitle> 37<emphasis role="strong">:</emphasis>29–36.</para>
          </listitem>
          <listitem id="ch0150s0000li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Mhmoud NA, Ahmed SA, Fahal AH, de Hoog GS, Gerrits van den Ende AH, van de Sande WW.</emphasis> 2012. <citetitle><emphasis>Pleurostomophora ochracea</emphasis></citetitle>, a novel agent of human eumycetoma with yellow grains. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 50<emphasis role="strong">:</emphasis>2987–2994.</para>
          </listitem>
          <listitem id="ch0150s0000li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Thianprasit M, Sivayathorn A.</emphasis> 1984. Black dot mycetoma. <citetitle><emphasis>Mykosen</emphasis></citetitle> 27<emphasis role="strong">:</emphasis>219–226.</para>
          </listitem>
          <listitem id="ch0150s0000li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Crous PW, Gams W, Wingfield MJ, van Wyk PS.</emphasis> 1996. <citetitle><emphasis>Phaeoacremonium</emphasis></citetitle> gen. nov. associated with wilt and decline diseases of woody hosts and human infections. <citetitle><emphasis>Mycologia</emphasis></citetitle> 88<emphasis role="strong">:</emphasis>786–796.</para>
          </listitem>
          <listitem id="ch0150s0000li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">de Albornoz MB.</emphasis> 1974. [<citetitle><emphasis>Cephalosporium serrae</emphasis></citetitle>, an etiologic agent of mycetoma]. <citetitle><emphasis>Mycopathol Mycol Appl</emphasis></citetitle> 54<emphasis role="strong">:</emphasis>485–498.</para>
          </listitem>
          <listitem id="ch0150s0000li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">McGinnis MR, Padhye AA, Ajello L.</emphasis> 1982. <citetitle><emphasis>Pseudallescheria boydii</emphasis></citetitle> Negroni et Fischer, 1943, and its later synonym <citetitle><emphasis>Petriellidium Malloch</emphasis></citetitle>, 1970. <citetitle><emphasis>Mycotaxon</emphasis></citetitle> 14<emphasis role="strong">:</emphasis>94–102.</para>
          </listitem>
          <listitem id="ch0150s0000li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">McGinnis M.</emphasis> 1992. Black fungi: a model for understanding tropical mycosis, p 129–149. <citetitle><emphasis>In</emphasis></citetitle> Walker DH (ed), <citetitle><emphasis>Global Infectious Diseases: Prevention, Control, and Eradication.</emphasis></citetitle> Springer Verlag, New York, NY.</para>
          </listitem>
          <listitem id="ch0150s0000li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Lim W, Parel F, de Hoog S, Verbon A, van de Sande WWJ.</emphasis> 2021. Melanin production in coelomycetous agents of black grain eumycetoma. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 115<emphasis role="strong">:</emphasis>324–327.</para>
          </listitem>
          <listitem id="ch0150s0000li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Sheehan G, Konings M, Lim W, Fahal A, Kavanagh K, van de Sande WWJ.</emphasis> 2020. Proteomic analysis of the processes leading to <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> grain formation in <citetitle><emphasis>Galleria mellonella</emphasis></citetitle> larvae. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 14<emphasis role="strong">:</emphasis>e0008190.</para>
          </listitem>
          <listitem id="ch0150s0000li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">de Klerk N, de Vogel C, Fahal A, van Belkum A, van de Sande WW.</emphasis> 2012. Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in <citetitle><emphasis>Madurella mycetomatis. Med Mycol</emphasis></citetitle> 50<emphasis role="strong">:</emphasis>143–151.</para>
          </listitem>
          <listitem id="ch0150s0000li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">van de Sande WW, Janse DJ, Hira V, Goedhart H, van der Zee R, Ahmed AO, Ott A, Verbrugh H, van Belkum A.</emphasis> 2006. Translationally controlled tumor protein from <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle>, a marker for tumorous mycetoma progression. <citetitle><emphasis>J Immunol</emphasis></citetitle> 177<emphasis role="strong">:</emphasis>1997–2005.</para>
          </listitem>
          <listitem id="ch0150s0000li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Kloezen W, van Helvert-van Poppel M, Fahal AH, van de Sande WW.</emphasis> 2015. A <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> grain model in <citetitle><emphasis>Galleria mellonella</emphasis></citetitle> larvae. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 9<emphasis role="strong">:</emphasis>e0003926.</para>
          </listitem>
          <listitem id="ch0150s0000li0105" role="bibliographyEntry">
            <para>105.<emphasis role="strong">Fahal AH, el Toum EA, el Hassan AM, Mahgoub ES, Gumaa SA.</emphasis> 1995. The host tissue reaction to <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle>: new classification. <citetitle><emphasis>J Med Vet Mycol</emphasis></citetitle> 33<emphasis role="strong">:</emphasis>15–17.</para>
          </listitem>
          <listitem id="ch0150s0000li0106" role="bibliographyEntry">
            <para>106.<emphasis role="strong">Verghese A, Klokke AH.</emphasis> 1966. Histologic diagnosis of species of fungus causing mycetoma. <citetitle><emphasis>Indian J Med Res</emphasis></citetitle> 54<emphasis role="strong">:</emphasis>524–530.</para>
          </listitem>
          <listitem id="ch0150s0000li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Segretain G, Destombes P.</emphasis> 1969. Recherche sur les mycetomes a <citetitle><emphasis>Madurella grisea</emphasis></citetitle> et <citetitle><emphasis>Pyrenochaeta romeroi. Sabouraudia</emphasis></citetitle> 7<emphasis role="strong">:</emphasis>51–61.</para>
          </listitem>
          <listitem id="ch0150s0000li0108" role="bibliographyEntry">
            <para>108.<emphasis role="strong">Destombes P.</emphasis> 1964. Histologic structure of mycetomas. <citetitle><emphasis>Ann Soc Belges Med Trop Parasitol Mycol</emphasis></citetitle> 44<emphasis role="strong">:</emphasis>897–908.</para>
          </listitem>
          <listitem id="ch0150s0000li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Hay RJ, Mackenzie DW.</emphasis> 1982. The histopathological features of pale grain eumycetoma. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 76<emphasis role="strong">:</emphasis>839–844.</para>
          </listitem>
          <listitem id="ch0150s0000li0110" role="bibliographyEntry">
            <para>110.<emphasis role="strong">Hemashettar BM, Siddaramappa B, Munjunathaswamy BS, Pangi AS, Pattan J, Andrade AT, Padhye AA, Mostert L, Summerbell RC.</emphasis> 2006. <citetitle><emphasis>Phaeoacremonium krajdenii</emphasis></citetitle>, a cause of white grain eumycetoma. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 44<emphasis role="strong">:</emphasis>4619–4622.</para>
          </listitem>
          <listitem id="ch0150s0000li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">Ahmed SA, van de Sande WW, Desnos-Ollivier M, Fahal AH, Mhmoud NA, de Hoog GS.</emphasis> 2015. Application of isothermal amplification techniques for identification of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle>, the prevalent agent of human mycetoma. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 53<emphasis role="strong">:</emphasis>3280–3285.</para>
          </listitem>
          <listitem id="ch0150s0000li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">El-Ani AS, Gordon MA.</emphasis> 1965. The ascospore sheath and taxonomy of <citetitle><emphasis>Leptosphaeria senegalensis. Mycologia</emphasis></citetitle> 57<emphasis role="strong">:</emphasis>275–278.</para>
          </listitem>
          <listitem id="ch0150s0000li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">Mayorga R, Close de León JE.</emphasis> 1966. [On a limb from which spore bearing <citetitle><emphasis>Madurella grisea</emphasis></citetitle> was isolated from a black grained mycetoma in a Guatemalan]. <citetitle><emphasis>Sabouraudia</emphasis></citetitle> 4<emphasis role="strong">:</emphasis>210–214.</para>
          </listitem>
          <listitem id="ch0150s0000li0114" role="bibliographyEntry">
            <para>114.<emphasis role="strong">Borelli D.</emphasis> 1976. <citetitle><emphasis>Pyrenochaeta mackinnonii</emphasis></citetitle> nova species agente de micetoma. <citetitle><emphasis>Castellania</emphasis></citetitle> 4<emphasis role="strong">:</emphasis>227–234.</para>
          </listitem>
          <listitem id="ch0150s0000li0115" role="bibliographyEntry">
            <para>115.<emphasis role="strong">Romero H, Mackenzie DW.</emphasis> 1989. Studies on antigens from agents causing black grain eumycetoma. <citetitle><emphasis>J Med Vet Mycol</emphasis></citetitle> 27<emphasis role="strong">:</emphasis>303–311.</para>
          </listitem>
          <listitem id="ch0150s0000li0116" role="bibliographyEntry">
            <para>116.<emphasis role="strong">Campbell CK.</emphasis> 1987. <citetitle><emphasis>Polycytella hominis</emphasis></citetitle> gen. et sp. nov., a cause of human pale grain mycetoma. <citetitle><emphasis>J Med Vet Mycol</emphasis></citetitle> 25<emphasis role="strong">:</emphasis>301–305.</para>
          </listitem>
          <listitem id="ch0150s0000li0117" role="bibliographyEntry">
            <para>117.<emphasis role="strong">Borman AM, Campbell CK, Linton CJ, Bridge PD, Johnson EM.</emphasis> 2006. <citetitle><emphasis>Polycytella hominis</emphasis></citetitle> is a mutated form of <citetitle><emphasis>Scedosporium apiospermum. Med Mycol</emphasis></citetitle> 44<emphasis role="strong">:</emphasis>33–39.</para>
          </listitem>
          <listitem id="ch0150s0000li0118" role="bibliographyEntry">
            <para>118.<emphasis role="strong">Horré R, Schaal KP, Marklein G, de Hoog GS, Reiffert SM.</emphasis> 2011. Physiological typing of Pseudallescheria <citetitle><emphasis>Pseudallescheria</emphasis></citetitle> and <citetitle><emphasis>Scedosporium</emphasis></citetitle> strains using Taxa Profile, a semi-automated, 384-well microtitre system. <citetitle><emphasis>Mycoses</emphasis></citetitle> 54(Suppl 3)<emphasis role="strong">:</emphasis>56–65.</para>
          </listitem>
          <listitem id="ch0150s0000li0119" role="bibliographyEntry">
            <para>119.<emphasis role="strong">Borman AM, Linton CJ, Miles SJ, Johnson EM.</emphasis> 2008. Molecular identification of pathogenic fungi. <citetitle><emphasis>J Antimicrob Chemother</emphasis></citetitle> 61(Suppl 1)<emphasis role="strong">:</emphasis>i7–i12.</para>
          </listitem>
          <listitem id="ch0150s0000li0120" role="bibliographyEntry">
            <para>120.<emphasis role="strong">Ahmed SA, van den Ende BH, Fahal AH, van de Sande WW, de Hoog GS.</emphasis> 2014. Rapid identification of black grain eumycetoma causative agents using rolling circle amplification. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 8<emphasis role="strong">:</emphasis>e3368.</para>
          </listitem>
          <listitem id="ch0150s0000li0121" role="bibliographyEntry">
            <para>121.<emphasis role="strong">Lackner M, Najafzadeh MJ, Sun J, Lu Q, Hoog GS.</emphasis> 2012. Rapid identification of <citetitle><emphasis>Pseudallescheria</emphasis></citetitle> and <citetitle><emphasis>Scedosporium</emphasis></citetitle> strains by using rolling circle amplification. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> 78<emphasis role="strong">:</emphasis>126–133.</para>
          </listitem>
          <listitem id="ch0150s0000li0122" role="bibliographyEntry">
            <para>122.<emphasis role="strong">Zhou X, Kong F, Sorrell TC, Wang H, Duan Y, Chen SC.</emphasis> 2008. Practical method for detection and identification of <citetitle><emphasis>Candida</emphasis></citetitle>, <citetitle><emphasis>Aspergillus</emphasis></citetitle>, and <citetitle><emphasis>Scedosporium</emphasis></citetitle> spp. by use of rolling-circle amplification. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 46<emphasis role="strong">:</emphasis>2423–2427.</para>
          </listitem>
          <listitem id="ch0150s0000li0123" role="bibliographyEntry">
            <para>123.<emphasis role="strong">Lim W, Siddig E, Eadie K, Nyuykonge B, Ahmed S, Fahal A, Verbon A, Smit S, van de Sande WW.</emphasis> 2020. The development of a novel diagnostic PCR for <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> using a comparative genome approach. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 14<emphasis role="strong">:</emphasis>e0008897.</para>
          </listitem>
          <listitem id="ch0150s0000li0124" role="bibliographyEntry">
            <para>124.<emphasis role="strong">Wedde M, Müller D, Tintelnot K, De Hoog GS, Stahl U.</emphasis> 1998. PCR-based identification of clinically relevant <citetitle><emphasis>Pseudallescheria/Scedosporium</emphasis></citetitle> strains. <citetitle><emphasis>Med Mycol</emphasis></citetitle> 36<emphasis role="strong">:</emphasis>61–67.</para>
          </listitem>
          <listitem id="ch0150s0000li0125" role="bibliographyEntry">
            <para>125.<emphasis role="strong">Hagari Y, Ishioka S, Ohyama F, Mihara M.</emphasis> 2002. Cutaneous infection showing sporotrichoid spread caused by <citetitle><emphasis>Pseudallescheria boydii</emphasis></citetitle> (<citetitle><emphasis>Scedosporium apiospermum</emphasis></citetitle>): successful detection of fungal DNA in formalin-fixed, paraffin-embedded sections by seminested PCR. <citetitle><emphasis>Arch Dermatol</emphasis></citetitle> 138<emphasis role="strong">:</emphasis>271–272.</para>
          </listitem>
          <listitem id="ch0150s0000li0126" role="bibliographyEntry">
            <para>126.<emphasis role="strong">Mancini N, Ossi CM, Perotti M, Carletti S, Gianni C, Paganoni G, Matuska S, Guglielminetti M, Cavallero A, Burioni R, Rama P, Clementi M.</emphasis> 2005. Direct sequencing of <citetitle><emphasis>Scedosporium apiospermum</emphasis></citetitle> DNA in the diagnosis of a case of keratitis. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> 54<emphasis role="strong">:</emphasis>897–900.</para>
          </listitem>
          <listitem id="ch0150s0000li0127" role="bibliographyEntry">
            <para>127.<emphasis role="strong">Willinger B, Obradovic A, Selitsch B, Beck-Mannagetta J, Buzina W, Braun H, Apfalter P, Hirschl AM, Makristathis A, Rotter M.</emphasis> 2003. Detection and identification of fungi from fungus balls of the maxillary sinus by molecular techniques. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 41<emphasis role="strong">:</emphasis>581–585.</para>
          </listitem>
          <listitem id="ch0150s0000li0128" role="bibliographyEntry">
            <para>128.<emphasis role="strong">Arastehfar A, Lim W, Daneshnia F, van de Sande WWJ, Fahal AH, Desnos-Ollivier M, de Hoog GS, Boekhout T, Ahmed SA.</emphasis> 2020. Madurella real-time PCR, a novel approach for eumycetoma diagnosis. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 14<emphasis role="strong">:</emphasis>e0007845.</para>
          </listitem>
          <listitem id="ch0150s0000li0129" role="bibliographyEntry">
            <para>129.<emphasis role="strong">Harun A, Blyth CC, Gilgado F, Middleton P, Chen SC, Meyer W.</emphasis> 2011. Development and validation of a multiplex PCR for detection of <citetitle><emphasis>Scedosporium</emphasis></citetitle> spp. in respiratory tract specimens from patients with cystic fibrosis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 49<emphasis role="strong">:</emphasis>1508–1512.</para>
          </listitem>
          <listitem id="ch0150s0000li0130" role="bibliographyEntry">
            <para>130.<emphasis role="strong">Chen M, Kondori N, Deng S, Gerrits van den Ende AHG, Lackner M, Liao W, de Hoog GS.</emphasis> 2018. Direct detection of <citetitle><emphasis>Exophiala</emphasis></citetitle> and <citetitle><emphasis>Scedosporium</emphasis></citetitle> species in sputa of patients with cystic fibrosis. <citetitle><emphasis>Med Mycol</emphasis></citetitle> 56<emphasis role="strong">:</emphasis>695–702.</para>
          </listitem>
          <listitem id="ch0150s0000li0131" role="bibliographyEntry">
            <para>131.<emphasis role="strong">Lu Q, Gerrits van den Ende AH, Bakkers JM, Sun J, Lackner M, Najafzadeh MJ, Melchers WJ, Li R, de Hoog GS.</emphasis> 2011. Identification of <citetitle><emphasis>Pseudallescheria</emphasis></citetitle> and <citetitle><emphasis>Scedosporium</emphasis></citetitle> species by three molecular methods. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 49<emphasis role="strong">:</emphasis>960–967.</para>
          </listitem>
          <listitem id="ch0150s0000li0132" role="bibliographyEntry">
            <anchor id="ch0150s0000a0095"/>
            <para>132.<emphasis role="strong">Bruker Daltonics GmbH.</emphasis> 2021. <citetitle><emphasis>MBT Filamentous Fungi Suite.</emphasis></citetitle> <ulink url="https://www.bruker.com/en/products-and-solutions/microbiology-and-diagnostics/microbial-identification/mbt-filamentous-fungi-library.html">https://www.bruker.com/en/products-and-solutions/microbiology-and-diagnostics/microbial-identification/mbt-filamentous-fungi-library.html</ulink>. Bruker Daltonics GmbH, Bremen, Germany. Accessed 19 July 2021.</para>
          </listitem>
          <listitem id="ch0150s0000li0133" role="bibliographyEntry">
            <para>133.<emphasis role="strong">Fraser M, Borman AM, Johnson EM.</emphasis> 2017. Rapid and robust identification of the agents of black-grain mycetoma by matrix-assisted laser desorption ionization–time of flight mass spectrometry. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 55<emphasis role="strong">:</emphasis>2521–2528.</para>
          </listitem>
          <listitem id="ch0150s0000li0134" role="bibliographyEntry">
            <para>134.<emphasis role="strong">Sleiman S, Halliday CL, Chapman B, Brown M, Nitschke J, Lau AF, Chen SC.</emphasis> 2016. Performance of matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of <citetitle><emphasis>Aspergillus</emphasis></citetitle>, <citetitle><emphasis>Scedosporium</emphasis></citetitle>, and <citetitle><emphasis>Fusarium</emphasis></citetitle> spp. in the Australian clinical setting. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 54<emphasis role="strong">:</emphasis>2182–2186.</para>
          </listitem>
          <listitem id="ch0150s0000li0135" role="bibliographyEntry">
            <para>135.<emphasis role="strong">Zvezdanova ME, Escribano P, Ruiz A, Martínez-Jiménez MC, Peláez T, Collazos A, Guinea J, Bouza E, Rodríguez-Sánchez B.</emphasis> 2019. Increased species-assignment of filamentous fungi using MALDI-TOF MS coupled with a simplified sample processing and an in-house library. <citetitle><emphasis>Med Mycol</emphasis></citetitle> 57<emphasis role="strong">:</emphasis>63–70.</para>
          </listitem>
          <listitem id="ch0150s0000li0136" role="bibliographyEntry">
            <para>136.<emphasis role="strong">Ahmed A, van de Sande W, Verbrugh H, Fahal A, van Belkum A.</emphasis> 2003. <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> strains from mycetoma lesions in Sudanese patients are clonal. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 41<emphasis role="strong">:</emphasis>4537–4541.</para>
          </listitem>
          <listitem id="ch0150s0000li0137" role="bibliographyEntry">
            <para>137.<emphasis role="strong">Lopes MM, Freitas G, Boiron P.</emphasis> 2000. Potential utility of random amplified polymorphic DNA (RAPD) and restriction endonuclease assay (REA) as typing systems for <citetitle><emphasis>Madurella mycetomatis. Curr Microbiol</emphasis></citetitle> 40<emphasis role="strong">:</emphasis>1–5.</para>
          </listitem>
          <listitem id="ch0150s0000li0138" role="bibliographyEntry">
            <para>138.<emphasis role="strong">van de Sande WW, Gorkink R, Simons G, Ott A, Ahmed AO, Verbrugh H, van Belkum A.</emphasis> 2005. Genotyping of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 43<emphasis role="strong">:</emphasis>4349–4356.</para>
          </listitem>
          <listitem id="ch0150s0000li0139" role="bibliographyEntry">
            <para>139.<emphasis role="strong">Nyuykonge B, Eadie K, Zandijk WHA, Ahmed SA, Desnos-Ollivier M, Fahal AH, de Hoog S, Verbon A, van de Sande WWJ, Klaassen CHW.</emphasis> 2021. A short-tandem-repeat assay (<citetitle><emphasis>Mmy</emphasis></citetitle>STR) for studying genetic variation in <citetitle><emphasis>Madurella mycetomatis. J Clin Microbiol</emphasis></citetitle> 59<emphasis role="strong">:</emphasis>e02331–20.</para>
          </listitem>
          <listitem id="ch0150s0000li0140" role="bibliographyEntry">
            <para>140.<emphasis role="strong">Bernhardt A, Sedlacek L, Wagner S, Schwarz C, Würstl B, Tintelnot K.</emphasis> 2013. Multilocus sequence typing of <citetitle><emphasis>Scedosporium apiospermum</emphasis></citetitle> and <citetitle><emphasis>Pseudallescheria boydii</emphasis></citetitle> isolates from cystic fibrosis patients. <citetitle><emphasis>J Cyst Fibros</emphasis></citetitle> 12<emphasis role="strong">:</emphasis>592–598.</para>
          </listitem>
          <listitem id="ch0150s0000li0141" role="bibliographyEntry">
            <para>141.<emphasis role="strong">Rainer J, de Hoog GS, Wedde M, Gräser Y, Gilges S.</emphasis> 2000. Molecular variability of <citetitle><emphasis>Pseudallescheria boydii</emphasis></citetitle>, a neurotropic opportunist. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 38<emphasis role="strong">:</emphasis>3267–3273.</para>
          </listitem>
          <listitem id="ch0150s0000li0142" role="bibliographyEntry">
            <para>142.<emphasis role="strong">Zouhair R, Defontaine A, Ollivier C, Cimon B, Symoens F, Hallet JN, Deunff J, Bouchara JP.</emphasis> 2001. Typing of <citetitle><emphasis>Scedosporium apiospermum</emphasis></citetitle> by multilocus enzyme electrophoresis and random amplification of polymorphic DNA. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> 50<emphasis role="strong">:</emphasis>925–932.</para>
          </listitem>
          <listitem id="ch0150s0000li0143" role="bibliographyEntry">
            <para>143.<emphasis role="strong">Defontaine A, Zouhair R, Cimon B, Carrère J, Bailly E, Symoens F, Diouri M, Hallet JN, Bouchara JP.</emphasis> 2002. Genotyping study of <citetitle><emphasis>Scedosporium apiospermum</emphasis></citetitle> isolates from patients with cystic fibrosis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 40<emphasis role="strong">:</emphasis>2108–2114.</para>
          </listitem>
          <listitem id="ch0150s0000li0144" role="bibliographyEntry">
            <para>144.<emphasis role="strong">Fahal AH, Finkelman MA, Zhang Y, van de Sande WW.</emphasis> 2016. Detection of (1→3)-β-d-glucan in eumycetoma patients. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 54<emphasis role="strong">:</emphasis>2614–2617.</para>
          </listitem>
          <listitem id="ch0150s0000li0145" role="bibliographyEntry">
            <para>145.<emphasis role="strong">ELbadawi HS</emphasis>, <emphasis role="strong">Mahgoub E</emphasis>, <emphasis role="strong">Mahmoud N</emphasis>, <emphasis role="strong">Fahal AH.</emphasis> 2016. Use of immunoblotting in testing <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> specific antigen. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 110<emphasis role="strong">:</emphasis>312–316.</para>
          </listitem>
          <listitem id="ch0150s0000li0146" role="bibliographyEntry">
            <para>146.<emphasis role="strong">Mahgoub ES.</emphasis> 1964. The value of gel diffusions in the diagnosis of mycetoma. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 58<emphasis role="strong">:</emphasis>560–563.</para>
          </listitem>
          <listitem id="ch0150s0000li0147" role="bibliographyEntry">
            <para>147.<emphasis role="strong">Murray IG, Mahgoub ES.</emphasis> 1968. Further studies on the diagnosis of mycetoma by double diffusion in agar. <citetitle><emphasis>Sabouraudia</emphasis></citetitle> 6<emphasis role="strong">:</emphasis>106–110.</para>
          </listitem>
          <listitem id="ch0150s0000li0148" role="bibliographyEntry">
            <para>148.<emphasis role="strong">Wethered DB, Markey MA, Hay RJ, Mahgoub ES, Gumaa SA.</emphasis> 1988. Humoral immune responses to mycetoma organisms: characterization of specific antibodies by the use of enzyme-linked immunosorbent assay and immunoblotting. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 82<emphasis role="strong">:</emphasis>918–923.</para>
          </listitem>
          <listitem id="ch0150s0000li0149" role="bibliographyEntry">
            <para>149.<emphasis role="strong">Gumaa SA, Mahgoub ES.</emphasis> 1975. Counterimmunoelectrophoresis in the diagnosis of mycetoma and its sensitivity as compared to immunodiffusion. <citetitle><emphasis>Sabouraudia</emphasis></citetitle> 13<emphasis role="strong">:</emphasis>309–315.</para>
          </listitem>
          <listitem id="ch0150s0000li0150" role="bibliographyEntry">
            <para>150.<emphasis role="strong">Zaini F, Moore MK, Hathi D, Hay RJ, Noble WC.</emphasis> 1991. The antigenic composition and protein profiles of eumycetoma agents. <citetitle><emphasis>Mycoses</emphasis></citetitle> 34<emphasis role="strong">:</emphasis>19–28.</para>
          </listitem>
          <listitem id="ch0150s0000li0151" role="bibliographyEntry">
            <para>151.<emphasis role="strong">Thornton CR.</emphasis> 2009. Tracking the emerging human pathogen <citetitle><emphasis>Pseudallescheria boydii</emphasis></citetitle> by using highly specific monoclonal antibodies. <citetitle><emphasis>Clin Vaccine Immunol</emphasis></citetitle> 16<emphasis role="strong">:</emphasis>756–764.</para>
          </listitem>
          <listitem id="ch0150s0000li0152" role="bibliographyEntry">
            <para>152.<emphasis role="strong">Mina S, Staerck C, Marot A, Godon C, Calenda A, Bouchara JP, Fleury MJJ.</emphasis> 2017. <citetitle><emphasis>Scedosporium boydii</emphasis></citetitle> CatA1 and SODC recombinant proteins, new tools for serodiagnosis of <citetitle><emphasis>Scedosporium</emphasis></citetitle> infection of patients with cystic fibrosis. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> 89<emphasis role="strong">:</emphasis>282–287.</para>
          </listitem>
          <listitem id="ch0150s0000li0153" role="bibliographyEntry">
            <para>153.<emphasis role="strong">Ahmed AO, van de Sande WWJ, van Vianen W, van Belkum A, Fahal AH, Verbrugh HA, Bakker-Woudenberg IA.</emphasis> 2004. <citetitle><emphasis>In vitro</emphasis></citetitle> susceptibilities of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-<citetitle><emphasis>bis</emphasis></citetitle>(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> 48<emphasis role="strong">:</emphasis>2742–2746.</para>
          </listitem>
          <listitem id="ch0150s0000li0154" role="bibliographyEntry">
            <para>154.<emphasis role="strong">Ahmed SA, Kloezen W, Duncanson F, Zijlstra EE, de Hoog GS, Fahal AH, van de Sande WW.</emphasis> 2014. <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> is highly susceptible to ravuconazole. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 8<emphasis role="strong">:</emphasis>e2942.</para>
          </listitem>
          <listitem id="ch0150s0000li0155" role="bibliographyEntry">
            <para>155.<emphasis role="strong">Kloezen W, Meis JF, Curfs-Breuker I, Fahal AH, van de Sande WWJ.</emphasis> 2012. In vitro antifungal activity of isavuconazole against <citetitle><emphasis>Madurella mycetomatis. Antimicrob Agents Chemother</emphasis></citetitle> 56<emphasis role="strong">:</emphasis>6054–6056.</para>
          </listitem>
          <listitem id="ch0150s0000li0156" role="bibliographyEntry">
            <para>156.<emphasis role="strong">Lim W, Eadie K, Konings M, Rijnders B, Fahal AH, Oliver JD, Birch M, Verbon A, van de Sande W.</emphasis> 2020. <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle>, the main causative agent of eumycetoma, is highly susceptible to olorofim. <citetitle><emphasis>J Antimicrob Chemother</emphasis></citetitle> 75<emphasis role="strong">:</emphasis>936–941.</para>
          </listitem>
          <listitem id="ch0150s0000li0157" role="bibliographyEntry">
            <para>157.<emphasis role="strong">van Belkum A, Fahal AH, van de Sande WW.</emphasis> 2011. In vitro susceptibility of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> to posaconazole and terbinafine. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> 55<emphasis role="strong">:</emphasis>1771–1773.</para>
          </listitem>
          <listitem id="ch0150s0000li0158" role="bibliographyEntry">
            <para>158.<emphasis role="strong">van de Sande WWJ, Fahal AH, Bakker-Woudenberg IAJM, van Belkum A.</emphasis> 2010. <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> is not susceptible to the echinocandin class of antifungal agents. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> 54<emphasis role="strong">:</emphasis>2738–2740.</para>
          </listitem>
          <listitem id="ch0150s0000li0159" role="bibliographyEntry">
            <para>159.<emphasis role="strong">van de Sande WWJ, Luijendijk A, Ahmed AO, Bakker-Woudenberg IA, van Belkum A.</emphasis> 2005. Testing of the in vitro susceptibilities of <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-<citetitle><emphasis>bis</emphasis></citetitle>(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> 49<emphasis role="strong">:</emphasis>1364–1368.</para>
          </listitem>
          <listitem id="ch0150s0000li0160" role="bibliographyEntry">
            <para>160.<emphasis role="strong">Ahmed SA, de Hoog GS, Stevens DA, Fahal AH, van de Sande WW.</emphasis> 2015. In vitro antifungal susceptibility of coelomycete agents of black grain eumycetoma to eight antifungals. <citetitle><emphasis>Med Mycol</emphasis></citetitle> 53<emphasis role="strong">:</emphasis>295–301.</para>
          </listitem>
          <listitem id="ch0150s0000li0161" role="bibliographyEntry">
            <para>161.<emphasis role="strong">Nyuykonge B, Croughs PD, Fahal AH, Verbon A, van de Sande WWJ.</emphasis> 2019. Pyomelanin secretion in <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> interferes with spectrophotometric endpoint reading using the Sensititre Yeastone Alamarblue assay but not with visual endpoint reading. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> 64<emphasis role="strong">:</emphasis>e01532–19.</para>
          </listitem>
          <listitem id="ch0150s0000li0162" role="bibliographyEntry">
            <para>162.<emphasis role="strong">Nyuykonge B, van Amelsvoort L, Eadie K, Fahal AH, Verbon A, van de Sande W.</emphasis> 2021. Comparison of disc diffusion, E-Test, and a modified CLSI broth microdilution method for in vitro susceptibility testing of itraconazole, posaconazole, and voriconazole against <citetitle><emphasis>Madurella mycetomatis. Antimicrob Agents Chemother</emphasis></citetitle> 65<emphasis role="strong">:</emphasis>e0043321.</para>
          </listitem>
          <listitem id="ch0150s0000li0163" role="bibliographyEntry">
            <para>163.<emphasis role="strong">Abd Algaffar SO, Verbon A, van de Sande WWJ, Khalid SA.</emphasis> 2021. Development and validation of an <citetitle><emphasis>in vitro</emphasis></citetitle> resazurin-based susceptibility assay against <citetitle><emphasis>Madurella mycetomatis. Antimicrob Agents Chemother</emphasis></citetitle> 65<emphasis role="strong">:</emphasis>e01338–20.</para>
          </listitem>
          <listitem id="ch0150s0000li0164" role="bibliographyEntry">
            <para>164.<emphasis role="strong">Lim W, Nyuykonge B, Eadie K, Konings M, Smeets J, Fahal A, Bonifaz A, Todd M, Perry B, Samby K, Burrows J, Verbon A, van de Sande W.</emphasis> 2022. Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 16<emphasis role="strong">:</emphasis>e0010159.</para>
          </listitem>
          <listitem id="ch0150s0000li0165" role="bibliographyEntry">
            <anchor id="ch0150s0000a0096"/>
            <para>165.<emphasis role="strong">Ahmed SA, Kloezen W, Fahal AH, de Hoog GS, van de Sande WW.</emphasis> 2015. In vitro interaction of currently used azoles with terbinafine against <citetitle><emphasis>Madurella mycetomatis. Antimicrob Agents Chemother</emphasis></citetitle> 59<emphasis role="strong">:</emphasis>1373–1374.</para>
          </listitem>
          <listitem id="ch0150s0000li0166" role="bibliographyEntry">
            <para>166.<emphasis role="strong">Lim W, Melse Y, Konings M, Phat Duong H, Eadie K, Laleu B, Perry B, Todd MH, Ioset JR, van de Sande WWJ.</emphasis> 2018. Addressing the most neglected diseases through an open research model: the discovery of fenarimols as novel drug candidates for eumycetoma. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 12<emphasis role="strong">:</emphasis>e0006437.</para>
          </listitem>
          <listitem id="ch0150s0000li0167" role="bibliographyEntry">
            <para>167.<emphasis role="strong">Eadie K, Parel F, Helvert-van Poppel M, Fahal A, van de Sande W.</emphasis> 2017. Combining two antifungal agents does not enhance survival of <citetitle><emphasis>Galleria mellonella</emphasis></citetitle> larvae infected with <citetitle><emphasis>Madurella mycetomatis. Trop Med Int Health</emphasis></citetitle> 22<emphasis role="strong">:</emphasis>696–702.</para>
          </listitem>
          <listitem id="ch0150s0000li0168" role="bibliographyEntry">
            <para>168.<emphasis role="strong">Kloezen W, Parel F, Brüggemann R, Asouit K, Helvert-van Poppel M, Fahal A, Mouton J, van de Sande W.</emphasis> 2018. Amphotericin B and terbinafine but not the azoles prolong survival in <citetitle><emphasis>Galleria mellonella</emphasis></citetitle> larvae infected with <citetitle><emphasis>Madurella mycetomatis. Med Mycol</emphasis></citetitle> 56<emphasis role="strong">:</emphasis>469–478.</para>
          </listitem>
          <listitem id="ch0150s0000li0169" role="bibliographyEntry">
            <para>169.<emphasis role="strong">Murray IG, Colichon H.</emphasis> 1962. Chemotherapy of maduromycosis. I. Preliminary experiments with diamidinodi-phenylamine dihydrochloride and amphotericin B in vivo and in vitro. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 56<emphasis role="strong">:</emphasis>156–165.</para>
          </listitem>
          <listitem id="ch0150s0000li0170" role="bibliographyEntry">
            <para>170.<emphasis role="strong">van de Sande WW, van Vianen W, ten Kate M, Fahal A, Bakker-Woudenberg I.</emphasis> 2015. Amphotericin B but not itraconazole is able to prevent grain formation in experimental <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> mycetoma in mice. <citetitle><emphasis>Br J Dermatol</emphasis></citetitle> 173<emphasis role="strong">:</emphasis>1561–1562.</para>
          </listitem>
          <listitem id="ch0150s0000li0171" role="bibliographyEntry">
            <para>171.<emphasis role="strong">Welsh O, Al-Abdely HM, Salinas-Carmona MC, Fahal AH.</emphasis> 2014. Mycetoma medical therapy. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 8<emphasis role="strong">:</emphasis>e3218.</para>
          </listitem>
          <listitem id="ch0150s0000li0172" role="bibliographyEntry">
            <para>172.<emphasis role="strong">DND<citetitle><emphasis>i</emphasis></citetitle>.</emphasis> 2022. Fosravuconazole. <ulink url="http://www.dndi.org/diseases-projects/portfolio/fosravuconazole/">http://www.dndi.org/diseases-projects/portfolio/fosravuconazole/</ulink>. Accessed 20 June 2020.</para>
          </listitem>
          <listitem id="ch0150s0000li0173" role="bibliographyEntry">
            <para>173.<emphasis role="strong">Mahgoub ES, Gumaa SA.</emphasis> 1984. Ketoconazole in the treatment of eumycetoma due to <citetitle><emphasis>Madurella mycetomii. Trans R Soc Trop Med Hyg</emphasis></citetitle> 78<emphasis role="strong">:</emphasis>376–379.</para>
          </listitem>
          <listitem id="ch0150s0000li0174" role="bibliographyEntry">
            <para>174.<emphasis role="strong">Zein HA, Fahal AH, Mahgoub el S, El Hassan TA, Abdel-Rahman ME.</emphasis> 2012. Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">106:</emphasis>639–644.</para>
          </listitem>
          <listitem id="ch0150s0000li0175" role="bibliographyEntry">
            <para>175.<emphasis role="strong">European Medicines Agency.</emphasis> 2013. European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole. <ulink url="https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-suspension-marketing-authorisations-oral-ketoconazole">https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-suspension-marketing-authorisations-oral-ketoconazole</ulink>. Accessed 20 June 2020.</para>
          </listitem>
          <listitem id="ch0150s0000li0176" role="bibliographyEntry">
            <para>176.<emphasis role="strong">U.S. Food and Drug Administration.</emphasis> 2016. FDA Drug Safety Communication: FDA warns that prescribing of Nizoral (ketoconazole) oral tablets for unapproved uses including skin and nail infections continues linked to patient death. <ulink url="https://www.fda.gov/drugs/drug-safety-and-availabilityt/fda-drug-safety-communication-fda-warns-prescribing-nizoral-ketoconazole-oral-tablets-unapproved">https://www.fda.gov/drugs/drug-safety-and-availabilityt/fda-drug-safety-communication-fda-warns-prescribing-nizoral-ketoconazole-oral-tablets-unapproved</ulink>. Accessed 20 June 2020.</para>
          </listitem>
          <listitem id="ch0150s0000li0177" role="bibliographyEntry">
            <para>177.<emphasis role="strong">Fahal AH, Rahman IA, El-Hassan AM, Rahman ME, Zijlstra EE.</emphasis> 2011. The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to <citetitle><emphasis>Madurella mycetomatis. Trans R Soc Trop Med Hyg</emphasis></citetitle> 105<emphasis role="strong">:</emphasis>127–132.</para>
          </listitem>
          <listitem id="ch0150s0000li0178" role="bibliographyEntry">
            <para>178.<emphasis role="strong">Sow D, Ndiaye M, Sarr L, Kanté MD, Ly F, Dioussé P, Faye BT, Gaye AM, Sokhna C, Ranque S, Faye B.</emphasis> 2020. Mycetoma epidemiology, diagnosis management, and outcome in three hospital centres in Senegal from 2008 to 2018. <citetitle><emphasis>PLoS One</emphasis></citetitle> 15<emphasis role="strong">:</emphasis>e0231871.</para>
          </listitem>
          <listitem id="ch0150s0000li0179" role="bibliographyEntry">
            <para>179.<emphasis role="strong">Negroni R, Tobón A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A.</emphasis> 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. <citetitle><emphasis>Rev Inst Med Trop São Paulo</emphasis></citetitle> 47<emphasis role="strong">:</emphasis>339–346.</para>
          </listitem>
          <listitem id="ch0150s0000li0180" role="bibliographyEntry">
            <para>180.<emphasis role="strong">N’diaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R.</emphasis> 2006. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. <citetitle><emphasis>Int J Dermatol</emphasis></citetitle> 45<emphasis role="strong">:</emphasis>154–157.</para>
          </listitem>
          <listitem id="ch0150s0000li0181" role="bibliographyEntry">
            <para>181.<emphasis role="strong">Desoubeaux G, Millon A, Freychet B, de Muret A, Garcia-Hermoso D, Bailly E, Rosset P, Chandenier J, Bernard L.</emphasis> 2013. Eumycetoma of the foot caused by <citetitle><emphasis>Exophiala jeanselmei</emphasis></citetitle> in a Guinean woman. <citetitle><emphasis>J Mycol Med</emphasis></citetitle> 23<emphasis role="strong">:</emphasis>168–175.</para>
          </listitem>
          <listitem id="ch0150s0000li0182" role="bibliographyEntry">
            <para>182.<emphasis role="strong">Bonifaz A, Saldaña M, Araiza J, Mercadillo P, Tirado-Sánchez A.</emphasis> 2017. Two simultaneous mycetomas caused by <citetitle><emphasis>Fusarium verticillioides</emphasis></citetitle> and <citetitle><emphasis>Madurella mycetomatis. Rev Inst Med Trop São Paulo</emphasis></citetitle> 59<emphasis role="strong">:</emphasis>e55.</para>
          </listitem>
          <listitem id="ch0150s0000li0183" role="bibliographyEntry">
            <para>183.<emphasis role="strong">Ahmed A, Desplaces N, de Hoog S, Verbrugh H, van Belkum A.</emphasis> 2003. Eumycetoma caused by <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> identified by PCR and sequencing: a report of two cases. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> 41<emphasis role="strong">:</emphasis>1813–1816.</para>
          </listitem>
          <listitem id="ch0150s0000li0184" role="bibliographyEntry">
            <para>184.<emphasis role="strong">Lacroix C, de Kerviler E, Morel P, Derouin F, Feuilhade de Chavin M.</emphasis> 2005. <citetitle><emphasis>Madurella mycetomatis</emphasis></citetitle> mycetoma treated successfully with oral voriconazole. <citetitle><emphasis>Br J Dermatol</emphasis></citetitle> 152<emphasis role="strong">:</emphasis>1067–1068.</para>
          </listitem>
          <listitem id="ch0150s0000li0185" role="bibliographyEntry">
            <para>185.<emphasis role="strong">Develoux M, Ndiaye B, Dieng MT.</emphasis> 1995. [Mycetomas in Africa]. <citetitle><emphasis>Sante</emphasis></citetitle> 5<emphasis role="strong">:</emphasis>211–217.</para>
          </listitem>
          <listitem id="ch0150s0000li0186" role="bibliographyEntry">
            <para>186.<emphasis role="strong">Beeckmans G, Ninane J, Vandepitte J.</emphasis> 1920. 1956. [First case of Madura foot caused by <citetitle><emphasis>Madurella grisea</emphasis></citetitle> in the Belgian Congo] Premier cas de pied de Madura par <citetitle><emphasis>Madurella grisea</emphasis></citetitle> au Congo Belge. <citetitle><emphasis>Ann Soc Belg Med Trop</emphasis></citetitle> 36<emphasis role="strong">:</emphasis>493–497.</para>
          </listitem>
          <listitem id="ch0150s0000li0187" role="bibliographyEntry">
            <para>187.<emphasis role="strong">Machado LA, Rivitti MC, Cucé LC, Salebian A, Lacaz CS, Heins-Vaccari EM, Belda Júnior W, de Melo NT.</emphasis> 1992. [Black-grain eumycetoma due to <citetitle><emphasis>Madurella grisea</emphasis></citetitle>. A report of 2 cases]. <citetitle><emphasis>Rev Inst Med Trop São Paulo</emphasis></citetitle> 34<emphasis role="strong">:</emphasis>569–580.</para>
          </listitem>
          <listitem id="ch0150s0000li0188" role="bibliographyEntry">
            <para>188.<emphasis role="strong">Mackinnon JE, Ferrada-Urzúa LV, Montemayor L.</emphasis> 1949. <citetitle><emphasis>Madurella grisea</emphasis></citetitle> n. sp. A new species of fungus producing the black variety of Maduromycosis in South America. <citetitle><emphasis>Mycopathologia</emphasis></citetitle> 4<emphasis role="strong">:</emphasis>384–392.</para>
          </listitem>
          <listitem id="ch0150s0000li0189" role="bibliographyEntry">
            <para>190.<emphasis role="strong">Vanbreuseghem R.</emphasis> 1920. 1956. [A culture of <citetitle><emphasis>Madurella grisea</emphasis></citetitle> Mackinnon 1949 isolated in the Belgian Congo] A propos d’une souche de <citetitle><emphasis>Madurella grisea</emphasis></citetitle> Mackinnon 1949 isolée au Congo Belge. <citetitle><emphasis>Ann Soc Belg Med Trop</emphasis></citetitle> 36<emphasis role="strong">:</emphasis>467–477.</para>
          </listitem>
          <listitem id="ch0150s0000li0190" role="bibliographyEntry">
            <para>191.<emphasis role="strong">Borman AM, Desnos-Ollivier M, Miles S-J, Linton CJ, Campbell CK, Bridge PD, Dannaoui E, Johnson EM.</emphasis> 2009. Molecular characterisation of the <citetitle><emphasis>Madurella grisea</emphasis></citetitle> complex reveals at least three new taxa associated with human mycetomas. Abstr MO-01-3. Abstr ISHAM 2009, Tokyo.</para>
          </listitem>
          <listitem id="ch0150s0000li0191" role="bibliographyEntry">
            <para>192.<emphasis role="strong">Courtois G, De Loof C, Thys A, Vanbreuseghem R.</emphasis> 1920. 1954. [Nine cases of maduromycosis in the Belgian Congo caused by <citetitle><emphasis>Allescheria boydii</emphasis></citetitle>, <citetitle><emphasis>Monosporium apiospermum</emphasis></citetitle> and Nocardia madurae] Neuf cas de pied de madura congolais par <citetitle><emphasis>allescheria boydii</emphasis></citetitle>, <citetitle><emphasis>monosporium apiospermum</emphasis></citetitle> et <citetitle><emphasis>nocardia maduroe. Ann Soc Belg Med Trop</emphasis></citetitle> 34<emphasis role="strong">:</emphasis>371–395.</para>
          </listitem>
          <listitem id="ch0150s0000li0192" role="bibliographyEntry">
            <para>193.<emphasis role="strong">Horré R, Schumacher G, Marklein G, Stratmann H, Wardelmann E, Gilges S, De Hoog GS, Schaal KP.</emphasis> 2002. Mycetoma due to Pseud<citetitle><emphasis>allescheria boydii</emphasis></citetitle> and co-isolation of <citetitle><emphasis>Nocardia abscessus</emphasis></citetitle> in a patient injured in road accident. <citetitle><emphasis>Med Mycol</emphasis></citetitle> 40<emphasis role="strong">:</emphasis>525–527.</para>
          </listitem>
          <listitem id="ch0150s0000li0193" role="bibliographyEntry">
            <para>194.<emphasis role="strong">Mohr JA, Muchmore HG.</emphasis> 1968. Maduromycosis due to <citetitle><emphasis>Allescheria boydii. JAMA</emphasis></citetitle> 204<emphasis role="strong">:</emphasis>335–336.</para>
          </listitem>
          <listitem id="ch0150s0000li0194" role="bibliographyEntry">
            <para>195.<emphasis role="strong">Béraud G, Desbois N, Coyo C, Quist D, Rozé B, Savorit L, Cabié A.</emphasis> 2015. Paradoxical response preceding control of <citetitle><emphasis>Scedosporium</emphasis></citetitle> apiospermum mycetoma with posaconazole treatment. <citetitle><emphasis>Infect Dis (Lond)</emphasis></citetitle> 47<emphasis role="strong">:</emphasis>830–833.</para>
          </listitem>
          <listitem id="ch0150s0000li0195" role="bibliographyEntry">
            <para>196.<emphasis role="strong">Porte L, Khatibi S, Hajj LE, Cassaing S, Berry A, Massip P, Linas MD, Magnaval JF, Sans N, Marchou B.</emphasis> 2006. <citetitle><emphasis>Scedosporium apiospermum</emphasis></citetitle> mycetoma with bone involvement successfully treated with voriconazole. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 100<emphasis role="strong">:</emphasis>891–894.</para>
          </listitem>
          <listitem id="ch0150s0000li0196" role="bibliographyEntry">
            <para>197.<emphasis role="strong">Cerar D, Malallah YM, Howard SJ, Bowyer P, Denning DW.</emphasis> 2009. Isolation, identification and susceptibility of <citetitle><emphasis>Pyrenochaeta romeroi</emphasis></citetitle> in a case of eumycetoma of the foot in the UK. <citetitle><emphasis>Int J Antimicrob Agents</emphasis></citetitle> 34<emphasis role="strong">:</emphasis>617–618.</para>
          </listitem>
          <listitem id="ch0150s0000li0197" role="bibliographyEntry">
            <para>198.<emphasis role="strong">Mhmoud NA, Santona A, Fiamma M, Siddig EE, Deligios M, Bakhiet SM, Rubino S, Fahal AH.</emphasis> 2019. <citetitle><emphasis>Chaetomium atrobrunneum</emphasis></citetitle> causing human eumycetoma: the first report. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> 13<emphasis role="strong">:</emphasis>e0007276.</para>
          </listitem>
          <listitem id="ch0150s0000li0198" role="bibliographyEntry">
            <para>199.<emphasis role="strong">Kaur M, Singla N, Bhalla M, Kundu R, Gulati N, Chander J.</emphasis> 2021. <citetitle><emphasis>Aspergillus candidus</emphasis></citetitle> eumycetoma with review of literature. <citetitle><emphasis>J Mycol Med</emphasis></citetitle> 31<emphasis role="strong">:</emphasis>101135.</para>
          </listitem>
          <listitem id="ch0150s0000li0199" role="bibliographyEntry">
            <anchor id="ch0150s0000a0097"/>
            <para>200.<emphasis role="strong">Ahmed SA, Abbas MA, Jouvion G, Al-Hatmi AM, de Hoog GS, Kolecka A, Mahgoub S.</emphasis> 2015. Seventeen years of subcutaneous infection by <citetitle><emphasis>Aspergillus flavus</emphasis></citetitle>; eumycetoma confirmed by immunohistochemistry. <citetitle><emphasis>Mycoses</emphasis></citetitle> 58<emphasis role="strong">:</emphasis>728–734.</para>
          </listitem>
          <listitem id="ch0150s0000li0200" role="bibliographyEntry">
            <para>201.<emphasis role="strong">Mahgoub ES.</emphasis> 1973. Can <citetitle><emphasis>Aspergillus flavus</emphasis></citetitle> cause maduromycetoma? <citetitle><emphasis>Bull Soc Pathol Exot</emphasis></citetitle> 66<emphasis role="strong">:</emphasis>390–395.</para>
          </listitem>
          <listitem id="ch0150s0000li0201" role="bibliographyEntry">
            <para>202.<emphasis role="strong">Witzig RS, Greer DL, Hyslop NE Jr.</emphasis> 1996. <citetitle><emphasis>Aspergillus flavus</emphasis></citetitle> mycetoma and epidural abscess successfully treated with itraconazole. <citetitle><emphasis>J Med Vet Mycol</emphasis></citetitle> 34<emphasis role="strong">:</emphasis>133–137.</para>
          </listitem>
          <listitem id="ch0150s0000li0202" role="bibliographyEntry">
            <para>203.<emphasis role="strong">Vera-Cabrera L, Cardenas-de la Garza JA, Cuellar-Barboza A, Gallardo-Rocha A, Molina-Torres CA, Escalante-Fuentes W, Ocampo-Candiani J.</emphasis> 2021. Case report: coral reef pathogen <citetitle><emphasis>Aspergillus sydowii</emphasis></citetitle> causing black grain mycetoma. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> 104<emphasis role="strong">:</emphasis>871–873.</para>
          </listitem>
          <listitem id="ch0150s0000li0203" role="bibliographyEntry">
            <para>204.<emphasis role="strong">Bonifaz A, De Hoog S, McGinnis MR, Saúl A, Rodríguez-Cortés O, Araiza J, Cruz M, Mercadillo P.</emphasis> 2009. Eumycetoma caused by <citetitle><emphasis>Cladophialophora bantiana</emphasis></citetitle> successfully treated with itraconazole. <citetitle><emphasis>Med Mycol</emphasis></citetitle> 47<emphasis role="strong">:</emphasis>111–114.</para>
          </listitem>
          <listitem id="ch0150s0000li0204" role="bibliographyEntry">
            <para>205.<emphasis role="strong">Badali H, Gueidan C, Najafzadeh MJ, Bonifaz A, van den Ende AH, de Hoog GS.</emphasis> 2008. Biodiversity of the genus <citetitle><emphasis>Cladophialophora. Stud Mycol</emphasis></citetitle> 61<emphasis role="strong">:</emphasis>175–191.</para>
          </listitem>
          <listitem id="ch0150s0000li0205" role="bibliographyEntry">
            <para>206.<emphasis role="strong">Mahgoub E.</emphasis> 1969. <citetitle><emphasis>Corynespora cassiicola</emphasis></citetitle>, a new agent of maduromycetoma. <citetitle><emphasis>J Trop Med Hyg</emphasis></citetitle> 72<emphasis role="strong">:</emphasis>218–221.</para>
          </listitem>
          <listitem id="ch0150s0000li0206" role="bibliographyEntry">
            <para>207.<emphasis role="strong">Bridges CH.</emphasis> 1957. Maduromycotic mycetomas in animals; <citetitle><emphasis>Curvularia geniculata</emphasis></citetitle> as an etiologic agent. <citetitle><emphasis>Am J Pathol</emphasis></citetitle> 33<emphasis role="strong">:</emphasis>411–427.</para>
          </listitem>
          <listitem id="ch0150s0000li0207" role="bibliographyEntry">
            <para>208.<emphasis role="strong">Shinde RS, Hanumantha S, Mantur BG, Parande MV.</emphasis> 2015. A rare case of mycetoma due to curvularia. <citetitle><emphasis>J Lab Physicians</emphasis></citetitle> 7<emphasis role="strong">:</emphasis>55–57.</para>
          </listitem>
          <listitem id="ch0150s0000li0208" role="bibliographyEntry">
            <para>209.<emphasis role="strong">Elad D, Orgad U, Yakobson B, Perl S, Golomb P, Trainin R, Tsur I, Shenkler S, Bor A.</emphasis> 1991. Eumycetoma caused by <citetitle><emphasis>Curvularia lunata</emphasis></citetitle> in a dog. <citetitle><emphasis>Mycopathologia</emphasis></citetitle> 116<emphasis role="strong">:</emphasis>113–118.</para>
          </listitem>
          <listitem id="ch0150s0000li0209" role="bibliographyEntry">
            <para>210.<emphasis role="strong">Garg A, Sujatha S, Garg J, Parija SC, Thappa DM.</emphasis> 2008. Eumycetoma due to <citetitle><emphasis>Curvularia lunata. Indian J Dermatol Venereol Leprol</emphasis></citetitle> 74<emphasis role="strong">:</emphasis>515–516.</para>
          </listitem>
          <listitem id="ch0150s0000li0210" role="bibliographyEntry">
            <para>211.<emphasis role="strong">Gunathilake R, Perera P, Sirimanna G.</emphasis> 2014. <citetitle><emphasis>Curvularia lunata</emphasis></citetitle>: a rare cause of black-grain eumycetoma. <citetitle><emphasis>J Mycol Med</emphasis></citetitle> 24<emphasis role="strong">:</emphasis>158–160.</para>
          </listitem>
          <listitem id="ch0150s0000li0211" role="bibliographyEntry">
            <para>212.<emphasis role="strong">Iriart X, Binois R, Fior A, Blanchet D, Berry A, Cassaing S, Amazan E, Papot E, Carme B, Aznar C, Couppié P.</emphasis> 2011. Eumycetoma caused by <citetitle><emphasis>Diaporthe phaseolorum</emphasis></citetitle> (<citetitle><emphasis>Phomopsis phaseoli</emphasis></citetitle>): a case report and a mini-review of <citetitle><emphasis>Diaporthe/Phomopsis</emphasis></citetitle> spp invasive infections in humans. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> 17<emphasis role="strong">:</emphasis>1492–1494.</para>
          </listitem>
          <listitem id="ch0150s0000li0212" role="bibliographyEntry">
            <para>213.<emphasis role="strong">Pattanaprichakul P, Bunyaratavej S, Leeyaphan C, Sitthinamsuwan P, Sudhadham M, Muanprasart C, Feng P, Badali H, de Hoog GS.</emphasis> 2013. An unusual case of eumycetoma caused by <citetitle><emphasis>Exophiala jeanselmei</emphasis></citetitle> after a sea urchin injury. <citetitle><emphasis>Mycoses</emphasis></citetitle> 56<emphasis role="strong">:</emphasis>491–494.</para>
          </listitem>
          <listitem id="ch0150s0000li0213" role="bibliographyEntry">
            <para>214.<emphasis role="strong">Neumeister B, Zollner TM, Krieger D, Sterry W, Marre R.</emphasis> 1995. Mycetoma due to <citetitle><emphasis>Exophiala jeanselmei</emphasis></citetitle> and <citetitle><emphasis>Mycobacterium chelonae</emphasis></citetitle> in a 73-year-old man with idiopathic CD4+ T lymphocytopenia. <citetitle><emphasis>Mycoses</emphasis></citetitle> 38<emphasis role="strong">:</emphasis>271–276.</para>
          </listitem>
          <listitem id="ch0150s0000li0214" role="bibliographyEntry">
            <para>215.<emphasis role="strong">Venugopal PV, Venugopal TV.</emphasis> 1990. <citetitle><emphasis>Leptosphaeria tompkinsii</emphasis></citetitle> mycetoma. <citetitle><emphasis>Int J Dermatol</emphasis></citetitle> 29<emphasis role="strong">:</emphasis>432–433.</para>
          </listitem>
          <listitem id="ch0150s0000li0215" role="bibliographyEntry">
            <para>216.<emphasis role="strong">Lee MW, Kim JC, Choi JS, Kim KH, Greer DL.</emphasis> 1995. Mycetoma caused by <citetitle><emphasis>Acremonium falciforme</emphasis></citetitle>: successful treatment with itraconazole. <citetitle><emphasis>J Am Acad Dermatol</emphasis></citetitle> 32<emphasis role="strong">:</emphasis>897–900.</para>
          </listitem>
          <listitem id="ch0150s0000li0216" role="bibliographyEntry">
            <para>217.<emphasis role="strong">Halde C, Padhye AA, Haley LD, Rinaldi MG, Kay D, Leeper R.</emphasis> 1976. <citetitle><emphasis>Acremonium falciforme</emphasis></citetitle> as a cause of mycetoma in California. <citetitle><emphasis>Sabouraudia</emphasis></citetitle> 14<emphasis role="strong">:</emphasis>319–326.</para>
          </listitem>
          <listitem id="ch0150s0000li0217" role="bibliographyEntry">
            <para>218.<emphasis role="strong">Milburn PB, Papayanopulos DM, Pomerantz BM.</emphasis> 1988. Mycetoma due to <citetitle><emphasis>Acremonium falciforme. Int J Dermatol</emphasis></citetitle> 27<emphasis role="strong">:</emphasis>408–410.</para>
          </listitem>
          <listitem id="ch0150s0000li0218" role="bibliographyEntry">
            <para>219.<emphasis role="strong">Negroni R, López Daneri G, Arechavala A, Bianchi MH, Robles AM.</emphasis> 2006. [Clinical and microbiological study of mycetomas at the Muñiz hospital of Buenos Aires between 1989 and 2004]. <citetitle><emphasis>Rev Argent Microbiol</emphasis></citetitle> 38<emphasis role="strong">:</emphasis>13–18.</para>
          </listitem>
          <listitem id="ch0150s0000li0219" role="bibliographyEntry">
            <para>220.<emphasis role="strong">Ajello L, Padhye AA, Chandler FW, McGinnis MR, Morganti L, Alberici F.</emphasis> 1985. <citetitle><emphasis>Fusarium moniliforme</emphasis></citetitle>, a new mycetoma agent. Restudy of a European case. <citetitle><emphasis>Eur J Epidemiol</emphasis></citetitle> 1<emphasis role="strong">:</emphasis>5–10.</para>
          </listitem>
          <listitem id="ch0150s0000li0220" role="bibliographyEntry">
            <para>221.<emphasis role="strong">Katkar VJ, Tankhiwale SS, Kurhade A.</emphasis> 2011. <citetitle><emphasis>Fusarium soloni</emphasis></citetitle> mycetoma. <citetitle><emphasis>Indian J Dermatol</emphasis></citetitle> 56<emphasis role="strong">:</emphasis>315–317.</para>
          </listitem>
          <listitem id="ch0150s0000li0221" role="bibliographyEntry">
            <para>222.<emphasis role="strong">Malisiewicz B, Uhrlaß S, Nenoff P, Schöfer H.</emphasis> 2019. [Eumycetoma due to <citetitle><emphasis>Fusarium chlamydosporum</emphasis></citetitle>: case report und review of the literature]. <citetitle><emphasis>Hautarzt</emphasis></citetitle> 70<emphasis role="strong">:</emphasis>612–617.</para>
          </listitem>
          <listitem id="ch0150s0000li0222" role="bibliographyEntry">
            <para>223.<emphasis role="strong">Zoutman DE, Sigler L.</emphasis> 1991. Mycetoma of the foot caused by <citetitle><emphasis>Cylindrocarpon destructans. J Clin Microbiol</emphasis></citetitle> 29<emphasis role="strong">:</emphasis>1855–1859.</para>
          </listitem>
          <listitem id="ch0150s0000li0223" role="bibliographyEntry">
            <para>224.<emphasis role="strong">Borjian Boroujeni Z, Hashemi SJ, Daie Ghazvini R, Khodavaisy S, Zareei M, Hosseinpour L, Ardi P, Shokri M.</emphasis> 2019. Recurrent eumycetoma caused by novel species <citetitle><emphasis>Madurella pseudomycetomatis</emphasis></citetitle>: a case report. <citetitle><emphasis>Med Mycol Case Rep</emphasis></citetitle> 26<emphasis role="strong">:</emphasis>13–15.</para>
          </listitem>
          <listitem id="ch0150s0000li0224" role="bibliographyEntry">
            <para>225.<emphasis role="strong">Mhmoud NA, Siddig EE, Nyuykonge B, Bakhiet SM, van de Sande WWJ, Fahal AH.</emphasis> 2021. Mycetoma caused by <citetitle><emphasis>Microascus gracilis</emphasis></citetitle>: a novel agent of human eumycetoma in Sudan. <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> 115<emphasis role="strong">:</emphasis>426–430.</para>
          </listitem>
          <listitem id="ch0150s0000li0225" role="bibliographyEntry">
            <para>226.<emphasis role="strong">Chiapello LS, Dib MD, Nuncira CT, Nardelli L, Vullo C, Collino C, Abiega C, Cortes PR, Spesso MF, Masih DT.</emphasis> 2011. Mycetoma of the scalp due to <citetitle><emphasis>Microsporum canis</emphasis></citetitle>: hystopathologic, mycologic, and immunogenetic features in a 6-year-old girl. <citetitle><emphasis>Diagn Microbiol Infect Dis</emphasis></citetitle> 70<emphasis role="strong">:</emphasis>145–149.</para>
          </listitem>
          <listitem id="ch0150s0000li0226" role="bibliographyEntry">
            <para>227.<emphasis role="strong">Kramer SC, Ryan M, Bourbeau P, Tyler WB, Elston DM.</emphasis> 2006. Fontana-positive grains in mycetoma caused by <citetitle><emphasis>Microsporum canis. Pediatr Dermatol</emphasis></citetitle> 23<emphasis role="strong">:</emphasis>473–475.</para>
          </listitem>
          <listitem id="ch0150s0000li0227" role="bibliographyEntry">
            <para>228.<emphasis role="strong">Yager JA, Wilcock BP, Lynch JA, Thompson AR.</emphasis> 1986. Mycetoma-like granuloma in a cat caused by <citetitle><emphasis>Microsporum canis. J Comp Pathol</emphasis></citetitle> 96<emphasis role="strong">:</emphasis>171–176.</para>
          </listitem>
          <listitem id="ch0150s0000li0228" role="bibliographyEntry">
            <para>229.<emphasis role="strong">Diongue K, Boye A, Bréchard L, Diallo MA, Dione H, Ndoye NW, Diallo M, Ranque S, Ndiaye D.</emphasis> 2019. Dermatophytic mycetoma of the scalp due to an atypical strain of <citetitle><emphasis>Microsporum audouinii</emphasis></citetitle> identified by MALDI-TOF MS and ITS sequencing. <citetitle><emphasis>J Mycol Med</emphasis></citetitle> 29<emphasis role="strong">:</emphasis>185–188.</para>
          </listitem>
          <listitem id="ch0150s0000li0229" role="bibliographyEntry">
            <para>230.<emphasis role="strong">de Vries GA, de Hoog GS, de Bruyn HP.</emphasis> 1984. <citetitle><emphasis>Phialophora cyanescens</emphasis></citetitle> sp. nov. with <citetitle><emphasis>Phaeosclera</emphasis></citetitle>-like synanamorph, causing white-grain mycetoma in man. <citetitle><emphasis>Antonie van Leeuwenhoek</emphasis></citetitle> 50<emphasis role="strong">:</emphasis>149–153.</para>
          </listitem>
          <listitem id="ch0150s0000li0230" role="bibliographyEntry">
            <para>231.<emphasis role="strong">Aamir S, Aman S, Haroon T.</emphasis> 2003. Mycetoma caused by <citetitle><emphasis>Scytalidium dimidiatum. Br J Dermatol</emphasis></citetitle> 148<emphasis role="strong">:</emphasis>174–176.</para>
          </listitem>
          <listitem id="ch0150s0000li0231" role="bibliographyEntry">
            <para>232.<emphasis role="strong">Criado PR, Belda Junior W, da Matta VLR.</emphasis> 2021. First report of cutaneous mycetoma by <citetitle><emphasis>Paecilomyces variotii</emphasis></citetitle> and the successful treatment with combined itraconazole and terbinafine along with resection surgeries. <citetitle><emphasis>Australas J Dermatol</emphasis></citetitle> 62<emphasis role="strong">:</emphasis>e397–e399.</para>
          </listitem>
          <listitem id="ch0150s0000li0232" role="bibliographyEntry">
            <para>233.<emphasis role="strong">Aguilar-Donis A, Torres-Guerrero E, Arenas-Guzmán R, Hernández-Hernández F, López-García L, Criales-Vera S, Teliz-Meneses MA.</emphasis> 2011. Mycetoma caused by <citetitle><emphasis>Phaeoacremonium parasiticum</emphasis></citetitle>—a case confirmed with B-tubulin sequence analysis. <citetitle><emphasis>Mycoses</emphasis></citetitle> 54<emphasis role="strong">:</emphasis>e615–e618.</para>
          </listitem>
          <listitem id="ch0150s0000li0233" role="bibliographyEntry">
            <para>234.<emphasis role="strong">Chander J, Singla N, Kundu R, Handa U, Chowdhary A.</emphasis> 2017. Phaeohyphomycosis caused by <citetitle><emphasis>Rhytidhysteron rufulum</emphasis></citetitle> and review of literature. <citetitle><emphasis>Mycopathologia</emphasis></citetitle> 182<emphasis role="strong">:</emphasis>403–407.</para>
          </listitem>
          <listitem id="ch0150s0000li0234" role="bibliographyEntry">
            <para>235.<emphasis role="strong">Koshi G, Padhye AA, Ajello L, Chandler FW.</emphasis> 1979. <citetitle><emphasis>Acremonium recifei</emphasis></citetitle> as an agent of mycetoma in India. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> 28<emphasis role="strong">:</emphasis>692–696.</para>
          </listitem>
          <listitem id="ch0150s0000li0235" role="bibliographyEntry">
            <para>236.<emphasis role="strong">Ahmed SA, De Hoog GS, Van de Sande WWJ.</emphasis> 2019. Fungi causing eumycotic mycetoma, p 2261–2277. <citetitle><emphasis>In</emphasis></citetitle> Carroll KC, Pfaller MA, Landry ML, McAdam AJ, Patel R, Richter SS, Warnock DW (ed), <citetitle><emphasis>Manual of Clinical Microbiology</emphasis></citetitle>, 12th ed. ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0150s0000li0236" role="bibliographyEntry">
            <para>237.<emphasis role="strong">Venugopal PV, Venugopal TV, Ramakrishna ES, Ilavarasi S.</emphasis> 1993. Antimycotic susceptibility testing of agents of black grain eumycetoma. <citetitle><emphasis>J Med Vet Mycol</emphasis></citetitle> 31<emphasis role="strong">:</emphasis>161–164.</para>
          </listitem>
          <listitem id="ch0150s0000li0237" role="bibliographyEntry">
            <para>238.<emphasis role="strong">Walsh TJ, Peter J, McGough DA, Fothergill AW, Rinaldi MG, Pizzo PA.</emphasis> 1995. Activities of amphotericin B and antifungal azoles alone and in combination against <citetitle><emphasis>Pseudallescheria boydii. Antimicrob Agents Chemother</emphasis></citetitle> 39<emphasis role="strong">:</emphasis>1361–1364.</para>
          </listitem>
          <listitem id="ch0150s0000li0238" role="bibliographyEntry">
            <para>239.<emphasis role="strong">González GM, Tijerina R, Najvar LK, Bocanegra R, Rinaldi MG, Loebenberg D, Graybill JR.</emphasis> 2003. Activity of posaconazole against <citetitle><emphasis>Pseudallescheria boydii</emphasis></citetitle>: in vitro and in vivo assays. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> 47<emphasis role="strong">:</emphasis>1436–1438.</para>
          </listitem>
          <listitem id="ch0150s0000li0239" role="bibliographyEntry">
            <para>240.<emphasis role="strong">Venugopal PV, Venugopal TV.</emphasis> 1993. Treatment of eumycetoma with ketoconazole. <citetitle><emphasis>Australas J Dermatol</emphasis></citetitle> 34<emphasis role="strong">:</emphasis>27–29.</para>
          </listitem>
          <listitem id="ch0150s0000li0240" role="bibliographyEntry">
            <anchor id="ch0150s0000a0098"/>
            <para>241.<emphasis role="strong">Gülmez D, Do</emphasis>ğ<emphasis role="strong">an Ö, Boral B, Dö</emphasis>ğ<emphasis role="strong">en A,</emphasis> İ<emphasis role="strong">lkit M, de Hoog GS, Arikan-Akdagli S.</emphasis> 2018. In vitro activities of antifungal drugs against environmental <citetitle><emphasis>Exophiala</emphasis></citetitle> isolates and review of the literature. <citetitle><emphasis>Mycoses</emphasis></citetitle> 61<emphasis role="strong">:</emphasis>561–569.</para>
          </listitem>
          <listitem id="ch0150s0000li0241" role="bibliographyEntry">
            <para>242.<emphasis role="strong">Fothergill AW, Rinaldi MG, Sutton DA.</emphasis> 2009. Antifungal susceptibility testing of <citetitle><emphasis>Exophiala</emphasis></citetitle> spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole. <citetitle><emphasis>Med Mycol</emphasis></citetitle> 47<emphasis role="strong">:</emphasis>41–43.</para>
          </listitem>
          <listitem id="ch0150s0000li0242" role="bibliographyEntry">
            <para>243.<emphasis role="strong">Andes D, Pascual A, Marchetti O.</emphasis> 2009. Antifungal therapeutic drug monitoring: established and emerging indications. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> 53<emphasis role="strong">:</emphasis>24–34.</para>
          </listitem>
          <listitem id="ch0150s0000li0243" role="bibliographyEntry">
            <para>244.<emphasis role="strong">Dolton MJ, Perera V, Pont LG, McLachlan AJ.</emphasis> 2014. Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic model. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> 58<emphasis role="strong">:</emphasis>48–54.</para>
          </listitem>
        </itemizedlist>
      </sect2>
    </sect1>
  </chapter>
